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I/ Introduction 
 
I-1. Synthesis of membrane proteins: The secretory pathway 
 
1.1  Membrane protein synthesis, folding and assembly 
 
  All proteins are synthesized in the cytosol by the ribosomes, but some 
selected proteins are captured by the endoplasmic reticulum (ER) as they 
are being synthesized. These proteins are of two types: membrane 
proteins, which are only partly translocated across the ER membrane and 
become embedded in it, and water-soluble proteins, which are fully 
translocated across the ER membrane and are released into the ER lumen. 
All of these proteins, regardless of their subsequent fate, are directed to 
the ER by the same kind of signal sequence and are translocated across it 
by similar mechanisms (Alberts et al., 1994). 
  Once their synthesis is complete, newly introduced polypeptides in the 
membrane and lumen of the ER must be folded, sorted, and transported. 
Secretory and membrane proteins undergo five principal modifications 
during their transit to the cell surface: (1) formation of disulfide bonds; 
(2) proper folding of the polypeptide; (3) addition and modification of 
carbohydrates; (4) specific proteolytic cleavages, and (5) formation of 
multichain proteins (assembly). Each modification takes place in a specific 
organelle through which these proteins pass. The first two and the fifth of 
these reactions take place exclusively in the ER, and addition of some 
carbohydrates and some proteolytic cleavages also occur in this organelle. 
The modifications that occur in the ER are essential for the protein to 
reach its proper cellular location. Only properly folded and assembled 
proteins are transported from the ER to the Golgi complex and to the cell 
surface. Unfolded, misfolded, or partly folded and assembled proteins are 
selectively retained in the ER, or are retrieved to the ER from the cis-Golgi 
reticulum. Misfolded proteins and unassembled subunits of multiple-
polypeptide complexes are either degraded within the ER or translocated I/ Introduction 
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back into the cytosol, where they are deglycosylated, ubiquitylated, and 
degraded in proteasomes. 
  Many important secretory and membrane proteins form oligomers, they 
are built of two or more polypeptides. Several prerequisite must be met in 
order for subunits to oligomerize. The associating subunits must co-exist 
spatially and temporally, recognize each other, and provide sufficient 
stabilization energy to form a stable structure (Deutsch, 2002). The 
formation of oligomeric proteins occurs in the ER membrane. Fig. 1 
illustrates the series of events contributing to the biogenesis of oligomeric 
membrane proteins and the temporal organization of these events. 
 
 
Fig. 1: Channel biogenesis in the endoplasmic reticulum (Deutsch, 2002). 
 
 
1.2  N-linked glycosylation 
 
  N-linked glycans in glycoproteins are attached to the amide nitrogens of 
asparagine side chains. Glycosylated asparagine residue are almost 
invariably found in the sequences Asn-X-Ser or Asn-X-Thr, where X can be 
any amino acid except proline. The different categories of N-linked I/ Introduction 
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glycans, such as high mannose and complex types, contain a common 
core-structure but differ in the terminal elaboration that extend from this 
core. 
  It is convenient to divide the biochemical pathway for N-linked glycan 
synthesis into three stages (Fig. 2A): (1) formation of a lipid-linked 
precursor oligosaccharide; (2) en bloc transfer of the oligosaccharide to 
the polypeptide; and (3) processing of the oligosaccharide. Processing 
steps include removal of some of the original sugar residues (trimming) 
followed by addition of new sugars at the non-reducing termini of the 
glycan (Fig. 2B). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2: (A) Overview of the pathway for glycoproteins biosynthesis and its 
location within a cell. (B) Processing of an initial high mannose N-linked glycan 
to generate complex glycans (Taylor and Drickamer, 2003). 
 
 
I-2. P2X receptors 
 
    P2X receptors are ligand-gated membrane ion channels that when 
activated by extracellular ATP mediate fast excitation in various cells, 
including central and peripheral neurons. P2X receptors belong to the 
superfamily of purine receptors, which is divided in two sub-families: the 
adenosine receptors called P1 receptors and the P2 receptors, recognizing 
Core-
glycosylated 
protein 
(ER) 
Complex-
glycosylated 
protein 
(Golgi) 
A B I/ Introduction 
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primarily ATP, ADP, UTP and UDP (Ralevic and Burnstock, 1998). P2 
receptors divide into two families, the P2X ligand-gated ion channels and 
the P2Y G protein-coupled receptors. 
 
2.1  Structure of cloned P2X receptors 
 
  The first cDNAs encoding P2X receptor subunits were isolated in 1994, 
their expression in heterologous cells substantiated the view that P2X 
receptors were ion channels gated by ATP. 
    There are seven genes for P2X receptor subunits. The P2X subunits 
proteins are 384 (cP2X4) to 595 (rP2X7) amino acids long (for recent 
review, see (North, 2002)). 
 
 
Fig. 3: Membrane topology of P2X2 receptors showing glycosylation, 
phosphorylation and possible disulfide bonding (North, 2002). Solid circles (N): 
indicate glycosylated sites in the native P2X2 receptor. Open circles (T, S): indicate 
positions phosphorylated by protein kinases (PKC, PKA). Open circles (C): indicate the 10 
conserved cysteines. Open squares (H): indicate histidine residues involved in zinc (His-
120, His-213) and proton binding (His-319). 
 
  Structural features of P2X receptors have been predicted from the amino 
acid sequences of cloned P2X receptor subunits (Brake et al., 1994). Each 
has two hydrophobic regions of sufficient length to cross the plasma 
membrane; the first of these extends from residue 30 to 50, and the I/ Introduction 
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second from residue 330 to 353 (numbers refer to the rat P2X2 receptor, 
see Fig. 3). These hydrophobic regions are separated by a large 
extracellular loop (Newbolt et al., 1998). The NH2 and COOH termini are 
presumed to be cytoplasmic (Torres et al., 1998b). The COOH-terminal 
regions diverge in sequence considerably (Fig. 4). 
 
|P2X1|    H-------------------ILPKRHYYKQKKFKYAEDMGPGEGEHDPVATSSTLGLQEN  395 
|P2X2|    T------------------FMNKNKLYSHKKFDKVRTPKHPSSRWPVTLALVLGQIPPPP  395 
|P2X3|    N------------------FLKGADHYKARKFEEVTETTLKGTASTNPVFASDQATVEKQ  382 
|P2X4|    Y-------------------CMKKKYYYRDKKYKYVEDYEQGLSGEMNQ             389 
|P2X5|    Y------------------LIRKSEFYRDKKFEKVRGQKEDANVEVEANEMEQERPEDEP  401 
|P2X6|    Y------------------VDREAGFYWRTKYEEARAPKATTNSA                 379 
|P2X7|    TYASTCCRSRVYPSCKCCEPCAVNEYYYRKKCEPIVEPKPTLKYVSFVDEPHIWMVDQQL  416 
 
 
|P2X1|     MRTS                                                         399 
|P2X2|     SHYSQDQPPSPPSGEGPTLGEGAELPLAVQSPRPCSISALTEQVVDTLGQHMGQRPPVP  454 
|P2X3|     STDSGAYSIGH                                                  393 
|P2X5|     LERVRQDEQSQELAQSGRKQNSNCQVLLEPARFGLRENAIVNVKQSQILHPVKT       455 
|P2X7|     LGKSLQDVKGQEVPRPQTDFLELSRLSLSLHHSPPIPGQPEEMQLLQIEAVPRSRDSPD  475 
 
 
|P2X2|     EPSQQDSTSTDPKGLAQL                                           472 
|P2X7|     WCQCGNCLPSQLPENRRALEELCCRRKPGQCITTSELFSKIVLSREALQLLLLYQEPLL  534 
 
 
|P2X7|     ALEGEAINSKLRHCAYRSYATWRFVSQDMADFAILPSCCRWKIRKEFPKTQGQYSGFKY  593 
 
 
|P2X7|     PY                                                           595 
 
 
Fig. 4: Amino acid sequence alignment of the C-terminal part of the seven 
cloned rat P2X receptors subunits. Sequences and genes structure are deduced from 
NCBI accession numbers P47824 (P2X1), 2020424A (P2X2), CAA62594 (P2X3), CAA61037 
(P2X4), CAA63052 (P2X5), CAA63053 (P2X6), and CAA65131 (P2X7). The alignment was 
made using the ClustalW program available in the Internet 
(http://clustalw.genome.ad.jp/). Identical amino acids are highlighted by shaded boxes. 
 
 
    The amino acid identity between P2X receptors subunits is distributed 
throughout the extracellular domain, in which residues are involved in 
ligand binding (Jiang et al., 2000). A striking feature of this extracellular 
domain is the conservation of 10 cysteine residues among all known 
receptors. Disulfide bonds are known to play an important role in the 
formation and maintenance of ion channel structures (Ennion and Evans, 
2002). I/ Introduction 
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    All P2X receptor subunits have consensus sequences for N-linked 
glycosylation (Asn-X-Ser/Thr), and some glycosylation is essential for 
trafficking to the cell surface (Rettinger et al., 2000a). The P2X2 receptor 
primary sequence, for example, contains three consensus sites for N-
glycosylation, these are 
182Asn, 
239Asn, 
298Asn. All are glycosylated in 
oocytes (Newbolt et al., 1998), and HEK293 cells (Torres et al., 1998a). 
All the three glycosylation consensus sequences become complex 
glycosylated en route to the plasma membrane in oocytes (unpublished 
results, Ph.D. thesis S. Aschrafi; Frankfurt, 2002). The other P2X 
receptors subunits also have consensus sequences for N-linked 
glycosylation; these are well conserved in their positions among species 
variants, but incompletely conserved among the receptors (P2X1, five 
sites; P2X3, four sites; P2X4, six sites; P2X5, two sites; P2X6, three sites; 
P2X7, three sites) (North, 2002). 
    Evidence for heteromultimeric receptors has come from functional 
expression studies. The pharmacological properties (see below) of 
endogenous P2X receptors in smooth muscle and PC12 cells correlate well 
with those of the recombinant receptors cloned from these tissues, P2X1 
and P2X2 receptors, respectively. However, this is not always the case. All 
P2X receptors except P2X7 are expressed in sensory glia, but ATP-gated 
currents at endogenous P2X receptors in rat nodose neurons present a 
pharmacological profile that does not correspond to any of the homomeric 
P2X receptors cloned (Lewis et al., 1995). It was suggested that a new 
heteromeric receptor, P2X2P2X3, is formed from the P2X3 and P2X2 
subunits. 
  In attempt to determine the number of P2X subunits contributing to the 
formation of oligomers or heteromers, different biochemical approaches 
have been used. Kim et al. purified a His-tagged form of the ectodomain 
of P2X2 expressed in E.coli (Kim et al., 1997). Using the equilibrium 
sedimentation centrifugation technique they proposed a tetrameric 
assembly of P2X2. In contrast, Nicke et al. using the Blue-native PAGE 
technique and performing cross-linking experiments showed that rP2X1 I/ Introduction 
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and rP2X3 subunits assemble into stable trimers (Nicke et al., 1998; Nicke 
et al., 2003). The trimeric structure of P2X receptors were confirmed 
many times in our group, particularly for the homomeric rP2X1 receptor. 
Jiang et al. proposed recently a “head-to-tail” subunit arrangement in the 
quaternary structure of P2X receptors and suggested that trimeric P2X2/3 
receptor would have the composition P2X2(P2X3)2 (Jiang et al., 2003). 
 
 
2.2  Signal transduction mechanisms 
 
    P2X receptors mediate the rapid (onset within 10 ms) non selective 
passage of cations (Na
+, K
+, Ca
2+) across the cell membrane resulting in 
an increase in intracellular Ca
2+ and depolarization (for review, see 
(Ralevic and Burnstock, 1998)). The response time is very rapid, which 
explains the important role that P2X receptors play in fast neuronal 
signaling and regulation of muscle contractility. 
 
 
 
Fig. 5: Fast (top) and slow (bottom) desensitization compared for homomeric 
rat P2X receptors (North, 2002). Note 10-fold difference in time scale. HEK293 cells 
were transfected with 1 µg/ml cDNA 48h before these whole cell recordings were made. 
ATP (30 µM, except 1 mM for P2X7) was applied either for 2s (top) or for 60s (bottom). 
 I/ Introduction 
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  Cations can modulate ATP-activated currents in native and endogenous 
P2X receptors. Mg
2+ and Ca
2+ generally inhibit P2X receptors currents, 
probably by decreasing the affinity of the ATP binding site by an allosteric 
change in the receptor (Nakazawa et al., 1990; Li et al., 1997). Zn
2+ 
potentiates the cation conductance induced by ATP at most P2X receptors, 
excepted the P2X7 receptor, which is inhibited by Zn
2+ and Cu
2+ (Virginio 
et al., 1997). Modulation of the affinity of the ATP-binding site also occurs 
by extracellular protons; acid pH causes an increase, and alkaline pH 
causes a decrease in currents (King et al., 1996). This may be particularly 
significant for P2X-receptor-mediated signaling in pathophysiological 
conditions where injury or inflammation can profoundly alter extracellular 
pH. Fig. 5 shows the electrophysiological response of the different 
homomeric P2X receptors transfected in HEK293 cells and their 
desensitization profile. 
  P2X receptors can be divided into two broad groups according to whether 
they desensitize rapidly, that is, within 100 to 300 ms as the rat P2X1 
receptor (Rettinger and Schmalzing, 2003; Rettinger and Schmalzing, 
2004), or slowly if at all (see table 1). 
 
 
-, weak or inactive; N.D., not determined 
 
Table 1: Distinguishing pharmacological characteristics of P2X receptors. 
 
P2X receptors  Desensitization 
α-β-meATP 
sensitivity 
PPADS 
sensitivity 
Suramin 
sensitivity 
P2X1  Rapid  Yes Yes Yes 
P2X2 Slow  -  Yes  Yes 
P2X3  Rapid  Yes Yes Yes 
P2X4  Slow  - - - 
P2X5 Slow  -  Yes  Yes 
P2X6  Slow  - - - 
P2X7 Slow  -  N.D.  Yes 
P2X2P2X3 Slow  Yes  N.D.  N.D. I/ Introduction 
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  α-β-meATP is a subtype-specific P2X receptor agonist. 
Electrophysiological studies at recombinant P2X receptor subtypes 
established the existence of two phenotypes of receptors for α-β-meATP 
(Table 1), which is a relatively potent agonist at P2X1, P2X3 and 
heteromeric P2X2P2X3 and P2X1P2X5 receptors. α-β-meATP is a weak 
partial agonist or inactive at homomeric P2X2, P2X4-7 and heteromeric 
P2X4/6 receptors (Ralevic and Burnstock, 1998; Lambrecht, 2000). 
  PPADS was first considered to be a P2 receptor antagonist selective for 
native P2X1-like receptor (Lambrecht et al., 1992), but it is now accepted 
that PPADS is a non-selective (but universal) P2 antagonist (Ralevic and 
Burnstock, 1998). It was shown by Dunn et al., that suramin antagonizes 
P2X1-like receptor-mediated effects (Dunn and Blakeley, 1988). In many 
studies, suramin has been found to be a non-selective antagonist at native 
P2X and P2Y receptors with relatively low potency (Ralevic and Burnstock, 
1998). However, NF279 and NF449, two suramine analogues, are potent 
and selective analogues of P1X1 receptors. NF279, incubated prior to ATP 
or simultaneously with ATP, was much more potent for P2X1 and P2X3 
receptors  than for P2X2 receptors. P2X4 receptors were the least sensitive 
subtypes for this compound (Rettinger et al., 2000b). NF449 showed 
inhibitory potency for rP2X1 at subnanomolar concentrations and the rank 
order of potency was P2X1>> P2X3> P2Y1> P2Y2 (Braun et al., 2001; 
Hülsmann et al., 2003). 
 
 
2.3  Distribution and biological effects 
 
    In this chapter it will only be focused on P2X2, P2X5, and P2X7 which 
were the subunits investigated in this study. Detailed information about 
P2X1, P2X3, P2X4, and P2X6 are available in a recent review written by R. 
Alan North (North, 2002). I/ Introduction 
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a- P2X2 receptor 
 
  The  rat  P2X2 receptor subtype was originally isolated from PC12 rat 
pheochromocytoma cell (Brake et al., 1994) and displays only 41% amino 
acid homology with the rat vas deferens P2X1 receptor. This receptor 
undergoes little or no desensitization. However, currents at P2X2 receptors 
in outside-out patches decline much more rapidly than in whole cell 
configuration (Ding and Sachs, 1999; Ding and Sachs, 2000). This 
observation implies that the decline of current is prevented in the whole 
cell configuration because of the presence of some intracellular modulator, 
which is lost slowly in the whole cell recording but lost rapidly in outside-
out patches (Ding and Sachs, 2000). 
  P2X2 receptor mRNA is distributed in bladder, brain, spinal cord, superior 
cervical ganglia, adrenal medulla, intestine, and vas deferens, with the 
highest levels found in the pituitary gland and vas deferens (Brake et al., 
1994). Distinct but restricted patterns of distribution of P2X2 mRNA have 
been described within the rat brain (Collo et al., 1996). Three cDNAs 
encoding splice variants of the P2X2 receptor were isolated from rat 
cerebellum, P2X2b, P2X2c, and P2X2d (Simon et al., 1997). P2X2b was the 
only one splice variant which was functional when expressed in either 
Xenopus laevis oocytes or in HEK 293 cells (Simon et al., 1997). P2X2b has 
a 69-amino acid (207-pb) deletion starting at the Val-370 codon (Brändle 
et al., 1997). A serine- and proline-rich region is thus deleted, shortening 
the carboxyl-terminal region. In contrast to the nondesensitizing P2X2a 
receptor, prolonged application of ATP produced a more rapid 
desensitization of the P2X2b receptor. Functional studies have suggested 
that alternative splicing of the receptor serves to modulate the response 
of the receptor to prolonged agonist exposure (Brändle et al., 1997; 
Simon et al., 1997; Koshimizu et al., 1998). The human homologue of the 
P2X2 receptor has been isolated in 1999 by Lynch et al. (Lynch et al., 
1999). Like the rat gene, the human P2X2 gene produces multiple 
transcripts in a variety of tissues. I/ Introduction 
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    Extracellular ATP has been implicated in the function of the 
neuroendocrine system. ATP induces secretion of hormones, including 
prolactin and leuteinizing hormone from cells of the pituitary gland. The 
existence of high levels of human P2X2 message in the pancreas and in 
the pituitary gland suggest a role of P2X2 receptors in the modulation of 
pancreatic functions and in the regulation of hormone release (Lynch et 
al., 1999). 
 
 
b- P2X5 receptor 
 
  The P2X5 receptor was first cloned from rat coeliac ganglia (Collo et al., 
1996). In situ hybridization shows P2X5 mRNA in motoneurons of the 
ventral horn of the cervical spinal cord, and in neurons in the trigeminal 
and dorsal root ganglia. Rat P2X5 was also cloned from rat heart (Garcia-
Guzman et al., 1996). With the exception of the mesencephalic nucleus of 
the trigeminal nerve, the brain does not express P2X5 mRNA. A chicken 
P2X receptor cDNA (cP2X8) homologous to mammalian P2X5 subunit but 
showing sequence divergence at the C-terminal end has been cloned from 
embryonic skeletal muscle (Bo et al., 2000). Ruppelt et al. isolated the 
same cDNA from chicken heart (Ruppelt et al., 2001) and considered 
cP2X8 the chicken orthologue of rP2X5. Moreover, the authors showed in 
this study that cP2X5 is permeable not only to cations but also to Cl
-. 
These data suggest, that chicken P2X5 receptors are expressed in 
developing muscle and might play a role in early muscle differentiation. 
 
 
c-  P2X7 receptor 
 
  The P2X7 receptor, which was cloned from rat macrophages and brain 
(Surprenant et al., 1996), is the cytolytic “P2Z receptor” previously 
described in mast cells, macrophages, fibroblasts, lymphocytes, I/ Introduction 
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erythrocytes, and erythroleukemia cells. Human and mouse cDNAs were 
cloned from monocytes and microglial cells respectively (Rassendren et 
al., 1997; Chessell et al., 1998). 
    One of the striking features of the P2X7 receptors is that they need 
concentrations of ATP greater than 100 µM to be activated, and that 
BzATP, an ATP analog, is 10-30 times more potent than ATP. Moreover, in 
low divalent cation solutions, agonists induce sustained currents and the 
channel becomes permeable to molecules up to 900 daltons, although in 
normal solution selectivity for small cations is observed (Surprenant et al., 
1996). This pore formation involves the cytoplasmic C-terminus of the 
protein because it does not occur with a truncated P2X7 receptor lacking 
the last 177 residues, although cation function of the receptor is retained 
(Ralevic and Burnstock, 1998). 
  P2X7 mRNA and protein are distributed in bone marrow cells, including 
granulocytes, monocytes/macrophages and B lymphocytes (Klapperstuck 
et al., 2000; Boldt et al., 2003), and in macrophages in brain (Collo et al., 
1997). Functional studies have shown that P2X7 receptor distribution is 
generally limited to cells of hemopoietic origin. P2X7 receptors are also 
present on hepatocytes and parotide and salivary gland acinar cells (for 
review, see (Ralevic and Burnstock, 1998)). 
  In murine and human macrophages activation of P2X7 receptors causes 
activation of phospholipase D, and activation of P2X7 receptors of human 
macrophages triggers the release of the inflammatory cytokine IL-1β, 
which may provide a clue to the physiological and/or pathophysiological 
role of this receptor (Ralevic and Burnstock, 1998). The increased 
permeability caused by activation of the P2X7 receptor results in large ion 
fluxes and leakage of small metabolites. On prolonged stimulation it may 
cause cell swelling, vacuolization, and cell death by necrosis or apoptosis. 
Finally, ATP or BzATP induces remarkable changes in the appearance of 
HEK293 cells transfected with the rat P2X7 receptor (Virginio et al., 
1999). After ~30 s of continuous application of BzATP (30 µM), the plasma I/ Introduction 
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membrane begins to develop large blebs, and after 1 or 2 min, these 
become multiple and sometimes coalesce. 
 
 
2.4  Methods to characterize protein complexes and aim of the 
experiments performed with the P2X receptors 
 
  The aim of the experiments performed with P2X receptors was to identify 
proteins that are involved in the intracellular transport and localization of 
these receptors in the brain. 
    In the nervous system, efficient signalling depends critically on the 
precise positioning of ligand-gated ion channels (LGICs) in high density in 
the cell membrane at sites postsynaptic to nerve terminals releasing 
neurotransmitters. Among the intracellular proteins which are enriched in 
the postsynaptic density and provide a link to the cytoskeleton are 
gephyrin (Kneussel and Betz, 2000), rapsyn (Kassner et al., 1998), and 
GABARAP (Wang et al., 1999). The tubulin binding protein gephyrin (Fig. 
12), for example, is crucial for the clustering and post-synaptic localization 
of inhibitory glycine receptors at synapses of the spinal cord by linking the 
heteropentameric αβ glycine receptor complex through the β subunit with 
microtubules (Kirsch et al., 1991; Kirsch and Betz, 1993). In addition, 
gephyrin mediates the post-synaptic clustering of GABAA receptors in the 
brain (Essrich et al., 1998; Kneussel and Betz, 2000). Likewise, GABARAP 
(Fig.  6), a 17 kDa protein, has been shown to associate with GABAA 
receptors and to bind to microtubules (Wang et al., 1999; Wang and 
Olsen, 2000) by serving as a linker between GABAA and gephyrin 
(Kneussel et al., 2000). In contrast to gephyrin, however, GABARAP 
appears to play a role in intracellular transport of GABAA receptor rather 
than in receptor anchoring at the synapse (Kneussel et al., 2000; Kittler et 
al., 2001). 
  It is becoming increasingly clear that an important level of organization 
is provided by multi protein complexes. Proteins interact with each other I/ Introduction 
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and form larger assemblages in a time- and space-dependent manner. To 
identify protein-protein interactions on a large scale, two types of 
approaches can be used: the two-hybrid system, which is used to detect 
binary interactions in vivo, and biochemical co-purification of complexes 
using affinity tags, coupled with protein identification using mass 
spectrometry, which defines the total spectrum of complexes for a 
particular tagged protein. These two approaches will be shortly presented 
and discussed in this chapter. 
 
 
Fig. 6: Post-synaptic gephyrin and its binding partners (Kneussel and Betz, 
2000). 
 
    The yeast two-hybrid assay provides a genetic approach to the 
identification and analysis of protein-protein interactions. In this assay, 
hybrid proteins are generated that fuse a protein X to the DNA binding 
domain and protein Y to the activation domain of a transcription factor. 
Interaction between X and Y reconstitutes the activation of the 
transcription factor and leads to expression of reporter genes with 
recognition sites for the DNA-binding domain. I/ Introduction 
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  Key advantages of the two-hybrid system assay are its sensitivity and 
flexibility. This sensitivity leads to the detection of interactions with 
dissociation constants around 10
-7M, in the range of most weak protein 
interactions found in the cell, and is more sensitive than co-purification, 
which requires stability of a complex through dilution from cell lysis, and 
through subsequent purification steps (Phizicky et al., 2003). 
  Disadvantages of the yeast assay include the unavoidable occurrence of 
false negatives and false positives. False negatives include proteins such 
as membrane proteins and secretory proteins that are not usually 
amenable to a nuclear-based detection system, proteins that activate 
transcription when fused to a DNA binding domain, proteins that fail to 
fold correctly, and interactions dependent on domains occluded in the 
fusion or on post-translational modifications. False positive seem to be 
due to spurious transcription that does not derive from any interaction 
occurring between the hybrid proteins (Phizicky et al., 2003). 
    The combination of biochemistry and mass spectrometry is driving 
progress in the field of functional proteomic today. The purification of 
protein complexes has been accomplished by a multitude of different 
techniques ranging from classical methods such as size exclusion or ion 
exchange chromatography to different varieties of affinity 
chromatography. Affinity-based methods include one highly discriminating 
separation step, which is essential considering the samples complexity. In 
these methods, one of the molecules is immobilized on a solid support and 
the interacting molecules can be purified from e.g. a cell lysate along with 
associated proteins. The immobilized molecules are most of the time 
recombinant proteins, epitope-tagged proteins and antibodies. For more 
specialized applications, peptides and nucleic acids have also been used 
(Bauer and Kuster, 2003). 
    A classical approach is the co-immunoprecipitation experiment using 
antibodies. It is probably the most frequently employed method for testing 
whether two proteins are associated in vivo but the method can also be 
successfully used for the discovery of novel interacting partners in a I/ Introduction 
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protein complex. A retrieved complex is washed extensively to remove 
non-specifically bound proteins and is subsequently eluted from the resin 
prior identification by mass spectrometry. There are several arguments 
that would favor an antibody approach. Importantly, antibodies allow the 
retrieval of protein complexes from endogenous components of cells and 
tissues which is obviously closest to resembling physiological conditions as 
there is no need for ectopic expression of the bait protein that could lead 
to variety of problems (see below). One limitation of antibody 
immunoprecipitation is that an individual antibody is needed for every bait 
protein. There are some other, more technical, limitations to the method: 
even mouse monoclonal antibodies might exhibit cross-reactivity with 
proteins other than the immunogen, leading to the generation of false 
positive. Cross-reactivity of the antibody aside, very abundant proteins 
might non-specifically bind to the resin. Specificity is typically increased 
by washing the immobilized protein complex briefly before elution using 
high stringency conditions (200-500 mM salt). However, components that 
are not tightly bound might be lost during this procedure. Although this 
point is raised in this section, other affinity approaches will suffer from the 
same limitation. Loss of particular components of a protein complex might 
be overcome by chemical cross-linking (Bauer and Kuster, 2003). 
  Antibodies can be used in a more generic way for the isolation of protein 
complexes that circumvents the need for producing specific antibodies. For 
this purpose, bait proteins can be fused to an epitope-tag and an antibody 
directed against the tag instead of the bait protein is used for complex 
retrieval. A variety of different epitope tags (e.g. Myc, HA, Flag, KT3) have 
been used successfully in the past and antibodies against these tags are 
commercially available. The underlying advantage of the approach is the 
high degree of reproducibility of the results because standardized 
technical procedures can be used that do not need to be optimized for 
each individual case. The downside of epitope-tagging is obviously the 
need to ectopically express proteins in cells which largely limits this 
approach to cell culture systems. Tight control over the expression level of I/ Introduction 
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bait proteins must be exercised as overexpression might adversely affect 
the assembly of the protein complex. In addition, overexpression can 
occasionally cause cytotoxicity. In addition, the artificially introduced tag 
may interfere with protein folding, protein function, or the ability to 
interact with other proteins. Despite some of these limitations, 
co-immunoprecipitation via epitope tags is used extensively on a normal 
lab scale to identify protein complexes (Bauer and Kuster, 2003). 
  The standard precipitation experiment with the aid of a recombinant GST 
fusion protein has been widely used for the discovery and analysis of 
individual protein interactions and, to a lesser extent, protein complexes. 
In this approach, the protein of interest is expressed in Escherichia coli as 
a recombinant fusion protein and immobilized on a solid support. 
Interacting proteins can then be precipitated (or “pulled-down”) by 
applying a cellular lysate to the column. An obvious advantage of this 
method is that it is robust, easy to use and capable of retrieving even 
weakly interacting and low abundant proteins owing the fact that large 
amounts of recombinant protein are present on the column. However, not 
all proteins can be easily overexpressed in a soluble form in E. coli. 
Furthermore interactions that may be dependent on the correct post-
translational processing of the bait protein may not be provided by the 
expression system used. 
    TAP (tandem affinity purification), a method that was recently 
developed, is highly discriminating against unspecific protein background 
and nevertheless retain essential components of the complex. First, the 
“TAP-tagged” protein is expressed in cells to form a complex with the 
endogenous components. The tagged protein along with associated 
partners is retrieved via interaction of the ProteinA tag with 
immunoglobulins that are immobilized on agarose beads. In order to 
remove proteins that are non-specifically bound to the column, the 
retrieved protein complex is released by protease cleavage using the TEV 
(Tobacco etch virus) protease. This enzyme is a site specific protease that 
cleaves a seven amino-acid recognition sequence located between the first I/ Introduction 
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and the second tag. This sequence is only found in very few human 
proteins known so far thus ensuring that components of retrieved 
complexes are not themselves cleaved by the protease. In the second 
affinity step, the complex is immobilized to calmoduline coated beads via 
the calmoduline binding peptide (CBP) tag. This step removes the TEV 
protease and further contaminants that may be present. The CBP-
calmoduline interaction is calcium dependent and, hence, the removal of 
calcium ions with chelating agents can be used as a second specific elution 
step that yields the final protein complex preparation (Fig. 7). Aside some 
of the limitations associated with epitope tagging mentioned earlier, the 
two step TAP approach has several advantages over traditional single step 
methods. Probably the most useful asset is the massive reduction of 
sample complexity through very efficient reduction of unspecific protein 
background. Stringent purification conditions (high salt or detergent 
concentrations) which tend to result in the loss of associated proteins can 
be avoided and the complex can be kept under close to physiological 
conditions all along the purification procedure. The results of TAP 
purifications are highly reproducible and comparable for different bait 
proteins which render the approach applicable to small- and large-scale 
studies alike (Bauer and Kuster, 2003). 
 
Fig. 7: Schematic representation of the tandem affinity purification method 
(Bauer and Kuster, 2003). I/ Introduction 
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  To isolate proteins interacting with P2X receptors, GST fusion proteins 
containing the intracellular C terminal tail of P2X2, P2X5, or P2X7 were 
used as bait to screen detergent extracts of rat brain synaptosomes by 
affinity chromatography. Proteins were resolved by 1D- or 2D SDS-PAGE, 
and bands/spots of interest were analysed by MALDI-TOF mass 
spectrometry. I/ Introduction 
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I-3. Glutamate transporters 
 
3.1  Roles of amino acid transporters 
 
  Intracellular communication in the central nervous system requires the 
precise control of the duration and the intensity of neurotransmitter action 
at specific molecular targets. After they have been released at the 
synapse, neurotransmitters activate pre- and/or postsynaptic receptors. 
To terminate synaptic transmission, neurotransmitters are in turn, 
inactivated by either enzymatic degradation or active transport in 
neuronal and/or glial cells by neurotransmitter transporters. These 
processes are responsible for homeostasis of neurotransmitter pools 
within nerve endings 
    Both at the plasma and the vesicular membranes, neurotransmitter 
influxes are directly coupled to transmembrane ion gradients which 
provide the energy for the retrotransport (Kanner and Schuldiner, 1987). 
  Neurotransmitter transporters can be classified in two superfamilies (for 
review see (Masson et al., 1999)): 1) the plasma membrane transporters 
and 2) the vesicular membrane transporters. The superfamily of plasma 
membrane transporters can be further divided into two families depending 
on their ionic dependence: 1) the Na
+/Cl
--dependent transporters and 2) 
the Na
+/K
+-dependent transporters. In this chapter only the plasma 
membrane Na
+/K
+-dependent neurotransmitters transporters will be taken 
into consideration. 
    A few words about the Na
+/Cl
--dependent transporters: the classical 
members of this family are the dopamine transporter (DAT), the 5-HT 
transporter (SERT), the GABA transporter [GAT(1-3)], the norepinephrine 
transporters (NET), the proline transporter (PROT), the taurine transporter 
(TaurT), and the glycine transporter [GLYT(1a, -b, -c, and –2)]. All share 
the same topology and are 40 to 60% homologous. The hydropathicity 
analysis of these clones revealed 12 stretches of 15 to 25 hydrophobic 
amino acids which have been interpreted as forming α-helical I/ Introduction 
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transmembrane domains. The N- and C-terminal regions are intracellular 
and the second large extracellular loop contains two to four potential N-
glycosylation sites (Masson et al., 1999). 
 
 
3.2  Sodium- and potassium-coupled glutamate transporters  
 
a- The importance of glutamate uptake 
 
  The amino acid L-amino acid L-glutamate (Fig. 8) is considered to be the 
major mediator of excitatory signals in the mammalian central nervous 
system and is probably involved in most aspects of normal brain functions 
including cognition, memory and learning (Danbolt, 2001). Glutamate also 
plays major roles in the development of the central nervous system, 
including synapse induction and elimination, and cell migration, 
differentiation and death. 
 
 
 
Fig. 8: Chemical structure of glutamate. 
 
  Brain glutamate is abundant, but mostly intracellular. The concentration 
gradient of glutamate across the plasma membranes is several thousand-
fold and the highest concentrations are found inside nerve terminals 
(Danbolt, 2001). Glutamate is continuously being released from cells and 
is continuously being removed from the extracellular fluid. 
  Glutamate exerts its signaling role by acting on glutamate receptors. It is 
of critical importance that the extracellular glutamate concentration is 
kept low. This is required for a high signal to noise (background) ratio in 
synaptic transmission. Further, excessive activation of glutamate 
receptors is harmful, and glutamate is thereby toxic in high 
H3N+ CH
C=O
O-
CH2 CH2 C
O
O- H3N+ CH
C=O
O-
CH2 CH2 C
O
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concentrations. Finallly, for economic reasons it is necessary to conserve 
the glutamate released. In contrast, intracellular glutamate is generally 
considered non-toxic (Danbolt, 2001). 
 
b- The EAAT family 
 
    The members of the glutamate transporter family that have been 
functionally characterized can be classified in three groups based on their 
substrate specificity: C4-dicarboxylate transporters (found in bacteria), 
glutamate/aspartate transporters (found in bacteria and eukaryotes) and 
neutral amino acid transporters (found in bacteria and eukaryotes) 
(Slotboom et al., 1999). A phylogenetic tree of the glutamate transporter 
family is presented in Fig. 9. 
  Five different eukaryotic “high-affinity” glutamate (excitatory amino acid) 
transporters have been cloned so far: EAAT1 (Storck et al., 1992), EAAT2 
(Pines et al., 1992), EAAT3 (Kanai and Hediger, 1992), EAAT4 (Fairman et 
al., 1995) and EAAT5 (Fairman et al., 1995). All five proteins catalyze 
Na
+- and K
+-coupled transport of L-glutamate as well as L- and 
D-aspartate. Originally, these transporters were referred to as the 
“sodium-dependent high-affinity transporters” to distinguish them from 
the “low-affinity transporters”. The “low-affinity” uptake exhibits Km 
values above 500 µM and, in contrast to the “high affinity system” is 
described as sodium independent and sensitive to inhibition by D-
glutamate and L-homocysteate. This uptake system has been suggested 
to supply brain cells with amino acids for metabolic purposes, but is poorly 
characterized (Danbolt, 2001). 
    The five cloned EAAT glutamate transporters (within a single species) 
share 50-60% amino acid sequence identity with each other, 30-40% 
identity with some carriers for neutral amino acids, and about 20-30% 
identity with proton-dependent bacterial glutamate and dicarboxylate 
transporters.(Danbolt, 2001). Between mammals, the five proteins are 
about 90% identical to the equivalent protein of another species. I/ Introduction 
  - 27 -  27
 
 
 
 
F
i
g
.
 
9
:
 
P
h
y
l
o
g
e
n
e
t
i
c
 
t
r
e
e
 
o
f
 
3
5
 
m
e
m
b
e
r
s
 
o
f
 
t
h
e
 
g
l
u
t
a
m
a
t
e
 
t
r
a
n
s
p
o
r
t
e
r
 
f
a
m
i
l
y
 
(
S
l
o
t
b
o
o
m
 
e
t
 
a
l
.
,
 
1
9
9
9
)
.
 
T
h
e
 
s
e
t
 
o
f
 
3
5
 
m
e
m
b
e
r
s
 
d
o
e
s
 
n
o
t
 
c
o
n
t
a
i
n
 
p
a
i
r
s
 
o
f
 
s
e
q
u
e
n
c
e
s
 
w
i
t
h
 
m
o
r
e
 
t
h
a
n
 
7
0
%
 
i
d
e
n
t
i
c
a
l
 
r
e
s
i
d
u
e
s
.
 
A
b
b
r
e
v
i
a
t
i
o
n
s
:
 
H
s
,
 
H
o
m
o
 
s
a
p
i
e
n
s
;
 
M
m
u
,
 
M
u
s
 
m
u
s
c
u
l
u
s
;
 
R
n
o
,
 
R
a
t
t
u
s
 
n
o
r
v
e
g
i
c
u
s
:
 
B
t
a
,
 
B
o
s
 
T
a
u
r
u
s
;
 
C
e
l
,
 
C
a
e
n
o
r
h
a
b
d
i
t
i
s
 
e
l
e
g
a
n
s
;
 
E
c
,
 
E
s
c
h
e
r
i
c
h
i
a
 
c
o
l
i
;
 
B
c
a
,
 
B
a
c
i
l
l
u
s
 
c
a
l
d
o
t
e
n
a
x
;
 
B
s
u
,
 
B
a
c
i
l
l
u
s
 
s
u
b
t
i
l
i
s
.
 
E
u
k
a
r
y
o
t
i
c
 
g
l
u
t
a
m
a
t
e
 
t
r
a
n
s
p
o
r
t
e
r
s
 
B
a
c
t
e
r
i
a
l
 
g
l
u
t
a
m
a
t
e
 
t
r
a
n
s
p
o
r
t
e
r
s
 
B
a
c
t
e
r
i
a
l
 
 
 
 
 
 
 
 
 
C
4
-
d
i
c
a
r
b
o
x
y
l
a
t
e
 
t
r
a
n
s
p
o
r
t
e
r
s
 
B
a
c
t
e
r
i
a
l
 
s
e
r
i
n
e
 
t
r
a
n
s
p
o
r
t
e
r
s
 
E
u
k
a
r
y
o
t
i
c
 
n
e
u
t
r
a
l
 
a
m
i
n
o
 
a
c
i
d
 
t
r
a
n
s
p
o
r
t
e
r
s
 I/ Introduction 
  - 28 -  28
c-  Molecular structure of glutamate transporters 
 
    The glutamate transporter topology is still debated. The first six 
transmembrane domains are clearly indicated by hydropathy plots, but 
there is not consensus with regard to the C-terminal one-third of the 
sequence (Danbolt, 2001). A proposed membrane topology for glutamate 
transporters is presented in Fig. 10. Four groups have tried to uncover the 
topology of the mammalian glutamate transporters, but have arrived at 
different results (for review, see (Danbolt, 2001)). All groups agree about 
the first six transmembrane (TM) domains (which they all believe are 
α-helices) and about the long stretch between TM3 and TM4. They also 
agree with the immunocytochemical data showing that both N- and 
C-terminals are intracellular. There is a relatively large intracellular stretch 
(residues 339-390 in EAAT2) between TM6 and TM7. Part of this stretch 
(the 20 residues in the middle) is not thought to be a true intracellular 
domain, but to form a reentrant loop, which resides in the membrane 
without forming an usual transmembrane segment. Residues 422-443 (in 
EAAT2) are suggested to make up a second reentrant loop, while the rest 
may form an extracellular superficial membrane associated linker to the 
last  α-helix. After the last TM, all models contain a long intracellular 
C-terminus. 
  The fact that affinity chromatography on a wheat germ lectin has been 
successfully used to isolate EAAT2 and that this lectin also binds EAAT1 as 
well as EAAT3, show that the glutamate transporters are glycosylated 
(Danbolt, 2001). The sugar groups are at least on EAAT2 N-linked 
because treatments of purified EAAT2 with PNGase F reduces the apparent 
molecular mass by about 10 kDa (Danbolt et al., 1992). Consensus sites 
for N-linked glycosylation are encoded in the large hydrophilic loop 
between putative TM3 and TM4 in all the cloned human glutamate 
transporters (EAAT5: one site; EAAT1, EAAT2, and EAAT3: two sites; 
EAAT4: three sites) (Danbolt, 2001). The two N-glycosylation sites in 
EAAT1 (
206N, 
216N) have been modified by site-directed mutagenesis, but I/ Introduction 
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the glycosylation was reported to be without functional significance 
(Conradt and Stoffel, 1995). 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 10: Topology of glutamate transporters (Danbolt, 2001). (A) The proposed 
topology of rat EAAT2 (Grunewald and Kanner, 2000). (B) The proposed topology of 
human EAAT1 (Seal et al., 2000).There is consensus (thick line) with regards to the first 
six transmembrane domains (which are thought to be α-helices) and the intracellular 
localization of the termini. Although there is still debate concerning the last 
transmembrane domain, most of the investigators seem to favor the notion that this is 
an α-helix too. There is as yet no consensus with regard to the other part of the proteins 
(thin line). 
 
 
  In addition to all types of ion channels (Nicke et al., 1999), also a variety 
of transport proteins have been shown to exist as oligomer. These include 
the glucose transporter GLUT1 (Hebert and Carruthers, 1992), the rat 
serotonin transporter (Jess et al., 1996; Schmid et al., 2001), the GABA 
transporter (Schmid et al., 2001), and erythrocyte band 3 (Blackman et 
al., 1998). When fresh brain tissue is directly homogenized and solubilized 
in SDS and the proteins immediately separated by SDS-polyacrylamide gel 
electrophoresis in the absence of reducing agents, only glutamate 
transporters monomers are seen (Danbolt et al., 1992). This can only 
imply that the subunits of putative oligomers in the brain must be non-
covalently attached. When fresh brain membranes (prior to solubilization) 
are exposed to chemical crosslinkers (in the presence of DTT) and then 
A 
B I/ Introduction 
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solubilized in SDS, oligomer bands appear on the gel (Haugeto et al., 
1996). Further, the different glutamate transporters subtypes do not form 
oligomeric complexes with each other suggesting that they are homo-
oligomers (Haugeto et al., 1996). 
    Multiple glutamate transporter subunits seem to contribute to the 
transporter pore (Kavanaugh, 1999). A freeze-fracture electron 
microscopical study (Eskandari et al., 2000) of human EAAT3 expressed in 
Xenopus laevis oocytes suggests that EAAT3 is a pentamer with a cross-
sectional area of 48 ± 5 nm
2 in the plasma membrane. EAAT3 particles are 
pentagonal in shape in which five domains could be identified. 
 
 
d- Mechanism of glutamate uptake 
 
  The transporters utilize the ion gradients of both Na
+ and K
+, and also 
H
+ as energy sources for the transport process (Zerangue and Kavanaugh, 
1996). According to studies of human EAAT3, expressed in Xenopus laevis 
oocytes (Zerangue and Kavanaugh, 1996) and rat EAAT2, stably and 
inducibly expressed in a mutant CHO cell line with deficient endogenous 
glutamate transport (Levy et al., 1998), the EAAT3 and EAAT2 glutamate 
transporters have the following stoichiometry: one glutamate is taken up 
together with three Na
+ and one H
+ in exchange for one K
+ (Fig. 11). It 
cannot be taken for granted that the stoichiometry of EAAT1, EAAT4, 
EAAT5 and the glutamate transporter in glutamatergic nerve terminals are 
the same. Fig 12 shows the possible mechanism of the role of Arg447 
(EAAT2) in the sequential interaction with glutamate and potassium. 
    Based on this stoichiometry it has been estimated that the energy 
consumed by the glutamate transporters in the cerebral cortex represents 
only about 2% of the total energy consumption of the tissue (Attwell and 
Laughlin, 2000). I/ Introduction 
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Fig. 11: Types of glutamate transporters at glutamatergic synapses (Danbolt, 
2001). I. Glutamate transporters in glial cells plasma membranes, EAAT1 and EAAT2 as 
well as some EAAT3. II. Glutamate transporters are also found post-synaptically in the 
plasma membrane of dendritic spines: EAAT3 and EAAT4 (only in cerebellar Purkinje 
cells). These transporters have a relatively high associated Cl
- channel activity. III. The 
glutamate transporter in glutamatergic nerve terminals has still not be molecularly 
identified. IV. Synaptic vesicles are loaded with glutamate from cytosol by means of a 
glutamate transporter located in the plasma membrane of synaptic vesicles. V. Cystine, 
which is essential for the synthesis of glutathione is transported into cells in exchange 
with glutamate. 
 
 
e- Localization of glutamate transporters 
 
  The localization of only EAAT2 will be detailed in this chapter. Data about 
the other EAAT transporters are very well reviewed in (Danbolt, 2001). 
    EAAT2 is the quantitatively dominating glutamate transporter in the 
forebrain, or to be more precise: it dominates in all regions of the 
mammalian central nervous system except in those regions where EAAT1 
is the major transporter (Fig. 13). So far the EAAT2 protein has only been 
found in astrocytes (fibrous as well as protoplasmic) in the normal adult 
rat brain and spinal cord (Danbolt et al., 1992) as well as in the adult 
human brain. EAAT2 protein has neither been detected in neurons nor in 
other cell types (oligodendrocytes, epithelial cells of the choroids plexus 
and tanycytes). If EAAT2 protein is expressed in neurons, then the 
Glial cell I/ Introduction 
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expression must be far lower than that of astroglia or the neurons must 
express an EAAT2 variant not recognized by the antibody used so far. 
 
 
 
 
Fig. 12: Possible mechanism of the role of Arg
447 (R447
+) in the sequential 
interaction with glutamate and potassium (Kanner et al., 2001). The transporter 
(T) is shown in its unloaded form (middle level), glutamate bound form (lower level), and 
its potassium bound form (upper level). 
 
  The mRNA encoding EAAT2 is expressed in astroglial cells in agreement 
with the localization of the protein, but the mRNA is also expressed in 
several populations of neurons including the pyramidal cells in CA3 
hippocampus and in layer VI of the parietal neocortex (Torp et al., 1994). 
In the the normal and mature mammalian retina, EAAT2 protein is not 
expressed in retina glial cells. It is exclusively expressed in neurons (cone 
photoreceptors and bipolar cells) (Rauen, 2000). Fig. 13 shows the 
subcellular distribution of EAAT2 and the other transporters at two 
different glutamatergic synapses. 
  Glutamate uptake also takes place in peripheral organs and tissues. Most 
cells and tissues have the ability to take up glutamate. Sodium-dependent 
glutamate uptake systems have been identified in fibroblasts from various 
tissues, in erythrocytes, in macrophages, in platelets, in muscle, in 
prostate, in liver, in taste bud, in mammalian oocytes, as well as in the 
heart, intestine, kidney, pancreas, placenta, bone and mammary gland 
(for review, see (Danbolt, 2001)). EAAT2 mRNA has been detected in the 
kidney (Welbourne and Matthews, 1999), but there are no published I/ Introduction 
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reports on the protein.  The EAAT2 protein has been identified in placenta 
(Matthews et al., 1998) and in the lactating mammary gland (Martinez-
Lopez et al., 1998). 
 
 
 
 
 
 
 
 
 
 
Fig. 13: Schematic representation of the detailed localization of glutamate 
transporters in the vicinity of the glutamatergic synapses (Danbolt, 2001). (A) 
Parallel fiber to Purkinje cell dendritic spine synapses in the cerebellar molecular layer. 
(B) Glutamatergic synapse in the hippocampus (e.g. Schaffer collateral to pyramidal cell 
synapse). 
 
 
f-  Ion channel activities 
 
  Activation of the excitatory amino acid carriers generates an electrogenic 
current attributable to the ion-coupled cotransport. In addition to this 
transport-associated current, a substrate-gated thermodynamically 
uncoupled anion flux has been identified that has been proposed to 
dampen neuronal excitability. In 1995, Fairman et al. demonstrated that 
EAAT4 has an intrinsic Cl
- conductance gated by glutamate, and 
subsequent studies showed that this property is shared by other EAAT 
transporters (Fairman et al., 1995; Wadiche et al., 1995). Sodium-
dependent glutamate binding to the transporters triggers the anion 
conductance, which has the following rank order of selectivity: SCN
-> ClO4
-
> NO3
-> I
-> Br
-> Cl
-> F
->> gluconate (Wadiche et al., 1995). This anion 
conductance is thermodynamically independent of the transport process. 
The transport rate does not depend on the anion concentration (as long as 
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the anions do not change the pH or membrane potential) and the 
transport occurs in the absence of these anions. Under conditions where 
no net glutamate transport is expected, the anion conductance is still 
observed (Danbolt, 2001). Consequently, the anions pass through 
glutamate transporters down their electrochemical gradients as if the 
anions were passing through a glutamate-gated channel. This property is 
particularly prominent in EAAT4 and EAAT5. 
 
 
3.3  Roles of glutamate transporters in disease 
 
    When neurons are exposed to a high concentration of glutamate, the 
neurons are excessively excited, causing acute and delayed degeneration, 
and finally necrosis (Ikematsu et al., 2002). This phenomenon is known as 
“neuroexcitotoxicity”. A link between glutamate transporter dysfunction, 
increased extracellular levels, and onset of excitotoxic neuronal damage 
has been established in animal models (Rothstein et al., 1996) and in 
some human neurodegenerative diseases such as amyotrophic lateral 
sclerosis (Rothstein et al., 1992; Rothstein et al., 1995). Altered 
glutamate transport has been implicated in Alzheimer’s disease, with 
biochemical studies showing reduced numbers of high-affinity glutamate 
uptake sites in Alzheimer’s disease in many cortical areas (for review, see 
(Scott et al., 1995)). It has also been suggested that under certain 
pathophysiological circumstances such as acute cerebral ischemia and 
epilepsy, glutamate neurotoxicity is propagated due to failure or reversal 
of glutamate transport. Even when the primary defect in epilepsy is nor of 
glutamatergic origin, reduced expression of glutamate transporters has 
been shown to cause or be associated with seizures in animal models. 
Mutant mice lacking the major glutamate transporter EAAT2 develop 
spontaneous seizures (Tanaka et al., 1997). 
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3.4  Methods to investigate the oligomeric structure of membrane 
proteins and aim of the experiments performed with the EAAT2 and 
ecgltP glutamate transporters in this study 
 
    Experimental determination of the physiologically relevant oligomeric 
state of a protein is technically demanding, but several complementary 
techniques can be used to probe the structures of proteins either in 
detergent solution or embedded in membranes. 
 
a- Quaternary structure in detergent solution 
 
    Although the quaternary structure of membrane proteins is analyzed 
more easily in the detergent-solubilized rather than the membrane 
embedded state, the structure of the protein in detergent might not be 
biologically relevant. Generally, enzyme activity is a good indicator of 
structural integrity. However, in the case of detergent-solubilized 
secondary transport proteins, the best that can be measured is ligand-
binding activity. It possible that the oligomeric complexes might dissociate 
during analysis. Whether oligomeric species are then observed depends on 
the strength of the protein-protein interactions, which can be influenced 
by the type of detergent used to solubilized the protein. The techniques to 
study the quaternary structure of membrane proteins in detergent 
solutions are gathered in Table 2. 
  The method which is used routinely in our laboratory to investigate the 
oligomeric structure of membrane proteins is the blue-native PAGE 
technique. Blue-native electrophoresis is a discontinuous electrophoretic 
system developed for the isolation of native membrane protein complexes 
from biological membranes (Schägger et al., 1994). Coomassie dyes are 
added to purified proteins to induce a charge shift and aminocaproic acid 
serves to improve solubilization of membrane proteins (Schägger and von 
Jagow, 1991). I/ Introduction 
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Techniques  Principles and unique features 
Prerequisites and 
drawbacks 
Sedimentation velocity 
In combination with the frictional 
coefficient, a reasonable estimate of 
the molecular mass can be obtained 
Rigorous assessment of sample 
heterogeneity 
Analytical 
ultracentrifugation 
Sedimentation equilibrium 
Independent of protein shape 
Determination of protein (or protein 
complex) size, stoichiometry and 
strength of the interactions between 
the subunits 
Determination of protein-protein 
interactions over a wide range of 
protein concentrations in a single 
experiment without perturbing the 
chemical equilibrium 
General 
Amount of bound 
detergent/lipids needs to be 
determined 
Sedimentation velocity is 
dependent on the shape of 
the protein; does not allow 
accurate mass 
determination 
Highly purified proteins that 
is homogeneous and stable 
for at least a few days 
 
Size-exclusion-
chromatography 
In combination with a sediment 
coefficient, a reasonable estimate of 
the molecular mass can be obtained 
Amount of bound 
detergent/lipids needs to be 
determined 
Dependent on protein shape 
Calibration is problematic 
for membrane proteins 
KD of the complex needs to 
be relatively low 
Blue-native PAGE 
electrophoresis 
Protein stops migrating when 
trapped at region of appropriate 
pore size 
Many different samples can be 
analyzed simultaneously 
Protein solubility and 
stability in the presence of 
Coomassie brilliant blue 
Non-equilibrium method 
KD of the complex needs to 
be relatively low 
Co-purification 
and co-immuno-
precipitation 
Truncated proteins can be used to 
define the protein parts that are 
involved in oligomerization 
Hetero-oligomer formation 
Differently tagged protein 
species are needed 
When association constants 
in detergent solution are 
high, these experiments 
depend on hetero-oligomer 
formation in the membrane 
and thus on co-expression 
in one and the same host 
 
Table 2: Techniques to study quaternary structure of membrane proteins in 
detergent solution (taken from (Veenhoff et al., 2002)). KD, dissociation constant. I/ Introduction 
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b- Quaternary structure in the membrane 
 
  The oligomeric state of a membrane protein is best determined when it is 
embedded in the membrane. However, low expression levels and 
interference by endogenous proteins complicate in vivo analyses. In vitro, 
there are the problems of membrane reconstitution, which can be 
inefficient, and correct insertion of the protein into the membrane, which 
can be difficult to achieve. The dimensions of a protein in the membrane 
can be estimated from high magnification electron-microscope images, the 
rotational mobility of the molecule, and multicolor co-localization 
experiments. 
    Cross-sectional area of freeze-fracture particles of α-helical membrane 
proteins varies linearly with the number of transmembrane α-helices 
(Eskandari et al., 1998). On average, each transmembrane α-helix 
occupies 1.4 nm
2. This value has been used to estimate the quaternary 
structure of membrane proteins that contain a known number of 
transmembrane  α-helix in each subunit. The freeze-fracture technique 
involves rapid freezing, followed by fracture of the membrane and 
shadowing with metal-carbon to replicate the specimen. One drawback of 
this technique relates to the thickness of the metal film, which can be as 
thick as the difference between the diameter of a monomeric and dimeric 
12-transmembrane α-helix subunit (Veenhoff et al., 2002). Problems can 
also arise if the secondary structure differs from the assumed α-helical 
organization, such as occurs with “reentrant loops” (elements that line 
water-filled cavities but do not span the membrane). 
    The motional time scales of measurements using saturation-transfer 
electron-spin resonance (ST-ESR) (10
-6-10
-3s) are appropriate to observe 
the rotational mobility of labeled proteins in membranes. The effective 
radius of the protein can be derived from the rotational diffusion 
coefficient, provided the viscosity of the protein is known (Spooner et al., 
2000). The rate of rotational motion is related to the size (effective 
volume) as well as to the shape, and assumptions must be made to I/ Introduction 
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accommodate these parameters. Membrane viscosity can be estimated by 
calibration with a membrane protein of known shape and structure. 
  Whether the monomeric or oligomeric structure represents the minimal 
functional unit can be deduced from the activity of a system after co-
expression of mutant alleles or coreconstitution of mutant proteins (Laube 
et al., 1998). Using this system, the presence of a nonfunctional mutant 
will not affect the activity of a wild-type protein that is fully functional as a 
monomer. However, if two or more subunits form the active molecule, the 
presence of the nonfunctional mutant will decrease the activity. 
  Finally, chemical cross-linking at the plasma membrane (or on purified 
proteins) is a simple method to demonstrate the close proximity of 
proteins in their native state. However, the target sites have to be 
accessible. 
 
  In this study, the subunit stoichiometry and processing of two distantly 
related glutamate transporters, the human glial glutamate transporter, 
hEAAT2 and the bacterial ecgltP from E. coli were investigated. For this 
purpose these two proteins were expressed in Xenopus laevis oocytes, 
purified under non-denaturing conditions and analyzed by blue-native or 
SDS-polyacrylamide gel electrophoresis. The results obtained with the 
blue native PAGE technique were confirmed by chemical cross-linking 
experiments followed by SDS-PAGE analyses. II/ Materials and methods 
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II/ Materials and methods 
 
 
II-1. Materials 
 
Chemicals: If not further specified, the chemicals were purchased from 
Merck (Darmstadt, Germany). 
 
II-2. Cloning of cDNAs in expression vectors 
 
2.1  PCR amplification 
 
a- PCR amplification using a pure plasmid as template 
 
  Most DNA constructs were amplified in the same way. A pair of primers 
flanking a region of interest, or a complete coding sequence, were 
designed. Each was composed of a portion, which annealed completely 
with the template, and at the 5´end a non-annealing sequence, which 
contained a stop-codon if necessary, a restriction site and three 
adenosines to facilitate cleavage by restriction enzymes close to the end 
of the DNA. 
 
Example: Reverse primer 944 used to amplify the Carboxyl-terminal tail of 
the P2X2 receptor 
 
 
5´AAAGAATTCTTATCAAAGTTGGGCCAAACCTTTGGG 3´ 
 
 
 
For the PCR the Pfu turbo
 DNA polymerase (delivered with the 
appropriate buffer; Stratagene, La Jolla, USA) was used. Different 
template dilutions (miniprep plasmid) were tried to find the optimal one. 
The deoxy-nucleotides (dNTPs, Stratagene, La Jolla, USA) were used at a 
final concentration of 0.15 mM, each. The final primer (Qiagen; Hilden, 
EcoRI 
Stop codon  Annealing part 
Ð II/ Materials and methods 
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Germany) concentration was 0.25 µM, each and 5 units of enzyme were 
used to catalyze the chain reaction. The elongation time was calculated on 
the basis of 2 minutes/kb of DNA to amplify. The annealing temperature 
was between 55 and 72°C, and was calculated as an average of the 
annealing temperature of the two primers used according to: 
[((% GC)Tm1 –5°C)+ ((% GC)Tm2 –5°C)]/2. 
 
b- PCR amplification from a cDNA library 
 
  The PCR principle was the same as in 2.1.a, but instead of one purified 
DNA template, the amplification was performed on a cDNA library, which 
corresponded to the total mRNAs expressed in a selected organ. To 
perform this type of PCR, the FailSafe
TM PCR PreMix Selection Kit from 
Epicentre (Madison, USA) was used. This kit contains twelve 2x 
“Premixes”  (100 mM Tris-HCl, pH 8.3; 100 mM KCl; 0.4 mM of each 
dNTPs) with MgCl2 ranging between 3 and 7 mM and a Failsafe PCR 
Enhancer (betaine) in various concentrations. This kit allows one to find 
the best conditions to amplify the sequence coding for the protein of 
interest. The amplification protocol was designed according to the same 
rules as in 2.1.a. 
 
 
2.2  Digestion with restriction enzymes, ligation, transformation, and 
DNA purification 
 
  I worked with three types of vectors:  
 pNKS vectors (pNKS2 (Gloor et al., 1995), pNKS 3 and 4 are modified 
versions of pNKS2) for the cRNA translation and expression in Xenopus 
oocytes, 
  pGEX-2T (Amersham Biosciences; Freiburg, Germany) for the 
production of GST fusion proteins in E.coli or II/ Materials and methods 
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  pcDNA3.1  (Invitrogen; Karlsruhe, Germany) for the expression in 
eukaryotic cells. 
 
  I always performed directional cloning with cohesive (“sticky”) ends, i.e. 
two different restriction enzymes were used in 5´ and in 3´of the 
fragment to be inserted. All restriction enzymes were purchased from New 
England Biolabs (Frankfurt am Main, Germany). Digested DNA fragments 
were purified from 1% agarose gels using the Jetsorb
 extraction kit 
(Genomed, Bad Oeynhausen, Germany) according to the instructions of 
the manufacturer. Ligations were performed for 2 h minimum at 16°C, or 
overnight, using a T4-DNA ligase (New England Biolabs; Frankfurt am 
Main, Germany). Then competent E.coli K12 (Top 10 or DH 5α) were 
transformed, and spread on LB-plates in the presence of an antibiotic 
corresponding to the resistance gene carried by the vector. The plates 
were incubated overnight at 37°C. Some colonies were picked, and 10 ml 
aliquots of LB-medium supplemented with an antibiotic (mostly ampicillin, 
0.05 mg/ml) were inoculated and incubated overnight under continuous 
shaking at 37°C. On the next day the bacteria were harvested and DNA 
was isolated using a miniprep kit (Sigma; Taufkirchen, Germany) following 
the protocol of the manufacturer. 
 
 
2.3  Mutagenesis 
 
    To carry out point mutations or DNA insertions, I used the 
QuickChange
TM site-directed mutagenesis kit from Stratagene (La Jolla, 
USA) consisting of a PCR, followed by a Dpn I digestion and 
transformation in XL1-Blue supercompetent E.coli (for more details, see 
the instructions of the manufacturer). 
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2.4  Deletion and ligation with primers 
 
  To delete more than one codon from a plasmid, the DNA portion to be 
removed was excised by digestion with two different restriction enzymes. 
The obtained linear vector was then “re-ligated” with the help of two 
primers. These primers (Qiagen; Hilden, Germany) were not fully 
overlapping, and corresponded to a DNA fragment missing in the linear 
plasmid to achieve the ready construct. The primers were solubilized at a 
concentration of 100 µM and annealed together (5 µM primer 1, 5 µM 
primer 2, 10 mM NaCl) for 1 min at 95°C, 2 min at 90°C, thereafter the 
temperature was decreased by 5°C every 5 min until a final temperature 
of 5°C was reached. Ligation between the linearized vector and the 
annealed primers was performed with T4-DNA ligase. 
 
 
2.5  Sequencing of DNA 
 
    All the DNA constructs were tested first with restriction enzymes to 
identify positive clones and then sequenced. The sequencing reaction is a 
PCR using only one primer in the presence of fluorescent dNTPs (BTRRM 
mix from Applied Biosystem). The PCR was followed by DNA precipitation 
with ethanol and sodium-acetate. The DNA pellet obtained by this method 
was washed once with 70% ethanol, dried by air and resuspended in HPLC 
water. This sample was then placed in a sequencing instrument (Applied 
Biosystem), which combines electrophoretic separation of DNA fragments 
through acrylamide gels with a laser detection of the fluorescent 
nucleotides. The sequence thus obtained was compared with a sequence 
generated by the VNTi (Vector Nti) program of the protein. This was 
achieved by alignment of the two sequences with the “Clustal” alignment 
program available in the Internet (http://clustalw.genome.ad.jp/). 
 II/ Materials and methods 
  - 43 -  43
Note: All the cloned constructs are listed in a table presented in the 
appendix (chapter VI-2), which also indicates the cloning sites and the 
primers used for amplification or mutagenesis. 
 
 
II-3. Protein expression and purification 
 
3.1.  Expression and purification in E.coli 
 
  All the proteins produced in E.coli were GST fusion proteins cloned in the 
pGEX-2T vector. 
 
a- Small-scale expression 
 
  The aim of this protocol is to find the best conditions (time, temperature, 
or concentration of IPTG) to express a new fusion protein in E.coli. First, 
E.coli BL21 cells, a protease-deficient strain, were transformed and spread 
on LB-plates containing 0.05 mg/ml ampicillin. All the following culture 
steps were done in LB medium supplemented with 0.05 mg/ml ampicillin 
at 37°C. 
 
LB medium (1 liter): Selected Pepton 140 (Gibco BRL): 10g; Yeast extract 
(ICN): 5g, NaCl: 5g. 
 
Two or three colonies were picked and cultured overnight at 37°C in 10 ml 
LB-Amp. On the next day 500 µl of this pre-culture were dispensed into 
many reaction tubes, diluted to 5 ml and grown until an optic density at 
600 nm of 0.5 was reached. At this step IPTG (PeqLab; Erlangen, 
Germany) was added to different final concentrations ranging between 
0.05 and 0.8 mM. Some cultures were induced for 1, 2, and 3 h and one 
culture was also induced overnight with 0.2 mM IPTG at 29°C. At the end 
of the induction period 1.5 ml of each culture (including sample without II/ Materials and methods 
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IPTG, as control) were centrifuged (14,000 rpm, 2 min, 4°C). The 
obtained bacterial pellet was washed once with PBS, and centrifuged once 
again (14,000 rpm, 2 min, 4°C). The washed pellet was resuspended with 
50  µl SDS-PAGE loading buffer and incubated for 5 min at 96°C. The 
samples were centrifuged for 5 min at 14,000 rpm and room temperature. 
A volume between 5 and 10 µl was applied on a SDS-PAGE gel 
(acrylamide concentration: 10% or 12.5%), which after running was 
stained with Coomassie Blue. 
 
b- Larger cultures 
 
    This protocol (Zhao et al., 2001) was adapted to the production of 
milligram amounts of GST fusion proteins. The principle was almost the 
same as for the small scale expression. BL21 bacteria containing a 
positive clone were preserved in 50% of glycerol at –80°C. 20 ml of LB 
medium were inoculated and incubated under continuous shaking 
overnight at 37°C. This small scale culture was diluted on the next day to 
1 liter. The culture was allowed to grow until an optic density at 600 nm of 
0.5 was reached, and was then induced with IPTG (usually 0.2 mM for 3 
h). At the end of the induction period the cells were centrifuged (6,000 
rpm, 10 min, 4°C), and the pellet was resuspended in 20 ml of lysis 
buffer. The protein lysate, which was maintained permanently on ice, was 
sonicated 6 times for 30 s, with 30 s rest in-between (Sonifier 450, 
Branson). The lysate was cleared by centrifugation at 12,000 rpm for 10 
min and 4°C. Before usage the glutathione-Sepharose 4B beads 
(Amersham Biosciences; Freiburg, Germany) were washed 3 times with 
lysis buffer to remove ethanol. The supernatant was incubated with 0.5 ml 
glutathione-Sepharose beads for 1 h at 4°C by end-over-end mixing. II/ Materials and methods 
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Table 1: Composition of the buffers used for purification of GST-fusion proteins. 
 
Compound  Lysis buffer  Washing buffer 
PBS  200 ml  25-50 ml 
Tris-HCl 50  mM  (1.2114g)   
MgCl2 
0.5 mM  
(20.3 mg) 
 
pH 8.0  (HCl)   
At the last time: 
Triton X-100 
10% (Roche) 
0.5% (v/v)  0.1% (v/v) 
Lysozyme 
(Boehringer) 
1 µg/µl - 
Pefabloc (BioMol)  100 µM - 
DTT 5  mM  - 
 
 
At the end of the incubation time, the beads were washed 5 times with 
washing buffer. After the last washing step, the supernatant was entirely 
removed, and the beads were resuspended in fresh washing buffer 
containing 50% of glycerol (v/v) and stored in aliquots at –80°C. 
  For a semi-quantitative determination of protein concentrations, the GST 
fusion proteins were released from the beads by boiling in SDS-PAGE 
loading buffer and resolved on linear SDS-polyacrylamide gels (12.5% 
acrylamide) in parallel with known amounts of bovine serum albumin (2.5-
15 µg per lane) as standards. After staining the gel with Coomassie Blue, 
the concentration of the various GST fusion proteins were estimated by 
visual comparison of the intensity of the protein bands. 
 
 
3.2  Expression and purification in Xenopus laevis oocytes 
 
a- In vitro cRNA synthesis 
 
  The cDNAs of the proteins to be expressed in the oocytes were cloned 
into pNKS vectors. A first step before the transcription of cRNAs in vitro is 
linearization of the plasmid. This step is achieved using restriction 
enzymes such as Not I, Eco RI, Xba I, or Sph I, which cleave the plasmid II/ Materials and methods 
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behind the poly(A) tail only. The linearized “template” was then purified 
by using the QIAquick Nucleotide Removal Kit (Qiagen; Hilden, Germany), 
following the instructions of the manufacturer. Finally, the template was 
eluted with RNase-free 10 mM Tris-Cl, pH 8.5 and precipitated with 
ethanol (67% v/v), and sodium acetate (3.3% v/v) (3M, pH 4.6) at -20°C. 
The DNA template was then centrifuged, washed, and dissolved in 0.5x 
TE-buffer (TE 100x (Sigma; Taufkirchen, Germany): Tris-Base 1M, EDTA 
0.1M, pH 8.0). 0.5-3 µg were used for the cRNA synthesis with SP6-RNA 
polymerase (Epicentre; Madison, USA) and cap-nucleotides (Epicentre; 
Madison, USA). The synthetized cRNAs were then purified through 
Sepharose G50 columns (Amersham Biosciences; Freiburg, Germany) to 
remove the nucleotides, extracted with phenol-chloroform, and dissolved 
in 5 mM Tris/HCl, pH 7.2. The quantification of the cRNA quantity was 
achieved by measuring the absorbance at 260 nm in an Eppendorf 
photometer. 
 
b- Isolation and maintenance of  Xenopus laevis oocytes 
 
  Xenopus laevis females were anesthetized by immersion for 5-15 min in 
a 0.2% solution of 3-aminobenzoic acid ethyl ester (Tricaine=MS 222 
(Sigma; Taufkirchen, Germany) in water; pH 7.4 adjusted with Hepes). 
The animal was laid down on the back, and an incision was made on the 
lateral side of the abdomen. The desired amount of ovary was pulled out 
and immediately transferred into ORi (Oocyte Ringer solution). The 
incisions in the abdominal muscles and in the skin were sutured 
separately. 
  To separate the oocytes that are enclosed and bound to each other by 
follicle cells, the ovary lobes were manually separated into small pieces 
and incubated for about 15 h at 19°C in a collagenase solution (1.5 mg/ml 
Ori supplemented with gentamycin; sterile filtered). The next day, the 
oocytes were first washed several times with ORi, and then incubated for 
10 min in nominally calcium free ORi to remove the follicle cells. The II/ Materials and methods 
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oocytes were finally washed with ORi until the supernatant was clear. 
Oocytes of the same size and stage of development (stages V-IV) were 
manually selected by means of a fire polished Pasteur pipette and injected 
with cRNAs. Until used, the oocytes were stored at 19°C. 
 
Table 2: Oocytes Ringer solutions composition. 
 
Compound  ORi  Calcium free ORi  
NaCl  90 mM  90 mM 
KCl  1 mM  1 mM 
CaCl2 1  mM  - 
MgCl2  1 mM  1 mM 
Hepes  10 mM  10 mM 
Gentamycin 
(optional) 
50 µg/ml - 
pH 7.4 7.4 
 
 
 
c-  Micro-injections of cRNA in Xenopus laevis oocytes 
 
  The oocytes were injected, one at a time, with 50 nl (about 0.5 µg/µl) of 
one cRNA or a mixture of two, occasionally three cRNAs (with various 
ratios). The injection setup was composed of one stereo microscope, one 
micromanipulator, and one microinjector (World of Precision Instruments). 
For each cRNA a new glass capillary filled with mineral oil was used, whom 
tip was broken under the microscope to permit to suck up a cRNA droplet. 
After injections, the oocytes were stored for 1 h at 19°C to allow them to 
recover from injections and to allow the cRNA(s) diffusion inside the cell 
before labeling with radioactive methionine was started. Non injected 
oocytes were used as control group, and were subjected to the same 
treatment as the other injected oocytes. 
 
d- Metabolic labeling with [
35S]methionine 
 
  For metabolic labeling, the oocytes were incubated for 4h or overnight 
with Revidue
TM L[
35S]methionine (Amersham Biosciences; Freiburg, II/ Materials and methods 
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Germany), at about 0.1 MBq/oocyte (for 10 oocytes: 250 µl ORi, 1 MBq 
methionine, 2.5 µl NaCl) and 19°C. For each cRNA, at least 10 oocytes 
were injected, and labeled together in specially coated tubes. After this 
“pulse” period, the oocytes were homogenized for protein purification, or 
let alive for the desired time at 19°C in non-radioactive ORi to perform a 
so called “chase” period. 
 
e- Purification of (His)6-tagged proteins 
 
Table 3: Buffers used for purification of (His)6-tagges proteins. 
 
Compounds  Homogenization  Incubation  Washing 
Sodium Phosphate 
Buffer 0.1M, pH 8.0 
+ + + 
Purified digitonin 
(Fluka) 
1% (w/v)  1% (w/v) 
0.2% (w/v) 
(non purified) 
Protease inhibitors
*  0.1% (v/v)  0.1% (v/v)  0.1% (v/v) 
Iodacetamide  50 mM  -  1 mM 
Imidazole  -  10 mM/tube  25 mM 
 
*Protease inhibitors: Antipain (10 mM), Pepstatin A (5 mM), Leupeptin 
(50 mM), Pefabloc SC (100 mM) (all from BioMol, Hamburg, Germany). 
 
Iodacetamide (Sigma; Taufkirchen, Germany) prevents the formation of 
artificial disulfide bonds by alkylating thiols that may form by oxidation. 
Imidazole was used to reduce non-specific binding to the nickel agarose 
beads. When dodecylmaltoside (Biomol, Hamburg, Germany) was 
employed as a detergent instead of digitonin, the following concentrations 
were used: homogenization/incubation: 0.5% (≈ 10 mM); washing: 0.1%; 
elution: 0.05-0.1%. 
    After labeling, oocytes were washed with nominally calcium free ORi. 
Each group of oocytes (10/group) was homogenized with 200 µl of ice-
cold homogenization buffer (10 µl/oocyte). The homogenate was vortexed 
(3 times for 15 s) and incubated for 15 min on ice before being cleared by 
two centrifugation steps (16,000g, for 10 min, 4°C). After each 
centrifugation step, the layer between the pellet and the lipids (located at 
the surface) was pipetted, and was transferred into a new tube. II/ Materials and methods 
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Table 4: Sodium phosphate buffer and elution buffer composition. 
 
Compound 
Sodium 
Phosphate 
Buffer pH 8.0 
Elution buffer 
Na2HPO4 93.2  mM  - 
NaH2PO4 6.8  mM  - 
Imidazole -  250  mM 
Lyophilized 
digitonin 
- 0.5%  (w/v) 
HCl -  pH  7.4 
 
 
  The incubation reaction mix was composed of 100 µl homogenate, 30 µl 
Ni
2+-NTA agarose beads (Quiagen, diluted 1:1 with phosphate buffer), 
400 µl incubation buffer and 10 mM imidazole. The affinity 
chromatography took place for 45 min by end-over-end mixing at room 
temperature. Then the beads were washed 6 times with 1 ml washing 
buffer pro tube and pro washing step. At the last washing step, the 
complete supernatant was removed. Proteins were eluted from the Ni
2+-
NTA agarose by addition of 50 µl elution buffer and shaking at room 
temperature for 15 min. This step was repeated once and the two aliquots 
were mixed. After elution, the proteins were ready for deglycosylation, 
Blue-Native and SDS-PAGE analyses. 
 
f-  Chemical cross-linking 
 
  Chemical cross-linking is an effective method to covalently link proteins, 
which are close enough to each other that the cross-linker can bridge the 
space between them. This holds true for example for oligomers, which 
consist of monomers noncovalently linked. Covalent cross-linking allows 
then to visualize the protein of interest in its oligomeric state of the on 
SDS-polyacrylamide gels. II/ Materials and methods 
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    Three different cross-linkers were used: DMA (Pierce, Rockford, USA), 
DMS (Uptima) and DTSSP (Pierce, Rockford, USA), which differ from the 
length of their spacer arm. 
 
Fig. 1: Structures of the different cross-linkers used in this study. 
 
 
 
    Chemical cross-linking was performed on purified His-tagged proteins 
still bound on Ni
2+-NTA agarose beads. His-tagged proteins were purified 
from cRNA-injected radiolabeled oocytes as described in 2.2.e. The beads 
were washed five times with 0.1 M sodium phosphate buffer pH 8.0-0.2% 
digitonin, containing 25 mM imidazole, and 10 mM iodacetamide, and then 
two times with 0.1 M phosphate buffer pH 8.0-0.2% digitonin. After the 
last washing step all the washing buffer was carefully removed and the 
cross linking reaction was performed in a volume of 50 µl. Each cross-
linker was dissolved just before use. DMA and DMS were dissolved in 0.2 
mM triethanolamine pH 8.0-0.5% digitonin, and 50 µl were added to the 
beads. DTSSP was dissolved in 0.1 M sodium phosphate buffer pH 7.4-
0.5% digitonin, and 50 µl were added to the beads. At the desired time 
the beads were centrifuged, and the cross-linker was removed by 
pipeting. Before elution a washing step with 0.1 M phosphate buffer pH 
8.0-0.2% digitonin was performed. The proteins were eluted from the 
Ni
2+-NTA agarose beads by two rounds of incubation, both for 15 min at 
room temperature: first with 50 µl of 250 mM imidazole pH 7.4-0.5% 
digitonin, and second with 50 µl of 1x SDS-loading buffer containing 20 
mM DTT. DTSSP was an exception, because the second elution had to be II/ Materials and methods 
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performed in 50 µl 1x SDS-loading buffer without DTT. Both elutions were 
kept separated. 
  2.5 µl of 5x SDS-loading buffer (with or without 0.1 M DTT) were added 
to 10 µl of the first elution. The remaining 40 µl left were preserved for 
BN-PAGE analysis. The samples in SDS-loading buffer from the first and 
the second elution were denatured for 10 min at 56°C and proteins were 
then resolved on SDS-polyacrylamide gradient gels. 
 
g- Deglycosylation 
 
    Deglycosylations of glycoproteins were performed using two 
endoglycosidases: EndoH (Endoglycosidase H) and PNGase F (Peptide: N-
glycosidase F) (both form New England Biolabs, Frankfurt am Main, 
Germany). EndoH is only able to remove high mannose chains formed in 
the endoplasmatic reticulum (ER), whereas PNGase F removes high 
mannose chains formed in the ER, and complex oligosaccharides formed 
in the Golgi apparatus. The enzymatic reaction was performed in 1 x SDS-
PAGE loading buffer for 3h at 37°C. 10 µl of protein sample (in elution 
buffer) were supplemented with 2.5 µl of 5x SDS-PAGE loading buffer 
(containing 0.1 M DTT) and incubated with 2 µl enzyme diluted 1:10. 
EndoH was diluted in 1 x SDS-PAGE loading buffer, and PNGase was 
diluted in 1% (w/v) NP-40 to counteract SDS inactivation of this enzyme. 
Before loading the samples on SDS-PAGE, 1% NP 40 was added to the 
control samples (without enzyme) and to the samples digested with 
EndoH. 
 
 
II-4. Rat brain Synaptosomes preparation and interaction assays using 
GST fusion proteins 
 
4.1  Rat brain Synaptosomes preparation 
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    This protocol describes the preparation of a protein detergent extract 
from a rat brain, which is suited for affinity chromatography assays. 
 
Table 5: Sucrose buffer and detergent phosphate buffer composition. 
 
Compounds  “Sucrose” buffer  Detergent-phosphate buffer 
Sucrose 0.32  M  - 
Tris-HCl 10  mM  - 
Na2HPO4 -  77.4  mM 
NaH2PO4 -  22.6  mM 
Triton X-100 10%  -  0.1% (v/v) 
Protease inhibitors  0.1% (v/v)  0.1% (v/v) 
pH 7.4  7.4 
 
If digitonin was chosen instead of Triton X-100, the following 
concentrations were used: homogenization: 1% (w/v); washing: 0.2% 
(w/v). 
 
An adult Sprague-Dawley rat was anaesthetized with isoflurane (Abbot) 
and killed by decapitation. The brain was rapidly removed, and dropped 
into ice-cold PBS. 
 
All the following steps (4.1, 4.2 and 4.3) except elution, were performed 
on ice and the different buffers were maintained cold. 
 
The complete rat brain was homogenized with 10 ml of sucrose buffer with 
the help of a Potter-Elvehjem tissue homogenizer, at slow speed. The 
formation of air bubbles during the homogenization was avoided as far as 
possible. This homogenate was centrifuged for 10 min at 1,000g. 
The resulting supernatant is once again centrifuged for 15 min at 15,000 g 
(Schmalzing, 1985). At the end of this centrifugation, the pellet was 
resuspended with 1 ml sucrose buffer and diluted with 4 ml phosphate 
buffer. This homogenate (= “synaptosomal detergent extract”) was 
incubated by end-over-end mixing for 15 min at 4°C. 
The synaptosomal detergent extract was centrifuged for 10 min at 
15,000g, and the supernatant was used for the pull-down experiments. II/ Materials and methods 
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4.2  Rat brain Synaptosomes purification through a Ficoll gradient 
 
    In some experiments, myelin was removed from the synaptosome 
preparation. For this purpose a supplementary step consisting of a 
centrifugation through a discontinuous Ficoll/sucrose gradient was added 
to the protocol described above (Booth and Clark, 1978). 
  As previously, the brain tissue was homogenized in sucrose buffer and 
centrifuged for 10 min at 1,000g, and the resulting supernatant was 
centrifuged for 15 min at 15,000g to obtain a crude 
mitochondrial/synaptosomal P2 pellet. The P2 pellet was resuspended with 
2.5 ml of a sucrose solution (0.32 M sucrose, 50 µM EDTA, pH 7.4) and 
diluted to 15 ml with 12% Ficoll/sucrose: 12% (w/w) Ficoll
TM PM 400 
(Amersham Biosciences; Freiburg, Germany) 0.32  M sucrose, 50 µM 
EDTA, pH 7.4. This suspension was transferred into a centrifugation tube 
and carefully overlaid with 11.75 ml of 7.5% Ficoll/sucrose (7.5% (w/w) 
Ficoll, 0.32 M sucrose, 50 µM EDTA, pH 7.4) and 11.75 ml sucrose solution 
(0.32 M sucrose, 50 µM EDTA, pH 7.4). The tube was centrifuged for 30 
min at 99,000 g and 4°C (SW 28 rotor, Beckman). At the end of the 
centrifugation, the purified synaptosomes are located at the border 
between 12% and 7.5% Ficoll (see Fig.2). 
  The synaptosomal layer was collected with a Pasteur pipette, diluted to 
15 ml with sucrose buffer and centrifuged for 10 min at 15,000 g and 4°C. 
The pellet was then subjected to the same detergent treatment as in 3.1. 
 
 
 
 
 
 
 
Fig. 2: Scheme of the fractionation of a crude mitochondrial pellet trough a 
Ficoll-Sucrose gradient. 
Synaptosomes
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Synaptosomes
Saccharose
Ficoll 7.5%
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4.3  “Pull-down” experiments: Interaction assays using GST fusion 
proteins 
 
  The complete synaptosomal detergent extract was pre-cleared by a 30 
min incubation with about 200 µg of GST protein alone, immobilized on 
glutathione-Sepharose. The beads were centrifuged (for 2 min, 10,000g 
and 4°C) and discarded. 1 ml of the pre-cleared supernatant (about 3 mg 
of synaptosomal proteins) was incubated with about 50 µg of one of the 
various GST-P2X fusion proteins (immobilized on glutathione-Sepharose) 
for 1 h at 4°C. The beads were washed 5 times with detergent-phosphate 
buffer, and proteins were then eluted by a 15 min incubation with 1x SDS-
PAGE loading buffer at 56°C. The samples were resolved by SDS-PAGE, 
and proteins were visualized by staining with Coomassie Blue. 
 
 
II-5. Protein separation: PolyAcrylamide Gel Electrophoresis 
 
5.1.  SDS-PAGE 
 
a- Linear SDS-PAGE 
  To pour the SDS-polyacrylamide gels, a vertical slab glass cuvette from 
Phase (Lübeck, Germany) was used, and the following volumes (in ml) are 
calculated for 1 gel of 1 mm thickness using this cuvette: 
 
Table 6: 5x SDS-loading buffer composition. 
 
Compound 
Vol. or weight 
(concentration) 
1M Tris/HCl pH 6.8  3.1 ml (310 mM) 
SDS  1 g (10%) 
87% glycerol  7g (50%) 
Bromophenol blue  50 mg (0.5%) 
H2O  Adjust vol. to 10 ml 
 
Just before use: add 5 µl of 2M DTT to 100 µl of 5x SDS-PAGE loading 
buffer II/ Materials and methods 
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Protein mass marker: [
14C]-labeled molecular mass marker (Rainbow, 
Amersham Biosciences; Freiburg, Germany) 
 
 
Table 7: Preparation of linear SDS-polyacrylamide gels. 
 
Compounds  1 gel 10%  1 gel 12.5% 
1 stacking gel 
(4%) 
H2O 3.635  3.167  3.17 
40% acrylamide
* 1.875  2.343  0.5 
1.5M Tris-HCl pH 8.8  1.875  1.875 - 
0.5M Tris-HCl pH 6.8  -  -  1.25 
20 % SDS  0.0375  0.0375  0.025 
10 % APS  0.075  0.075  0.05 
TEMED  0.003 0.003 0.005 
* 40% acrylamide/Bis-acrylamide solution (29:1) Bio-Rad 
 
Running buffer: 10xTris/glycine/SDS 
250 mM Tris, pH 8.3, 1.92 M glycine, 1% SDS 
It is not necessary to adjust the pH, this is achieved automatically, 
furthermore chloride ions would disturb the migrations of proteins. 
 
Fixing solution to facilitate the drying of a SDS-polyacrylamide gels: 
65% H2O; 25% Isopropanol; 10% acetic acid 
 
Coomassie Blue staining : 
 
Table 8: Staining and destaining solutions composition for Coomassie blue 
staining. 
 
Solution  Compound  Weight, or vol. 
Coomassie 
Brilliant Blue 
R250 
0.3 g 
Methanol  1.5 ml 
Staining 
(200 ml) 
TCA  198.5 ml 
Methanol 300  ml 
Acetic acid  150 ml 
Destaining 
(2 l) 
H2O 1550  ml 
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b- Gradient SDS-PAGE 
 
  The  gradient  SDS-polyacrylamide  gels are poured with the same gel 
solutions as for the linear SDS-PAGE system, but consist of a mixture of 
two preparations with different acrylamide concentrations. The volumes 
are calculated such that when the gradient gel is poured there is no 
solution left. The stacking gel is exactly the same as in 4.1.a-. 
 
 
Table 9: Preparation of gradient SDS-polyacrylamide gels. 
 
Compounds  1 gel 4 %  1 gel 10 % 
H2O 2.699  2.061 
40% acrylamide
* 0.4254  1.0635 
1.5M Tris-HCl pH 8.8  1.0635  1.0635 
20 % SDS  0.0213  0.0213 
10 % APS  0.0425  0.0425 
TEMED 0.0017  0.0017 
 
* 40% acrylamide/Bis-acrylamide solution (29:1) Bio-Rad 
Volumes in ml. 
 
The gels are run at 100V when the proteins are in the stacking gel, and at 
125V when the proteins are in the running gel. 
 
 
c-  Tricine-SDS-PAGE 
 
The Tricine-SDS-PAGE system is a discontinuous SDS-PAGE method, 
which enhances the resolution for small proteins (Schägger and von 
Jagow, 1987). Tricine is used instead of glycine as trailing ion. The gels 
are run at 70V when the proteins are in the stacking gel, and at 100V 
when the proteins are in the running gel. 
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Table 10: Buffers used in the tricine-SDS-PAGE system. 
 
Compounds  Gel buffer  Anode buffer  Cathode buffer 
Tris  3 M  0.2 M  0.1 M 
Tricine -  -  0.1  M 
% SDS  0.3  -  0.1 
pH
* 8.45 8.9 
8.859 
(automatic) 
pH
* : The pH values are adjusted with HCl 
 
 
Table 11: Preparation of tricine-SDS-polyacrylamide gels. 
 
Volumes in ml for 1 gel (1mm) 
 
Compound  Spacer gel 10% 
Running gel 
16.5% (optional) 
Stacking gel 4% 
Gel  buffer  1.67 1.67 0.62 
40% acrylamide
* 1.26  2.079  0.25 
H2O 2.07  0.761  1.63 
Glycerin  - 0.6  g - 
10%  APS  0.025 0.025 0.013 
TEMED 0.0025 0.0025 0.0013 
*40% acrylamide/Bis-acrylamide solution (29:1) Bio-Rad 
 
 
Table 12: 5x tricine-SDS-loading buffer. 
 
Compound  %/concentration 
Tris/HCl pH 6.8  250 mM 
SDS 20% 
Glycerol 60%  (w/v) 
Serva Blue G  0.05% 
 
Just before use: add 5 µl of 2M DTT to 100 µl of 5x SDS-PAGE loading 
buffer 
 
 
d- Tris-Borate-EDTA SDS-PAGE 
 
  This protocol is inspired from the work of J.F. Poduslo (Poduslo, 1981). 
Glycoproteins often behave anomalously in SDS-PAGE systems, because 
the binding of constant amounts of SDS per protein molecule is not II/ Materials and methods 
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achieved compared with non-glycosylated proteins. The glycoprotein 
migrates at a higher apparent molecular mass. 
    During my experiments I was confronted to the problem that some 
glycoproteins were not migrating as sharp bands in SDS-PAGE. For this 
reason borate salt was included in the gel solutions. Borate ions can react 
with neutral sugars converting them to charged complexes at alkaline pH. 
The formation of borate complexes could increase the net negative charge 
of glycoproteins which would compensate for the decreased binding of 
SDS, resulting in a charge density consistent with an electrophoretic 
migration of glycoproteins that now correlates with their molecular mass. 
    Proteins were purified from injected oocytes as described in 2.2.e. 
Elution was performed as usual with 100 µl of 250 mM imidazole, pH 7.4, 
and 0.5% digitonin. 9 µl of protein sample in 1x SDS-loading buffer was 
incubated overnight at 4°C with 1 µl of a borate solution (1 M Tris, 1 M 
boric acid, 25 mM EDTA, pH 8.3). The next day the sample was applied on 
a borate SDS-polyacrylamide gel prepared as follows. The gel was poured 
like a conventional SDS-PAGE, the only difference is the composition of 
the gel solutions. 
 
Borate gel buffer: 1 M Tris, 1M boric acid, 25 mM EDTA, 1% SDS, pH 8.3 
 
 
Table 13:. Preparation of Tris-Borate-EDTA-SDS-polyacrylamide gels. 
 
Compounds  1 gel 10% 
1 stacking gel 
(4%) 
H2O 4.800  4.195 
40% acrylamide
* 1.875  0.5 
Borate gel buffer  0.750  0.250 
10 % APS  0.075  0.05 
TEMED 0.003  0.005 
* 40% acrylamide/Bis-acrylamide solution (29:1) Bio-Rad 
 
Running buffer: 0.1 M Tris, 0.1 M boric acid, 2.5 mM EDTA, 0.1% SDS, 
pH 8.5 
The gel run 4.5 h at constant power (15W) with a cooling system. II/ Materials and methods 
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5.2.  BN-PAGE 
 
    B l u e  n a t i v e  ( B N )  P A G E  a n a l y s i s  permits gel electrophoresis under non 
denaturing conditions (Schägger et al., 1994) and thus the determination 
of the oligomeric structure of proteins. BN acrylamide gels are gradient 
polyacrylamide gels. The gels were let run for 3 h, or overnight to allow 
the proteins to reach their equilibrium migration point. 
 
 
Table 14: Buffers used in the BN-PAGE system. 
 
Compounds  Gel buffer 3 x  Anode buffer  Cathode buffer 
Tricine -  - 50  mM 
Bistris  150 mM  50 mM  15 mM 
Aminocaproic acid 
(Sigma) 
1.5 M  -   
pH
* 7.0 7.0 7.0 
Serva Blue G  -  - 
0.005% 
just before use 
pH
* : The pH values were adjusted with HCl 
 
 
 
 
Table 15: Preparation of BN-Polyacrylamide gels. 
 
Compound  Gel 4%  Gel 16%  Gel 6%  Gel 20% 
Stacking 
gel 4% 
Gel  buffer  1.362  1.362  1.09 1.09 1.67 
30% 
acrylamide
* 
0.575 2.265  0.86  3  0.667 
H2O  2.3  - 2.35 - 2.64 
Glycerin  -  0.903 g  -  0.72 g   
10% APS  14.875 µl  14.875  14.875 µl 14.875  µl 20.µl 
TEMED 2.875  µl 2.875 2.875  µl 2.875  µl 4  µl 
 
 
 
*30% acrylamide/Bis-acrylamide solution (29:1) Bio-Rad 
 
 
Gel run for 3h  Gel run for 12h II/ Materials and methods 
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Protein mass marker: Combithek II (Boehringer Ingelheim, Germany), 
calibration proteins in native conformation for chromatography (MW 
18,000-300,000 kDa). 
 
Table 16:. 5x BN-loading buffer. 
 
Compound  %/concentration 
Serva Blue G  1% 
Aminocaproic acid  100 mM 
Glycerol 50%  (w/v) 
 
2.5 µl BN-loading buffer 5x were added to 10 µl of protein sample. 
 
    Before being loaded on the BN-gel, some samples were subjected to 
treatments (in BN-loading buffer) that might denature proteins such as   
heating (1h-37°C or 1h-56°C) or incubation with urea (4M or 8M), DTT 
(0.1M), or SDS (0.01 to 1%). Urea (Sigma; Taufkirchen, Germany) was 
freshly dissolved in 2.5 µl 5x BN-loading buffer by flickering, then 10 µl 
sample were added. For samples in native condition, BN-loading buffer 
was added just before loading on the gel. 
    It is important to wash the pockets of the BN-gel with buffer before 
loading the samples, because there is still non-polymerized acrylamide 
inside after removing the comb. 
 
 
Table 17: Staining and destaining solutions composition for Coomassie blue 
staining of BN-polyacrylamide gels. 
 
Solution  Compound  Weight, or vol. 
Coomassie 
Brilliant Blue 
R250 
1 g 
methanol  450 ml 
acetic acid  100 ml 
Staining 
1 l 
H2O  450 ml 
methanol 100  ml 
acetic acid  100 ml 
Destaining 
1 l 
H2O 800  ml 
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  The radioactive SDS-polyacrylamide gels were dried for 2h at 80°C, and 
the tricine- or BN-gels were dried for 3 h at 70°C (Gel dryer model 583, 
Bio-Rad). The signal on the gels was then revealed either with BioMax MS 
films (Kodak), or by using PhosphorImager screens (Amersham 
Biosciences; Freiburg, Germany) in combination with a Storm 820 
PhosphorImager. Kodak films were developed manually using fixing and 
developing solutions from Kodak according to the instructions of the 
manufacturer. 
 
 
5.3.  2D-electrophoresis 
 
  Two-dimensional electrophoresis is a powerful method for the analysis of 
complex protein mixtures extracted from cells, tissues or other biological 
samples. This technique separates proteins according to two independent 
properties in two steps: 
 the first dimension step: isoelectric focusing (IEF) separates the 
proteins according to their isoelectric point (pI) 
 the second-dimension step, SDS-PAGE, separates proteins according 
to their molecular mass. 
Each spot on the resulting two-dimensional array is assumed to 
correspond to a single protein species in the sample. 
  For IEF (first dimension), the Multiphor
TM II apparatus and immobilized 
non-linear pH gradients (18 cm IPG strips, pH 3-10; Amersham 
Biosciences, Freiburg, Germany; ordering number: 17-1235-01) were 
used. For the second dimension large SDS-polyacrylamide gels (18x16 cm 
plates) were poured according to the recipe described in 4.1.a, and were 
run with a Biometra Maxigel apparatus (Göttingen, Germany). The 
complete protocol, including solution compositions is extremely well 
described in a booklet available through Amersham Biosciences 
(Berkelman and Stenstedt, 1998). II/ Materials and methods 
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  2-D electrophoresis was performed after pull-down experiments (3.3.). 
After the washing steps, proteins were eluted with reduced glutathione 
(Amersham Biosciences; Freiburg, Germany) instead of 1x SDS-loading 
buffer. The elution solution contained 10 mM glutathione freshly 
solubilized in Tris-HCl 50 mM, pH 8.0. For elution proteins were incubated 
for 1h at room temperature by end-over-end mixing with 1 ml of 
glutathione solution per 50 µl beads. Proteins were then precipitated with 
3 ml of ice cold acetone per ml of protein solution in glutathione for at 
least 2 h at -20°C. Proteins were collected by centrifugation (20,000g for 
15 min at 4°C), the pellet was dried by air and finally solubilized in 
rehydration solution for IPG strips (Amersham Biosciences; Freiburg, 
Germany), which volume depended on the size of the protein pellet and 
ranged between 500 µl and 1 ml. IPG strips were rehydrated overnight at 
room temperature with IPG rehydration solution in which eluted proteins 
were dissolved. Details of the electrophoretic separation in the first and 
second dimensions are well described in the reference cited above. 
 
 
II-6. Other techniques 
 
6.1.  Silver staining 
 
  The 2-D polyacrylamide gels were stained with silver nitrate to visualize 
the protein spots. The following protocol is adapted from (Blum et al., 
1987), and is compatible with tryptic digestion for mass spectrometry 
analysis. 
    For the sensitization step a 10% NaS2O3 (pentahydrate) solution was 
prepared, which was diluted 500 fold before use (2 ml of 10% stock 
solution in 1l) because the 0.8 mM NaS2O3 solution is stable for 1 week 
only. II/ Materials and methods 
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  The staining protocol was the following: The gels were fixed 3 times for 
30 min in fixing solution and rinsed 4 times for 10 min with water. The 
sensitizing step lasted only 1 min (1 gel at a time). 
 
Table 18: Composition of the solutions used for silver staining. 
 
Compound  Fixation  Sensitizing  Staining   Developing  Stop 
NaS2O3 
(pentahydrate) 
- 0.8  M -  0.00125%  - 
NiAg - -  2  g/l  - - 
K2CO3 - - -  3%  - 
37% 
formaldehyde 
solution 
- - -  0.00925  - 
Tris -  -  -  -  4% 
Absolute 
ethanol 
30% -  -  -   
Acetic acid  5%  -  -  -  2% 
 
 
Immediately thereafter the gels were rinsed twice for 1 min with water, 
incubated in silver nitrate for 30-60 min, and rinsed once for 5-15 s with 
water. Development was performed by an incubation for 10-20 min with 
the developing solution. The development was stopped by immerging the 
gels into the stop solution for 30-60 min. Finally the gels were rinsed 
several times with water. 
  After silver staining the gels were dried (see 5.2.) and scanned using the 
Snapscan 1236 scanner from Agfa. Protein spots of interest were excised 
from the gels after drying, subjected to proteolytic digestion with trypsin 
(Promega; Mannheim, Germany) in the gel matrix and fragments were 
analysed by Maldi-TOF mass spectrometry by the group of K. Aktories 
(Institute of Experimental and Clinical Pharmacology and Toxicology, 
Albert Ludwigs-University, Albertstrasse 25, D-79104 Freiburg, Germany) 
using a Bruker Biflex mass spectrometer (Schmidt et al., 1999). 
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6.2  Western-Blotting 
 
    The first step of a Western-blot is the transfer of the proteins from 
acrylamide gels onto nitrocellulose membranes. The transfer was 
performed with a semi dry blotter (Pegasus blotter, Phase, Lübeck, 
Germany). The transfer buffer contained 25 mM Tris, 192 mM glycine,   
and 20% methanol. PVDF nitrocellulose membrane (Millipore) was used, 
which was soaked in methanol before use. The advantage of this type of 
membrane is that proteins are trapped on the membrane and can not 
pass through it. The transfer was performed for 2 h at ∼2 mA/cm
2 of gel 
surface, and a maximum of 40 volts. 
 
Fig. 3: Protein transfer principle. 
 
 
 
    The main buffer used for Western-blot is called TBST (10 mM Tris 
pH 8.0, 150 mM NaCl, 0.05% Tween 20 (Sigma; Taufkirchen, Germany)). 
All the steps of the Western-blot were performed at room temperature. 
After transfer, the membrane was blocked for 1 h with TBST 
supplemented with 1% (w/v) of non-fat dry milk and 1% (w/v) of BSA, 
and then incubated for 1 h with the “primary” antibody diluted in 
TBST/1% milk/1% BSA. The membrane was then washed 3 times for 10 
min with TBST/1% of milk/1% of BSA. The incubation (for 1 h) with the 
“secondary” antibody (HRP-conjugated antibody, diluted with TBST/1% 
milk/1% BSA) was followed by 3 washing steps (15 min each) with TBST. 
The membrane was at this step ready for enhanced chemiluminescence 
(ECL), which is a method to detect the bound antibodies. During this 
study the following antibodies were used: antibody anti-ßIII  tubulin 
Cathode, steel
Anode, Pt titan
Filter papers
(Whatman)
SDS-Gel
PVDF membrane
Cathode, steel
Anode, Pt titan
Filter papers
(Whatman)
SDS-Gel
PVDF membraneII/ Materials and methods 
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(1:400, Sigma), anti-MBP (1:400, PharMingen), and goat antibody anti-
mouse IgG HRP-conjugated (1:5000, Amersham Biosciences). 
    The ECL-solution was composed of 0.1 M Tris-HCl, pH 8.5, 25 µM 
Luminol (Sigma), and 0.44 µM Comaric acid (Sigma). At the last time 6.25 
µl of H2O2 were added to 10 ml of ECL solution. For ECL, the membrane 
was incubated in ECL-solution for 1 min in a dark room, and placed 
between two plastic sheets. A film (Hyperfilm
TMMP, Amersham 
Biosciences; Freiburg, Germany) was then exposed to the membrane. The 
time of exposure was adjusted to the intensity of the signal. The film was 
then developed with a developing machine (Optimax Type TR, MS 
Laborgeräte). 
 
 
6.3.  Overlay assays 
 
    This protocol for overlay assays was adapted from the work of 
McPherson et al. (McPherson et al., 1994), all the steps were performed at 
room temperature. GST fusion proteins w e r e  p r o d u c e d  a s  d e s c r i b e d  i n  
2.1.b, but after the washing steps, directly eluted with a 10 mM 
glutathione solution (in Tris 50 mM, pH 8.0). Glutathione solution was 
exchanged against sodium phosphate buffer (0.1 M, pH 8.0) by size 
exclusion chromatography using Hi-Trap desalting columns (Amersham 
Biosciences; Freiburg, Germany). 
After determining the protein concentration with a BCA protein assay 
reagent kit from Pierce (Rockford, USA; for details see the instructions of 
the manufacturer), the GST fusion protein was stored in aliquots at -80°C. 
  A Triton X-100 extract of synaptosomes was supplemented with reducing 
SDS-PAGE loading buffer, boiled for 2 min (95°C), and then resolved on 
an SDS-polyacrylamide gel (10% acrylamide). After semi-dry protein 
transfer, the PVDF membrane was blocked by overnight incubation with 
Blotto buffer. The membrane was then washed and incubated for 1 h in II/ Materials and methods 
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buffer B containing 3% BSA, 1 mM DTT and 4.5 µg/ml of one of the GST 
fusion proteins. 
 
Tables 19, 20: Composition of the buffers used for overlay assays 
 
 
 
Blotto Buffer 
Compound  Concentration 
NaCl 150  mM 
Na2HPO4 50  mM 
Non-fat dry milk 
5% (w/v) 
(at the last time) 
pH 7.5 
 
 
 
    The membrane was washed three times with buffer B containing 3% 
BSA, and then incubated with an antibody against GST (Amersham 
Biosciences; 1:10,000) in buffer B, 3% BSA. Subsequently, the membrane 
was washed twice with buffer “C” (10 mM Tris-HCl, pH 7.4, 150 mM NaCl), 
four times with buffer “D” (0.2% SDS, 0.5% Triton X-100, 0.5% BSA, 
0.9% NaCl, pH 7.0), and twice with buffer C. Bound GST-antibody was 
labeled by incubation with [
125I]protein A (Amersham Biosciences; 30,000 
cpm/ml) for 1 h in buffer C, followed by a series of washing steps (2x 
buffer C, 5x buffer D, 3x buffer C). Visualization of bound radioactivity 
was achieved by PhosphorImaging. 
Buffer B 
Compound  Concentration 
Tris 20  mM 
Tween 20  0.1% 
pH 7.4 
At the last time: 
DTT (optional)  1 mM 
BSA 3%  (w/v) 
GST fusion protein 
(optional) 
4.5 µg/ml III/ Results 
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III/ Results 
 
III-1. Identification of proteins interacting with the C-terminal tail of P2X 
receptors 
 
  To isolate proteins interacting with the C-terminal tail of P2X receptors, 
GST fusion proteins containing the C-terminal portion of rat P2X2, P2X5 
and P2X7 were produced and used as baits to screen detergent extracts of 
rat brain synaptosomes by affinity chromatography. To identify potential 
interacting partners, proteins were resolved by SDS-PAGE and/or 2D-
electrophoresis. Protein bands/spots of interest were excised from the 
gels, digested with trypsin and proteolytic fragments were analyzed by 
MALDI-TOF mass spectrometry. The proteolytic profiles were then 
compared with those deposited in databases. 
 
1.1  Design and expression of GST-rP2X2
356-472, GST-rP2X5
364-457 and 
GST-rP2X7
433-596 fusion proteins 
 
    The members of the P2X receptor family share a common membrane 
topology with two membrane spanning segments linked by a large, 
glycosylated ectodomain (Fig. 1). The first transmembrane segment is 
preceded by an intracellular N-terminal domain, which has a similar length 
of 24-31 amino acids on all P2X subunit isoforms. In contrast, the C-
terminal tails show no apparent sequence homology and their lengths vary 
considerably between the various P2X isoforms ranging from 27 (P2X6) to 
239 amino acids (P2X7). These characteristics suggest that the C-terminal 
tails may carry isoform-specific information important for the subcellular 
targeting and membrane clustering of the receptor. 
  For a search of putative binding proteins, we focused on the three P2X 
subunits that possess the longest C-terminal domains within the P2X 
family: P2X2, P2X5, P2X7, assuming that they have the highest probability 
to be involved in protein-protein interactions. Three GST-P2X fusion 
proteins were engineered all consisting of glutathione S-transferase fused III/ Results 
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N-terminally to the C-terminal tail of one of the three rat P2X isoforms 
(see Fig.2). 
 
 
Fig. 1: Membrane topology of P2X2 receptors showing glycosylation, 
phosphorylation and possible disulfide bonding (North, 2002). Solid circles (N): 
indicate glycosylated sites in the native P2X2 receptor. Open circles (T, S): indicate 
positions phosphorylated by protein kinases (PKC, PKA). Open circles (C): indicate the 10 
conserved cysteines. Open squares (H): indicate histidine residues involved in zinc (His-
120, His-213) and proton binding (His-319). 
 
 
a- Expression of the three GST-rP2X fusion proteins 
 
  Small quantities of GST fusion proteins were first produced to find the 
optimal culture and induction conditions and to see the pattern of 
expression of the different proteins. Fig. 3 shows GST-P2X2 fusion protein 
resolved by SDS-PAGE after small scale expression, and Fig. 4 shows the 
pattern of expression of the three GST-P2X fusion proteins expressed in 
E.coli BL21. The optimal induction conditions for all the fusion proteins 
were 0.2 mM IPTG for 3h at 37°C. These culture and induction conditions 
were also used for the expression of large amounts of fusion proteins. As 
shown in Fig. 4, the full-size GST-P2X2 and GST-P2X5 were produced as 
full-length proteins in E.coli BL 21 as judged from the correct mass of the III/ Results 
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major protein species. In addition, several degradation products were 
observed in small quantities. 
  Unfortunately  GST-P2X7 was degraded either during the protein 
synthesis or during the purification steps. Reducing the temperature of 
culture from 37°C to 25°C or using E.coli K-12 TG1 as a bacterial host 
strain did not eliminate this problem. Also usage of a milder detergent 
(digitonin) or reducing the intensity of ultrasonication did not reduce 
GST-P2X7 degradation (results not shown). Pull-down experiments were 
nevertheless performed with these samples. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2: Design of the GST-P2X fusion proteins and map of the pGEX-2T vector. 
(A) Superscripts refer to the amino acid sequence of the corresponding full length P2X 
subunit. The total mass of the fusion protein including the GST portion is indicated. 
(B)  Map of the pGEX-2T vector (Amersham Biosciences). All the P2X sequences were 
cloned between the BamH I and EcoR I cleavage sites of this vector. 
 
    An upper band of approximately 70  kDa was always observed to co-
purify with the fusion proteins. A protein of an apparently identical mass 
has already previously been observed to co-purify in pull-down 
experiments and has been identified to represent the product of the gene 
dnaK from E.coli (Amersham Biosciences, 2001). This protein is involved 
in the degradation of “abnormal” proteins in E.coli and binds to GST or the 
Sepharose matrix. 
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433-596
38 kDa
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b- Pull-down experiments: Tubulin binds specifically to the P2X2 
subunit 
 
    To identify possible interacting proteins, the GST fusion proteins 
incorporating the C-terminal domains of the rat P2X2, P2X5 and P2X7 
isoforms were incubated with a detergent extract of rat brain 
synaptosomes. After washing and centrifugation, bound proteins were 
eluted from the glutathione-Sepharose beads and resolved by tricine-SDS-
PAGE followed by Coomassie blue staining. 
    For each fusion protein, two samples were treated identically: one 
sample consisted of fusion protein (immobilized on glutathione-Sepharose 
beads) and detergent extract of synaptosomes, the other sample (control) 
consisted of the same quantity of immobilized GST-P2X fusion protein and 
the detergent buffer used for the synaptosome preparation and extraction 
(sucrose/phosphate buffer, see II-4.1). After finishing the pull-down 
experiment, the two samples were resolved on the same tricine-SDS-
polyacrylamide gel. Protein bands present in the sample incubated with 
synaptosome detergent extract, and absent in the control sample were 
considered to represent potential interacting proteins. These bands were 
excised from the gel, digested with trypsin in the gel matrix, and analyzed 
by MALDI/TOF mass spectrometry. MALDI/TOF analyses were performed 
by Dr. J. Schirmer from the Institute of Experimental and Clinical 
Pharmacology and Toxicology in Freiburg, Germany. As additional control, 
pull-down experiments were performed (-/+ synaptosome extracts) with 
glutathione-Sepharose beads loaded with the GST moiety alone to 
distinguish proteins that interact non-specifically with the GST part of the 
fusion protein. 
    Pull-down experiments were performed with synaptosome extracts 
prepared either with Triton X-100, or with digitonin, which is considered to 
be a milder detergent than Triton X-100. The results are presented in 
Fig. 5 and 6. A protein band of approximately 55 kDa was detected in the  
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Fig. 3: Small-scale expression of GST-P2X2. BL21 bacteria were induced by IPTG for 
different time periods and at different concentrations as indicated (for further details see 
Materials and Methods 3.1.a). After the induction the bacteria were harvested and lysed 
with 1x SDS-loading buffer and the proteins were resolved on a 12.5% SDS-
polyacrylamide gel. Arrow, GST-P2X2 polypeptide. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 4: Pattern of expression of GST-P2X2 (A), GST-P2X5 (B), and GST-P2X7 (C) 
in E.coli. The different fusion proteins were expressed in E.coli BL21, and purified with 
glutathione-Sepharose beads. For semi-quantitative determination of protein 
concentrations, the various GST fusion proteins were released from glutathione beads 
(different volumes) by boiling in SDS-loading buffer and resolved on linear 12.5% SDS-
polyacrylamide gels in parallel with known amounts of bovine serine albumin as 
standards. The gels were stained with Coomassie blue, and the concentration of the 
various GST fusion proteins were estimated by visual comparison of the intensity of the 
protein bands. # Product of the gene dnaK from E.coli, which was consistently co-purify 
with the GST-fusion proteins; ** degradation products; arrow, indicated P2X fusion 
protein. 
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samples incubated with GST-P2X2
356-472 (=GST-P2X2) and brain detergent 
extract (Fig. 5 and 6, lane 2). In contrast, this band was neither observed 
when the brain detergent extract was incubated with GST alone (Fig. 5 
and 6, lane 4), with GST-P2X5 (Fig. 5 and 6, lane 7), nor with GST-P2X7 
(Fig. 5 and 6, lane 9). The 55 kDa band was identified by MALDI/TOF 
mass spectrometry as ßIII tubulin (accession number: P04691), a brain-
specific ß tubulin isoform. These results were corroborated by immunoblot 
analyses (Fig. 7), which clearly demonstrate that tubulin was pulled-down 
with GST-P2X2
356-472, but not with the two other GST-P2X fusion proteins 
nor with GST alone. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5: Pull-down of proteins from a Triton X-100 extract of rat brain 
synaptosomes with GST-P2X fusion proteins. Proteins were pulled-down from a 
Triton X-100 extract of crude rat brain synaptosomes as described in Materials and 
Methods. Proteins were resolved in a tricine-SDS-polyacrylamide gel stained 
subsequently by Coomassie blue. Incubation conditions: (S): Synanaptosomes; (B): 
Buffer. Black arrow: interacting protein. 
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Fig. 6: Pull-down of proteins from a Digitonin extract of rat brain synaptosomes 
with GST-P2X fusion proteins.. Proteins were pulled-down from a digitonin extract of 
crude rat brain synaptosomes as described in Materials and Methods. Proteins were 
resolved in a tricine-SDS-polyacrylamide gel stained subsequently by Coomassie blue. 
Incubation conditions: (S): Synaptosomes; (B): Buffer. Black arrow: interacting proteins. 
 
 
 
 
 
 
Fig. 7: Immunoblot analysis after pull-down experiments with GST, GST-P2X2, 
GST-P2X5, and GST-P2X7. The samples used for Western-blot are the same as in 
Fig. 5, but only the samples incubated with synaptosomes were tested. The transferred 
proteins were probed with an antibody against ßIII tubulin followed by ECL. In the 
control lane a few µl of the crude synaptosome detergent extract was applied as a 
positive control of the blotting reaction. 
 
 
c-  Results confirmed by 2D-electrophoresis 
 
    Because of the limited resolution capacity of 1-D-SDS-PAGE, potential 
interacting partners of P2X receptors may be hidden behind the large 
amount of fusion protein. To address this problem, the 2D-electrophoresis 
technique was used. To this end, pulled-down proteins were eluted with 
reduced glutathione, and precipitated with acetone as described in the 
methods (4.3). The proteins were then resolved on immobilized pH 
gradients (IPG) gel strips between pH 3 and 10. The second dimension 
was performed with 12.5% SDS-polyacrylamide gels and the gels were 
stained with silver nitrate. This protocol was used only with GST-P2X2 and 
GST as control. As in 1.1.b, two samples were handled in parallel, one 
with synaptosome detergent extract, and one with buffer as control. Two 
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2D-gels corresponding to pull-down with GST-P2X2 are presented in 
Fig.  8. By comparison of the two gels, some news spots were detected 
(not detected after pull-down with GST, data not shown), which can 
correspond to new proteins interacting with the P2X2 subunit. These spots 
are still to be analysed by mass spectrometry. 
    In experiments destined for detection of proteins by Western-blotting, 
the silver staining was omitted. Proteins were transferred onto 
nitrocellulose membranes and blotted with an antibody against ßIII 
tubulin. The ßIII tubulin was detected in the sample pulled-down with 
GST-P2X2 in the acidic region of the strip, which is in agreement with the 
low isoelectric point (4.6) of ßIII tubulin (Fig. 8C). III/ Results 
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Fig. 8: Pull-down of rat brain proteins with GST-P2X2 fusion protein followed by 
2D-electrophoresis and Western-blot analysis. (A, B) Proteins were pulled-down 
from a Triton X-100 extract of crude rat brain synaptosomes and resolved by 2D-gel 
electrophoresis followed by silver staining. (A) GST-P2X2 was incubated with detergent 
buffer (sucrose-phosphate buffer), (B) GST-P2X2 was incubated with synaptosome 
detergent extract. (C) Same sample as in (B), proteins were resolved on a 2D-
polyacrylamide gel, transferred onto a nitrocellulose membrane and blotted with an 
antibody against ßIII tubulin. The black arrows show the potential interacting proteins, 
and the white rectangle shows the position of the ßIII tubulin on the 2D-gel. All 
polyacrylamide gels were 12.5% SDS-gels. 
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1.2  All three GST-P2X fusion proteins bind MBP 
 
  An additional protein band of about 20 kDa was observed to occur with 
all three GST-P2X fusion proteins (Fig. 6) and identified by MALDI/TOF 
mass spectrometry to constitute myelin basic protein (MBP, accession 
number: CAA10807). Consistent with this result, probing of an 
immunoblot with an antibody against MBP labeled protein bands of about 
20 kDa in the same samples (Fig. 9), supporting the view that MBP 
interacts with the three fusion proteins GST-P2X2, GST-P2X5, and GST-
P2X7. The antibody against MBP recognized several protein bands. This 
can be attributed to the occurrence of four major MBP isoforms of 21.5, 
18.5, 17 and 14 kDa in rat generated by alternative splicing of a single 
primary MBP transcript (Boggs et al., 2000). The amount of MBP was 
greatly reduced when Triton X-100 instead of digitonin was used for 
protein extraction (Fig. 9), indicating that the interaction was more stable 
in the presence of a mild detergent. 
  To examine whether MBP isolated through the GST-P2X fusion proteins 
originates predominantly or exclusively from the large amount myelin 
present in the crude P2 synaptosome preparation, myelin was removed 
from the synaptosomes by Ficoll density gradient centrifugation as 
described in materials and methods. A pull-down experiment with a 
digitonin extract of the purified synaptosomes, followed by immunoblot 
analysis with the antibody against MBP showed that MBP could be isolated 
in significant amounts with GST-P2X2 even when contaminating myelin 
was greatly reduced (Fig. 10B). This suggest that the interaction between 
P2X receptors and MBP is not an artefact due to the contamination of 
synaptosomes with myelin, but occurs with MBP present in the nerve 
terminals. III/ Results 
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Fig. 9: Immunoblot analysis of MBP after pull-down of rat brain proteins with 
GST-P2X fusion proteins. The synaptosomal detergent extract was prepared either 
with Triton X-100 or with digitonin and proteins were pulled-down with the indicated 
GST-P2X fusion proteins. The Western-Blot was developed by ECL. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 10: Pull-down experiments with GST-P2X2 and purified synaptosomes. The 
crude P2 synaptosome preparation was purified through a Ficoll gradient. (S) purified 
synaptosomes, (My) myelin, (Mi) mitochondria. Each fraction was pulled-down with GST-
P2X2. The proteins were resolved on tricine-SDS-polyacrylamide gels. (A) tricine-SDS-
polyacrylamide gels stained with Coomassie blue. (B) Same samples as in (A), proteins 
were transferred on PVDF membrane and blotted with an antibody anti-MBP. 
 
 
1.3  The P2X2 subunit binds tubulin directly 
 
  To examine whether tubulin binds directly to the C terminus of the P2X2 
subunit or requires a linker protein, an overlay assay was carried out. A 
Triton X-100 (0.1%) extract of synaptosomes was resolved by SDS-PAGE, 
transferred to a PVDF membrane, and overlaid with GST-P2X2
356-472. 
Binding of the fusion protein was then revealed with a GST antibody and 
[
125I]protein A (Fig. 11). 
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Fig. 11: Overlay assay with GST-P2X2
356-472. Synaptosomal proteins (lane 1/4, 25 µg; 
lane 2/5, 50 µg; lane 3/6, 75 µg) solubilized with Triton X-100 were resolved on a SDS- 
polyacrylamide gel (10% acrylamide) and then transferred on a PVDF membrane. (A) 
Synaptosomal proteins were overlaid with GST-P2X2
356-472 or GST alone as indicated, and 
then probed by a GST antibody and [
125I]protein A. Radioactivity was detected by 
PhosphorImaging. (B) The same membranes as in (A) were probed with the antibody 
against ßIII tubulin to confirm the identity of the band labeled in (A), and to verify that 
the both membranes contained the same amount of synaptosomal proteins. 
 
The protein that became labeled corresponded in molecular mass to 
tubulin (Fig. 11A, lanes 1-3). The identity of this protein band with 
ßIII tubulin was verified by immunoblot analysis of the same membrane, 
which led to the labeling of exactly the same protein band(Fig. 11B, lanes 
1-6). GST alone did not exhibit any binding (Fig. 11A, lanes 4-6). These 
results suggest that ßIII tubulin binds directly to the C-terminal tail of the 
P2X2 receptor subunit. 
 
 
1.4  Tubulin binding is mediated by a prolin-rich segment of the P2X2 
C-terminal tail 
 
  In an attempt to map the ßIII tubulin binding motif of the P2X2 subunit, 
four additional GST-P2X2 fusion proteins were generated containing 
various portions of the intracellular C-terminal domain of the P2X2 
subunit. A sequence comparison of the P2X2 portions of these proteins is 
shown in Fig. 12A. These GST-P2X2 fusion proteins were used in pull-down 
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experiments with a Triton X-100 extract of synaptosomes, followed by 
immunoblot analysis with the antibody against ßIII tubulin. ßIII tubulin 
was isolated with a fusion protein including the first half of the P2X2 C-
terminal tail (Fig. 12B; construct B, amino acids 356-412), but not at all 
with the second half of the C terminus (Fig 12B; construct C, amino acids 
406-472).The highly positively charged region of fusion protein B (amino 
acids 356-381 of the P2X2 subunit, construct D) was therefore first 
considered as a possible tubulin binding motif similar to that of GABARAP 
(Simon et al., 1997). However, fusion protein D comprising the basic 
portion of construct B interacted only weakly with tubulin (Fig. 12B). In 
contrast, fusion protein E comprising the second half of construct B 
(amino acids 371-412) bound tubulin as efficiently as the full length P2X2 
C-terminal tail (construct A) or construct F, lacking the basic domain, but 
including all C-terminal proline residues (amino acids 371-472). 
  Two shorter constructs were finally designed each containing a half of 
the tubulin binding motif (construct E). These GST-fusion proteins (GST-
P2X2
371-390 and P2X2
391-412) were used for pull-down experiments followed 
by Western-blot with the antibody anti ßIII tubulin. The two constructs 
(Fig. 13) failed to bind tubulin as efficiently as the complete binding motif. 
The first half still bound tubulin, whereas the second half showed almost 
no binding. These results suggest that the entire motif (amino acids 371-
412) is needed for an efficient binding of P2X2 to ßIII tubulin. III/ Results 
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Fig. 13: Mapping of the tubulin binding domain of P2X2. Pull-down of ßIII tubulin 
from Triton X-100 extract of rat synaptosomes with two GST-P2X2 fusion proteins, each 
containing one half of the tubulin binding motif identified in Fig. 12. 
 
 
1.5  Co-injections of cRNAs coding for P2X2 and tubulin in Xenopus laevis 
oocytes 
 
The pull-down experiments described above suggest that P2X2 subunits 
bind via their C-terminal tail to tubulin. To examine whether such an 
interaction also takes place between the full-length P2X2 subunit and 
tubulin inside a cell, the two proteins were expressed by cRNA injection in 
Xenopus oocytes. To allow for pull-down of tubulin with the P2X2 receptor 
or vice versa, one cRNA coding for a (His)6-tagged protein and another 
coding for a protein without (His)6-tag were co-injected. Co-purification of 
both proteins through the Ni
2+-NTA column may signify that they interact 
together and that this binding is strong enough to be preserved along the 
purification steps. 
    The cRNA-injected oocytes were metabolically labeled by overnight 
incubation with [
35S]methionine. The proteins were purified directly after 
the pulse period, because the oocytes became unhealthy when subjected 
to an additional chase period. The result of the co-expression of (His)6-
rP2X2 with ßIII tubulin is shown in Fig. 14. (His)6-ßIII tubulin was 
expressed alone (Fig. 14, lanes 2/7) to observe its position on the gel, 
thus allowing a comparison to be made with the sample corresponding to 
the co-expression of (His)6-rP2X2 with ßIII tubulin (Fig. 14, lanes 4/9). 
ßIII tubulin has a molecular mass of about 51 kDa (calculated from the 
cDNA sequence). (His)6-rP2X2 is a glycoprotein which contains three 
P2X2 portion in the GST-
fusion protein 
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consensus sequences for N-glycosylation (Asn-X-Ser/Thr) at the positions: 
188N, 
245N, and 
304N (N=Asn=Asparagine). All these sites are core-
glycosylated (Torres et al., 1998b; Newbolt et al., 1998) and all the three 
become complex-glycosylated en route to the plasma membrane 
(unpublished results, Ph.D. thesis S. Aschrafi; Frankfurt, 2002). The 
molecular mass of the (His)6-rP2X2 apoprotein is 53 kDa (including His-
tag, mass calculated from the cDNA sequence), therefore the mass of the 
core-glycosylated (His)6-rP2X2 can be estimated to be 62 kDa, assuming 
that the three N-glycans have a mass of 3 kDa each. 
  This experiment shows that ßIII tubulin is co-purified with (His)6-rP2X2 
(Fig. 14, lanes 4/9). As a positive control, (His)6-ßIII tubulin was co-
injected with gephyrin, a tubulin-binding protein essential for the 
recruitment of inhibitory glycine receptors and GABAA receptors to 
postsynaptic sites (Kirsch et al., 1991; Kneussel and Betz, 2000). Indeed, 
when co-expressed in Xenopus oocytes, gephyrin, a 93 kDa protein was 
co-purified with (His)6-ßIII tubulin (Fig. 14, lanes 3/8). Two different 
detergents were tested, Triton X-100, and as a milder detergent, 
digitonin, to observe in which conditions the protein interactions are more 
stable. More (His)6-ßIII tubulin was isolated in presence of Triton X-100, 
but the interaction (His)6-rP2X2/ßIII tubulin seemed to be more stable 
when digitonin was used as detergent. 
    An important control in co-injection/co-purification experiments is to 
verify that the protein, which does not posses a (His)6-tag, does not bind 
non-specifically to the Ni
2+-NTA beads when it is expressed alone. Fig. 15 
shows the result of the injection and expression of ßIII  tubulin in 
comparison to the co-expression of (His)6-rP2X2 with ßIII tubulin. In this 
experiment, the combination (His)6-ßIII tubulin/rP2X2 was also injected. 
Three detergent were tested for the protein purification: Triton X-100 
(Fig. 15, lanes 1-5), digitonin (Fig. 15, lanes 6-10), and dodecyl maltoside 
(Fig. 15, lanes 6-10). As shown in Fig. 15, lane 3, ßIII tubulin without 
(His)6-tag was purified by the Ni
2+-NTA matrix in a quantity similar to that 
seen in lane 2, where ßIII tubulin was co-expressed together with III/ Results 
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(His)6-rP2X2. In contrast, non-tagged rP2X2 did not show non-specific 
binding (lane 4,9,14) , but was also not observed to co-purify with (His)6-
ßIII tubulin. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 14: Protein expression in Xenopus oocytes. Co-expression of ßIII tubulin 
and rP2X2. The cRNAs coding for the indicated proteins were injected in Xenopus laevis 
oocytes (cRNAs were mixed to a ratio 1:1). The cells were metabolically labeled 
overnight with [
35S]methionine. The proteins were purified direct after the pulse period 
by affinity chromatography with Ni
2+-NTA agarose beads and eluted from the beads with 
1x SDS-loading buffer. The purification steps were performed in the presence of the 
indicated detergent (the percentages indicate the concentrations used in the 
“homogenizing” buffer). The proteins were finally resolved on a 10% SDS-polyacrylamide 
gel, and the radioactivity was visualized by PhosphorImaging. Control lane: proteins from 
non injected oocytes that bound non-specifically to the Ni
2+-NTA agarose beads. 
 
 
It is therefore likely, that the interaction between (His)6-rP2X2 and ßIII 
tubulin observed in Fig. 14 was at least partly due to non-specific binding 
of ßIII tubulin to the Ni
2+-NTA beads. In Fig. 14, lane 2, and in Fig. 15, 
lane 10, additional bands were observed in addition to the major band of 
(His)6-ßIII tubulin. These bands represent either degradation products of 
ßIII tubulin, or proteins associated to the microtubules that co-purify with 
(His)6-ßIII tubulin such as MAPs, microtubule-associated proteins, for 
example. 
  The conclusion of these results is that the interaction rP2X2-ßIII tubulin 
could not be demonstrated reproducibly in Xenopus oocytes. 
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Fig. 15: Protein expression in Xenopus oocytes. Co-expression of ßIII tubulin 
and rP2X2. The cRNAs coding for the indicated proteins were injected in Xenopus laevis 
oocytes. The cells were metabolically labeled overnight with [
35S]methionine. Proteins 
were purified direct after the pulse period by affinity chromatography with Ni
2+-NTA 
agarose beads and eluted from the beads with 1x SDS-loading buffer. The purification 
steps were performed in the presence of the indicated detergent (the percentages 
indicate the concentrations used in the “homogenizing” buffer). The proteins were finally 
resolved on a 10% SDS-polyacrylamide gel, and the radioactivity was visualized by 
PhosphorImaging. Control lane: proteins from non injected oocytes that bound  non-
specifically to the Ni
2+-NTA agarose beads. 
 
 
1.6  Pull-down of ßIII tubulin expressed in Xenopus oocytes by the GST-
P2X2
356-472 fusion protein 
 
    To reproduce the results obtained with the synaptosome detergent 
extract (interaction P2X2/ßIII tubulin), a series of experiments was 
performed in Xenopus oocytes. Purified GST-P2X2 or GST (as control) 
proteins were pre-injected in Xenopus oocytes, then the same oocytes 
were injected with the cRNA coding for ßIII tubulin without hexahistidyl 
tag. After metabolic labeling with [
35S]methionine (overnight), the 
proteins were extracted with 1% digitonin, purified by affinity 
chromatography with glutathione-Sepharose beads, and resolved by SDS-
PAGE. These experiments were done to examine whether GST-P2X2 is able 
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to pull-down ßIII tubulin in intact cells rather than a detergent extract of 
rat brain synaptosomes. The results are presented in Fig. 16. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 16: Co-injection of GST-P2X2
356-472 and the cRNA coding for ßIII tubulin no 
His in Xenopus laevis oocytes. GST-P2X2 and GST (as control) fusion proteins were 
purified from E.coli and injected into Xenopus oocytes (about 40 ng/cell) together with 
the cRNA coding for ßIII tubulin without hexahistidyl tag. The cells were metabolically 
labeled overnight with [
35S]methionine. Proteins were purified directly after the pulse 
period by affinity chromatography with glutathione-Sepharose beads, eluted from the 
beads with 1x SDS-loading buffer and resolved on a 10% SDS-polyacrylamide gel. (A) 
Silver staining of the gel. (B) Autoradiography of the gel (PhosphorImager). Some 
endogenous proteins of oocytes interacted non-specifically either with the GST-fusion 
proteins or with the glutathione-Sepharose beads and are specified on both figures. 
 
 
  Fig. 16A shows a photography of the silver stained gel. On this gel the 
amount of fusion protein purified by this method can be observed. The re-
isolated GST is masked by a large amount of oocyte proteins, which 
interact non-specifically either with the GST proteins or with the 
glutathione-Sepharose beads. Part of these oocytes proteins are also 
visible on the autoradiography of the same gel shown in Fig. 16B. On this 
figure a thin protein band was observed which co-purified with GST-P2X2. 
This protein band has the same molecular mass as ßIII tubulin and was 
not co-purified with GST alone. These results show that it is possible to 
pull-down ßIII tubulin in Xenopus oocytes with GST-P2X2. 
    I finally tried to isolate the [
35S]-labeled rP2X2 receptor produced in 
Xenopus oocytes by purification of the intact microtubules from Xenopus 
oocytes. To this end, about 50 oocytes were injected with the cRNA coding 
for rP2X2 subunit without hexahistidyl tag and metabolically labeled with 
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B 
Non-specifically 
bound proteins 
Non-specifically 
bound proteins 
GST-P2X2 
38 kDa 
1  2 
-  + 
+  - 
GST-P2X2
356-472 
GST 
25 
32.5 
47.5 
62 
83 
kDa 
A 
-  +  GST-P2X2
356-472 
97 
66 
45 
30 
20.1 
kDa 
2 
+  -  GST 
1 
ßIII tubulin III/ Results 
  - 86 -  86
[
35S]methionine overnight. The next day the microtubules of all the 
oocytes were purified by the method of R.B. Vallee (Vallee, 1986): the 
oocytes were homogenized in PEM buffer (0.1 M PIPES-NaOH, pH 6.6, 
containing 1 mM EGTA and 1 mM MgSO4), then GTP and taxol were added 
to initiate polymerization of all the endogenous tubulin in the cold. 
Microtubules were centrifuged and washed. The microtubule pellet was 
finally resuspended with 1x SDS-loading buffer and the proteins were 
resolved by SDS-PAGE. Unfortunately I was not able to co-isolate rP2X2 
and tubulin by this method. 
 
 
1.7  Perspectives 
 
    This part of the results presents preliminary results, which lead to 
suggestions for further experiments. The aim of these experiments was to 
see in which compartments of eukaryotic mammal cells (COS-7 cell for 
example) the rP2X2 receptor is localized and to observe if tubulin does 
affect its sub-cellular localization. For this purpose, we engineered a fusion 
protein consisting of the rP2X2 subunit fused C-terminally to the green 
fluorescent protein (EGFP), which is a protein able to emit fluorescent light 
when excited with UV light. This construct was first cloned into the pNKS 
vector for expression in Xenopus oocytes, and then sub-cloned into the 
pcDNA3.1 vector for transfection of COS-7 cells. 
  rP2X2A-GFP was first expressed in Xenopus laevis oocytes to confirm that 
the protein in produced is its full-length and that it is glycosylated on its 
three N-glycosylation consensus sequences. The results are presented in 
Fig. 17. Lanes 3/6 show the expression of (His)6-rP2X2A-GFP in Xenopus 
oocytes. (His)6-rP2X2-GFP migrated at a position in agreement with the 
calculated molecular mass of the core-glycosylated form of the protein of 
90 kDa (81 kDa apoprotein and 3x3 kDa of N-glycans). The 
electrophoretic mobility of the P2X2A-GFP subunit is similar to that of 
gephyrin, a 93 kDa protein (lanes 2 and 5). When P2X2A-GFP was purified III/ Results 
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with Triton X-100 as detergent instead of digitonin (lane 6), a second 
band with the same electrophoretic mobility as P2X2A (lane 7) appeared on 
the gel. This may suggest that P2X2A-GFP was partially unstable and was 
cleaved between the P2X2A portion and the GFP portion of the fusion 
protein either in the oocytes or during protein purification. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 17: Expression of rP2X2A-GFP (A) and rP2X2B-GFP (B) in Xenopus oocytes. 
The cRNAs coding for the indicated proteins were injected in Xenopus laevis oocytes 
(cRNAs were mixed in a ratio 1:1). The cells were metabolically labeled overnight with 
[
35S]methionine. The proteins were purified directly after the pulse period by affinity 
chromatography with Ni
2+-NTA agarose beads and eluted from the beads with 1x SDS-
loading buffer. The purification steps were performed in the presence of the indicated 
detergent (the percentages indicate the concentrations used in the “homogenizing” 
buffer). The proteins were finally resolved on a 10% SDS-polyacrylamide gel, and the 
radioactivity was visualized by PhosphorImaging. Control lane: proteins from non 
injected oocytes that bound non-specifically to the Ni
2+-NTA agarose beads. 
 
 
  P2X2-GFP was then expressed in COS-7 cells and the cells were observed 
in culture or fixed with paraformaldehyde using a conventional 
fluorescence microscope. Fig. 18 A and B show the fluorescence of P2X2-
GFP in living cells, Fig. C is a picture taken from fixed cells at a higher 
magnification. P2X2A-GFP was very well expressed particularly in the 
intracellular compartments and was also present at the cell surface 
(Fig. 18C). An interesting experiment would be to compare the pattern of 
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localization of P2X2A-GFP and P2X2B-GFP, a splice variant of P2X2 (Simon 
et al., 1997) in COS-7 cells. However, for unknown reasons, this second 
construct could not be observed in COS-7 cells, although it was 
synthesized as a protein of expected mass of 46.4 kDa in Xenopus oocytes 
(Fig. 17B, lane 3). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 18: Expression of rP2X2-GFP in COS-7 cells. COS-7 cells were transfected with 
the cDNA coding for rP2X2-GFP cloned in pcDNA 3.1 vector (transfection with FuGENE 6, 
Roche diagnostic). (A,B) COS-7 cells observed in culture using the Axiovert 200M 
fluorescence microscope (Zeiss). Cells were viewed through a 40x0.6 objective lens 
(Zeiss). (A) shows an overlay of phase contrast and fluorescence images, (B) shows only 
the fluorescence image of the same view. (C) COS-7 cells were fixed with 4% 
paraformaldehyde and observed using the same microscope. Cells were viewed through a 
100x1.3 oil immersion objective lens (Zeiss). 
 
 
  Another point of interest would be the influence of microtubules on the 
expression of P2X2A-GFP or P2X2B-GFP at the plasma membrane. To 
answer this question it would be interesting to perform co-localization 
studies with tubulin or to disturb the microtubular network (with drugs like 
taxol or exposing the cells to cold temperatures), and observe with a 
confocal microscope the effects of these culture conditions on the 
subcellular localization of P2X2-GFP and P2X2B-GFP. 
  All these possibilities have still to be investigated. 
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III-2. Investigations of the quaternary structure of two glutamate 
  transporters: hEAAT2 and ecgltP 
 
  In the context of a collaboration work with the group of Prof. C.Fahlke 
from the Institute for Physiology (University Hospital of Aachen) I 
investigated the subunit stoichiometry of two distantly related glutamate 
transporters, the human glial glutamate transporter, hEAAT2 and the 
E.coli bacterial glutamate transporter, ecgltP. 
  Glutamate transporters mediate glutamate uptake into neuronal and glial 
cells and play a central role in the termination of synaptic transmission 
and in extracellular glutamate homeostasis. To resolve the question of the 
quaternary structure of hEAAT2 and ecgltP, these two transporters were 
expressed in Xenopus laevis oocytes in a (His)6-tagged form, and the 
native proteins were analyzed with the blue-native PAGE technique. 
 
 
2.1  hEAAT2 and ecgltP transporters migrate as trimers in blue-native 
PAGE gels 
 
    cDNA constructs coding for (His)6-hEAAT2 and (His)6-ecgltP were 
provided by the group of Prof. C.Fahlke. cRNAs were synthetized in vitro 
and injected into Xenopus laevis oocytes. Hexahistidyl tags allow the 
purification of proteins by Ni
2+-NTA affinity chromatography and were 
placed either NH2- or COOH-terminally. 
 
a- His-tagged hEAAT2 transporters exhibit unaltered functional 
properties 
 
  The uptake process is driven by the electrochemical gradient across the 
cell membrane, sodium is required for glutamate binding while potassium 
is required for net transport (Danbolt, 2001). The process is electrogenic 
(positive charge moving in). The transporters utilize the ion gradients of III/ Results 
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both sodium, potassium, and also protons; the transport of one glutamate 
requires a minimum of two Na
+ and one K
+ (Danbolt, 2001). It is possible 
to perform electrophysiological recordings from single cells expressing a 
single transporter subtype and thereby to exploit the electrogenic nature 
of the transport to measure the specificity and the kinetic of the uptake 
process. In addition, some transporters appear to have an extraordinary 
additional function as glutamate-gated chloride channel (Wadiche et al., 
1995; Fairman et al., 1995); this anion conductance is thermodynamically 
independent of the transport process. 
    To test whether the addition of a hexahistidyl tag alters transport 
functions, oocytes expressing wild-type and His-tagged transporters were 
examined with two-electrode voltage clamp techniques (experiments 
realized by the group of Prof. C.Fahlke). When cRNA coding for (His)6-
tagged  ecgltP was injected in Xenopus  oocytes, neither glutamate-
induced inward current nor glutamate-induced increase of anion currents 
were observed. As ecgltP is effectively translated in oocytes (see below), 
this result was most likely due to an impaired surface targeting of the 
prokaryotic protein. The His-tag in N-terminal or C-terminal left the 
stoichiometrically coupled and the pore-mediated current amplitudes of 
hEAAT2 unaffected (data not shown). 
 
 
b- hEAAT2 and ecgltP transporters migrate as trimers in blue-native 
PAGE gels 
 
  Blue-native (BN) PAGE analysis (Schägger et al., 1994) allows to study 
membrane proteins under non-denaturing conditions by gel 
electrophoresis. hEAAT2 and ecgltP were heterologously expressed in 
Xenopus laevis oocytes, metabolically labeled with [
35S]methionine, 
extracted with 1%  (w/v) digitonin, and purified by metal affinity 
chromatography. Both proteins expressed at high levels in Xenopus III/ Results 
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oocytes (Fig. 19A) and were metabolically stable during a sustained chase 
(data not shown). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 19: SDS-PAGE analysis of His-ecgltP and His-hEAAT2 in Xenopus oocytes. 
(A) His-ecgltP and His-hEAAT2 were purified from Xenopus oocytes by Ni-NTA 
chromatography after a 4h [
35S]methionine pulse and were resolved by reducing SDS-
PAGE (10% acrylamide) in parallel with [
14C]-labeled molecular mass markers. 
(B) Ferguson plot of molecular masses of the ecgltP and hEAAT2 polypeptides determined 
by SDS-PAGE at various polyacrylamide concentrations versus the polyacrylamide 
concentration. Solid circles: His-ecgltP; solid squares: His-hEAAT2. 
 
 
  When denatured by SDS and resolved by reducing SDS-PAGE, the ecgltP 
and the hEAAT2 polypeptides migrated both at 10-20% lower masses than 
calculated from their amino acid sequences, particularly in gels of low 
acrylamide concentration. To determine the correct molecular mass of 
these two polypeptides, a Ferguson analysis was performed (FERGUSON, 
1964). To this end, His-ecgltP and His-hEAAT2 were resolved on SDS-
polyacrylamide gels of different acrylamide percentages. When the derived 
apparent masses were plotted against the reciprocal of the acrylamide 
concentrations, straight lines were obtained with both proteins (Fig. 19B). 
According to Ferguson, the intercept point with the ordinate indicates the 
genuine mass of the protein of interest. This analysis yielded molecular 
masses of 46 kDa and 69 kDa for the His-tagged ecgltP and the His-
tagged hEAAT2, respectively (calculated masses: 48 kDa for His-ecgltP 
and 63 kDa for non-glycosylated His-hEAAT2). Therefore, anomalous 
migration, as observed for many other hydrophobic membrane proteins, 
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likely caused the observed differences between the apparent and the 
calculated masses. 
 
  Both ecgltP and hEAAT2 transporters migrated predominantly as a single 
band when analyzed by BN-PAGE (Fig. 20A, lane 3; Fig. 20C, lane 2, 
respectively). The non-denatured ecgltP transporter and hEAAT2 
transporter migrated at ~150 kDa (Fig. 20A, lane 3) and ~200 kDa (Fig. 
20C, lane 2), respectively, when compared with the defined membrane 
protein complexes generated by partial denaturing of the homopentameric 
α1 GlyR (calculated mass: 260 kDa including carbohydrates) (Griffon et 
al., 1999) or the homomeric P2X1 receptor (calculated mass: 171 kDa 
including carbohydrates) (Nicke et al., 1998). These molecular masses are 
well above those of respective monomers, suggesting that both ecgltP and 
hEAAT2 exist exclusively as multimers in Xenopus oocytes. 
  The electrophoretic mobility is biased by dye binding and protein shape 
to an unclear extent, and therefore the exact number of monomers 
incorporated per protein complex cannot be readily deduced from the 
estimated masses alone. A reliable approach to determine the number of 
polypeptide chains incorporated in one transporter complex consists in 
weakening non-covalent subunit interactions by treatment with heat and 
low concentrations of SDS, thus inducing a dissociation the protein 
complexes into lower order intermediates (Griffon et al., 1999; Nicke et 
al., 1998). For hEAAT2, a 1h incubation at 56°C both in the presence 
(Fig. 20C, lane 4) and absence (lane 5) of Coomassie dye generated a 
ladder-like pattern of three protein bands. Incubation in the additional 
presence of increasing concentrations of SDS (lanes 6-10) led to a gradual 
disappearance of the ~200 kDa protein and an enhanced appearance of 
the two additional proteins of masses of ~130 kDa and ~65 kDa. At 
≥0.05% SDS, the ~65 kDa band became the predominant one (lanes 9-
10). No polypeptide migrated faster than the ~65 kDa band, suggesting 
that the ~65 kDa band corresponds to the hEAAT2 monomer with a 
calculated mass of 66 kDa in a high mannose form (see 2.4). Fig. 19D III/ Results 
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shows PhosphorImager analysis of the gel shown in Fig. 20C. All the 
conditions that led to a dissociation of the hEAAT2 caused the appearance 
of a total of three bands with masses corresponding to the assembly of 
three, two and one minimal units. The monomer became the dominant 
species at high SDS concentrations (Fig. 20D). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 20: Oligomeric state of the ecgltP and hEAAT2 transporters in Xenopus 
oocytes determined by BN-PAGE. Samples were treated as indicated to induce 
dissociation into lower order intermediates. (A), (C) Autography of the gels. (B), (D) 
Quantitative profiles of the gel lanes shown in (A) and (C), respectively, were obtained 
by PhosphorImager analysis and are marked by the same lane numbers. The origin of 
the abscissa corresponds to the top of the polyacrylamide gel. The five bands that 
became visible upon partial denaturing of the GlyR are consistent with the pentameric 
state of this class of ligand-gated ion channels. Numbers specify the oligomeric state of 
the corresponding peak. The mass markers shown on both sides of the gels were 
generated by partial dissociation of the ligand-gated ion channels with SDS as indicated. 
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  The natively purified ecgltP protein migrated predominantly at ~150 kDa 
(Fig. 20A, lane 3) when compared with the homomeric P2X1 receptor (lane 
2) or the partially dissociated α1 GlyR (lane 8). In addition, a slower 
migrating distinct band, presumably an ecgltP hexamer, and an 
amorphous mass of proteins, most likely ecgltP aggregates, were visible. 
Quantification of the various ecgltP forms by PhosphorImager analysis 
indicated that the 150 kDa band is the most prominent one (Fig. 20B). A 
1h incubation at 56°C both in the absence (not shown) as well as in the 
presence of Coomassie dye (Fig. 20A, lane 4) and denaturing with 
increasing concentrations of SDS led to the dissociation of the 150 kDa 
band into the monomeric and dimeric ecgltP species (Fig. 20A, lanes 5-7). 
 
 
2.2  Results obtained with a concatenated ecgltP dimer are consistent 
with a trimeric ecgltP structure 
 
  The results shown above demonstrate that both hEAAT2 and ecgltP 
glutamate transporters are assembled into trimers from a minimal 
unit that migrates close to the expected molecular mass of the monomer 
in BN-PAGE. 
  To rule out the possibility that the lowest molecular band corresponds to 
an unusually stable dimer and correspondingly the intermediate and 
higher molecular mass bands to tetramers and hexamers, a concatenated 
cDNA construct was engineered for one of the transporters (ecgltP-ecgltP) 
by linking two ecgltP coding regions in a single open reading frame. By 
reducing SDS-PAGE, the (ecgltP-ecgltP) polypeptide was resolved as a 74 
kDa protein (Fig. 21B, lane 2), i.e. twice the mass of the apparent 
molecular mass of 37 kDa for the ecgltP monomer (lane 4). In BN-PAGE 
two major bands were observed (Fig. 22, lane 1), and dissociating 
treatment with SDS led to the appearance of a third major non further 
dissociable band of ecgltP-ecgltP (lane 2), which migrated at 
approximately the same position as the non covalently associated ecgltP III/ Results 
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dimer, (ecgltP)2 (lane 10). These results show that the intermediate 
molecular mass band dissociated from the ecgltP protein indeed 
corresponds to the dimeric form and, accordingly, the lowest and higher 
molecular band to the monomer and trimer, respectively. The 
intermediate band of concatenated ecgltP-ecgltP (Fig. 22B, lane 2) 
migrated slightly higher than the trimer formed from ecgltP monomers 
(lane 9) and most likely corresponds to the association of two dimers 
((ecgltP-ecgltP)2). Likewise, the slowest migrating band corresponds to a 
trimer formed by three ecgltP-ecgltP concatamers ((ecgltP-ecgltP)3). 
Under non-denaturing conditions (lane 1) these two bands are prominent 
indicating that both conformations are stable and occur with comparable 
probability. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 21: Biochemical analysis of an ecgltP-ecgltP concatamer expressed in 
Xenopus oocytes. (A) Schematic representation of the ecgltP-ecgltP concatamer (the 
membrane topology of ecgltP is inspired from (Slotboom et al., 2001a)). Two ecgltP 
monomers were joined tail-to-head by a 18 residues linker sequence (gray box). 
(B) Reducing SDS-PAGE analysis of the isolated polypeptides. Proteins were resolved on 
a 10% SDS-polyacrylamide gel. During the chase interval two polypeptides appeared 
with masses corresponding to the ecgltP monomer that are barely detectable after the 
pulse. Co, non injected control oocytes. 
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Fig. 22: Oligomeric state of the concatenated ecgltP dimer determined by BN-
PAGE. (A) Autoradiography of the gel. The oligomeric state of the monomeric ecgltP 
form is shown for easier comparison. Dissociation into lower order intermediates was 
induced by partial denaturing with SDS as indicated. The monomeric byproducts (#) 
formed during the chase interval assemble into non-covalently linked trimeric ecgltP 
proteins (*), that migrate at the same position as the ecgltP trimer assembled from 
expressed monomers. (B) Cartoon showing the assembly of full length concatenated 
ecgltP dimers and monomeric byproducts. The ecgltP concatamer consist of two ecgltP 
m o n o m e r s  ( i n d i c a t e d  b y  g r a y  c i r c l e s )  j o ined tail-to-head by a 18 residues linker 
sequence. Concatenated dimers assemble predominantly to a trimer that comprises a 
total of six ecgltP copies. To a lower extent dimers of concatenated dimers with a total of 
four ecgltP copies are also formed. In addition, monomeric sides products that arise most 
likely from proteolytic cleavage of concatenated dimers assemble to trimers of three 
monomers. 
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  This observation further supports a trimeric structure that predicts two 
oligomeric populations from dimeric concatamers (Fig. 22B): an assembly 
of two concatamers, one of them providing two subunits ((ecgltP-ecgltP)2) 
or the association of three dimeric concatamers, each of them contributing 
one subunit ((ecgltP-ecgltP)3) to the trimer interface. 
    An additional faint band (lane 1 of Fig. 22A) migrated at exactly the 
same position as the ecgltP trimer assembled from three ecgltP 
monomers, (ecgltP)3 (lane 9). This band became more abundant after an 
additional chase period (Fig. 22A, lane 5). The occurrence of this 
oligomeric complex is most likely due to proteolytic formation (Nicke et 
al., 2003) of a single coding region of ecgltP. Upon treatment with SDS, 
this protein dissociated into a polypeptide migrating at virtually the same 
position as the ecgltP monomer (Fig. 22A, lanes 6-8). This is confirmed in 
SDS-PAGE analysis, where two byproducts were observed in addition to 
the full length concatamer, one migrating virtually at the same position as 
the ecgltP monomer (Fig. 21B, lane 4), and a second one with 1-2 kDa 
larger mass and probably corresponding to the ecgltP monomer plus the 
18 residue linker (Fig. 21B, lane 3). The findings that two distinct 
concatameric constructs, the one used in this study, and the one of Nicke 
et al. (Nicke et al., 2003) are both subjected to proteolytic digestion (Fig. 
22B) demonstrates the limitations of using tandem constructs to study 
heteromultimeric proteins in Xenopus oocytes. 
 
 
2.3  Cross-linking of hEAAT2 or ecgltP generates covalently bound 
dimers and trimers 
 
  To confirm the trimeric structure of hEAAT2 and ecgltP resolved with the 
BN-PAGE technique, protein cross-linking was used to study 
intermolecular interactions within glutamate transporters subunits. Two 
homobifunctional imidoesters reagents, DMA (dimethyl adipimidate) and 
DMS (Dimethyl suberimidate) were tested for their ability to covalently III/ Results 
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link transporter molecules extracted from Xenopus oocytes. The cross-
linking reagents were incubated with purified proteins still bound to the 
Ni
2+-NTA beads just before elution. The cross-linked proteins were then 
eluted once with 250 mM imidazole 0.5% (w/v) digitonin. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 23: Cross-linking of digitonin-solubilized, purified ecgltP. EcgltP transporter 
(A, B) was purified from [
35S]methionine labeled oocytes and incubated with cross-linkers 
as indicated while still bound to beads. After elution with non-denaturing elution buffer, 
samples were supplemented with SDS sample buffer containing 20 mM DTT and resolved 
by SDS-PAGE (4-10% acrylamide gradient gel) followed by autoradiography. Numbered 
arrows indicate the positions of monomers, dimers, and trimers. 
 
 
DMS differs from DMA by a slightly longer spacer arm (11 Å vs. 8.6 Å) and 
was more efficient in cross-linking ecgltP to dimers and trimers at both 
22°C (Fig. 23B, lanes 2-4) and 37°C (Fig. 23B, lanes 5-7). 
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DMS also cross-linked hEAAT2 transporter subunits to dimers and to 
trimers preferentially at higher concentrations (Fig. 24). Adducts larger 
than trimers were neither observed with ecgltP nor with hEAAT2 
transporters, corroborating the results obtained by BN-PAGE analysis that 
the natively purified glutamate transporters possess a trimeric 
architecture. 
 
 
2.4  hEAAT2 is complex-glycosylated 
 
    Membrane proteins are often N-glycosylated when expressed in 
eukaryotic cells. Glycosylation alters the molecular mass of proteins and 
thus has to be taken into consideration in gel electrophoresis analysis. 
Moreover, oligosaccharide side chains are sequentially processed in the 
Golgi apparatus from a high mannose to the complex-glycosylated form, 
and this process can be used to monitor the efficiency of ER exit of the 
protein. 
  The hEAAT2 sequence shows two glycosylation sequences, 
206NATS and 
216NETV, which are both located on the predicted large ectodomain 
(residues 143-239) between transmembrane regions TM3 and TM4 
(Danbolt, 2001). Complete deglycosylation of newly synthesized hEAAT2 
polypeptide produced in Xenopus oocytes during a 4 h pulse period 
resulted in a 3 kDa decrease of the molecular mass (Fig. 25A, lanes 1-2), 
corresponding to the mass of one single N-glycan, suggesting that only 
one of the two possible glycosylation sites is used. No mass shift by 
PNGase F was observed when the asparagines residues of both 
N-glycosylation sequons were replaced by glutamine (Fig. 25A, lanes 7 & 
8). Glutamine substitution of only one of the two asparagine residues 
resulted in polypeptides migrating at the same position as the wild-type 
hEAAT2 (Fig. 25A, lanes 3 & 5), thus indicating that 
206N and 
216N can 
substitute for each other to carry the N-glycan. If both N-glycosylation 
acceptor sites were present as on the parent hEAAT2 polypeptide, one of III/ Results 
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the two remained unused presumably because of the small distance of 
only 10 amino acids between the two sites. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 25: Comparison of the deglycosylation of wild-type (His)6-hEAAT2 and 
single (His)6-hEAAT2 mutants (A), and deglycosylation of (His)6-EAAT2 and 
EAAT2-(His)6 after a chase period (B). (A) SDS-PAGE analysis (Tricine-SDS-Gel, 8% 
acrylamide) of the parent hEAAT2 polypeptide and N-glycan minus mutants purified from 
Xenopus oocytes after 4h [
35S]methionine pulse. Both possible glycosyl acceptor sites, 
Asn206 and Asn216 had to be replaced by Gln, to prevent addition of a single N-glycan 
to the hEAAT2 polypeptide. Proteins were deglycosylated by PNGase F as indicated. 
(B)  SDS-PAGE analysis (Tricine-SDS-Gel, 8% acrylamide) of the (His)6-hEAAT2 and 
hEAAT2-(His)6 polypeptides. Both proteins were purified from Xenopus oocytes after 4h 
[
35S]methionine pulse and a subsequent 36h chase. After 36h chase an Endo H resistant 
EAAT2 polypeptide (¶) appeared on the gel, which can be reduced to the protein core (*) 
by PNGase F. 
 
 
  After a 36h chase interval, most of the (His)6-hEAAT2 or hEAAT2-(His)6 
polypeptides migrated as a broad band (75-95 kDa) well above that of the 
core-glycosylated hEAAT2 polypeptide (~60 kDa in Fig. 25B, lanes 1 and 4 
respectively). These broad bands could be reduced to the hEAAT2 
apoprotein by incubation with PNGase F (~57 kDa in Fig. 25B, lanes 3 and 
6), but was resistant to Endo H (Fig. 25B, lanes 2 and 5). Resistance to 
cleavage by Endo H occurs if high mannose type N-linked glycans are 
processed to complex type oligosaccharides in the Golgi apparatus. These 
results showed that the broad bands correspond to the mature complex-
glycosylated hEAAT2 polypeptides. Quantification by phosphorimage 
analysis suggested that 66% of the total hEAAT2 protein had left the ER 
within the 36h chase interval. The conclusion of these results is that the 
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majority of hEAAT2 subunits are in a mature state located in post-ER 
compartment including the plasma membrane. 
    After an additional chase period to allow for post-translational 
modifications, two native forms of the hEAAT2 transporter (His-tag in 
N-terminal or C-terminal) were observed on BN-polyacrylamide gels 
(Fig. 26A), one migrating at the same position as described in 2.1.b and a 
second slower migrating band with an apparent mass larger than that of 
the 260 kDa homopentameric GlyR (Fig. 26A, lanes 2 and 5). This slower 
migrating band was not observed with the non-glycosylated N
206,216Q-
hEAAT2 mutant (Fig. 26A, lane 7-8), implying that the additional band 
originates from the post-translational processing of N-glycans (cf. ¶ in Fig. 
25B) and represents a homotrimer of the complex-glycosylated hEAAT2 
form. The analysis of the quantitative profiles presented in Fig. 26B leads 
to the conclusions that for both (His)6-hEAAT2 and hEAAT2-(His)6 the 
proportion of the trimer composed of complex-glycosylated EAAT2 raised 
with the duration of the chase period. Moreover, hEAAT2-(His)6 seemed to 
acquire the complex-glycosylated state faster than (His)6-hEAAT2 (Fig. 
26C). 
    The ability to assembly into trimers of each of the various EAAT2 
N-glycan mutants presented in Fig. 25A was investigated by BN-PAGE 
analysis (Fig. 26D). Both the single mutants (N
206Q-hEAAT2 and N
216Q-
hEAAT2) and the double mutant (N
206,216Q-hEAAT2) were able to assemble 
into trimers as efficiently as the wild-type (His)6-EAAT2. Apparently, the 
lack of core and complex glycosylation does not disturb the assembly of 
the transporter. 
    The prokaryotic ecgltP polypeptide does not possess any glycosylation 
sites precluding such an analysis for this particular transporter. When 
ecgltP was expressed in Xenopus oocytes it did not exhibit any 
electrophysiological activity (see 2.1). This may either signify that the 
ecgltP transporter does not acquire a functional conformation in Xenopus 
oocytes or that it is not exported to the plasma membrane. To 
discriminate between these possibilities, a consensus site for III/ Results 
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N-glycosylation was incorporated into the ecgltP sequence. A glutamine 
(Q) residue located at the position 133 (
133QSS) in the ecgltP protein 
sequence was replaced by an asparagine (N) by site-directed mutagenesis 
(
133NSS). 
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Fig. 26: BN-PAGE analysis of (His)6-hEAAT2 and hEAAT2-(His)6 after different 
chase periods (A) and comparison of the oligomerization state of wild-type 
(WT) (His)6-hEAAT2, N
206-, N
216-, and N
206,216  hEAAT2 mutants after a chase 
period (D). (A), (D) Autography of the BN-polyacrylamide gels, (B) quantitative profiles 
of the gel lanes shown in (A), arrows show the peaks corresponding to trimers composed 
of complex-glycosylated hEAAT2 (# in A). (C), Graph representing the ratio of the 
complex-glycosylated form of (His)6-hEAAT2 or hEAAT2-(His)6 versus the duration of the 
chase period. The values were obtained from the areas under the peaks represented in 
(B). (A) Proteins were purified from Xenopus oocytes by Ni-NTA chromatography after a 
4h [
35S]methionine pulse and the indicated chase period, then resolved by BN-PAGE (4-
16% acrylamide). (D) Proteins were purified from Xenopus oocytes after a 12h 
[
35S]methionine pulse and then resolved by BN-PAGE (4-16% acrylamide). (A,D) 
Samples were treated as indicated to induce dissociation into lower order intermediates 
including monomers. 
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Fig. 27: Deglycosylation of the wild-type ecgltP-(His)6 and the 
133NSS ecgltP-
(His)6 mutant. Proteins were purified from Xenopus oocytes by Ni-NTA chromatography 
after a 12h [
35S]methionine pulse and the indicated chase period. Proteins were then 
digested by EndoH or PNGase F and resolved by SDS-PAGE (10% acrylamide). 
 
 
  The 
133NSS-ecgltP mutant was expressed in Xenopus laevis oocytes and 
its glycosylation state was analyzed by deglycosylation with EndoH and 
PNGase F. As expected, the wild-type ecgltP was not glycosylated as no 
shift was observed after treatment with EndoH or PNGase F (Fig. 27, lanes 
2 and 3 respectively). On the other hand, the 
133NSS-ecgltP mutant 
migrated at a 2-3 kDa higher mass consistent with the presence of one 
oligosaccharide side chain. Indeed, deglycosylation by EndoH decreased 
the mass of the 
133NSS-ecgltP mutant to that of the non-glycosylated 
parental ecgltP protein (Fig. 27, lanes 5 and 6). After an additional 36h 
chase period, it was however not possible to observe any complex-
glycosylation, indicating that the ecgltP mutant resisted in the 
EndoH-sensitive form (Fig. 27, lane 8). 
    The acquisition of an N-glycan at position 133 indicates that the 
underlying consensus sequence assumed the predicted extracellular 
location, thus implying that the ecgltP mutant is capable of adopting a 
correct transmembrane disposition in the ER. The question whether egltP 
can leave the ER or not cannot be definitively answered from these data, 
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since it cannot be completely ruled out that the egltP mutant is exported 
from the ER, yet the N-glycan at Asn133 is not accessible to Golgi 
enzymes for sterical reasons. However, given that the hEAAT2 transporter 
acquires complex-type carbohydrates at a corresponding position and that 
the egltP transporter is non-functional in Xenopus oocytes, it appears 
more likely that ER export does not take place. 
 
 
2.5  Does hEAAT2 form hetero-oligomers with hEAAT3 or ecgltP? 
 
    An interesting question concerning the oligomerization of glutamate 
transporters is to know if they are able to form hetero-oligomers by 
co-assembly with other members of the family. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 28: Co-expression of (His)6-hEAAT2 and (His)6-ecgltP with hEAAT2 or 
hEAAT3 in Xenopus laevis oocytes. (A) His-tagged proteins were purified from 
Xenopus oocytes by Ni-NTA chromatography after a 12h [
35S]methionine pulse and were 
resolved by reducing SDS-PAGE (10% acrylamide) in parallel with [
14C]-labeled 
molecular mass markers. Oocytes were injected with a combination of two cRNAs (ratio 
1:1) as indicated. (B) Same experiment as in (A), in which some control injections were 
performed: cRNAs coding for hEAAT2 and hEAAT3 without His-tag were injected alone, 
cRNA coding for (His)6-hEAAT2 too. 
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    To explore this possibility, protein co-expression experiments were 
performed in Xenopus laevis oocytes. Two cRNAs, one coding for an 
hexahistidyl tagged protein, and another one coding for a non-tagged 
protein were mixed in a 1:1 ratio and injected into oocytes. The oocytes 
were metabolically labeled by overnight incubation with [
35S]methionine. 
If both proteins are purified through the Ni
2+-NTA column, this may signify 
that they existed as hetero-oligomers and that their interaction was strong 
enough to preserve the oligomeric nature along the purification steps. The 
results of these experiments are presented in Fig. 28. Fig. 28A shows the 
proteins isolated after co-expression of (His)6-ecgltP or (His)6-hEAAT2 with 
hEAAT3. The comparison between lane 2 and lane 3 (hEAAT3 co-injected 
with (His)6-ecgltP) reveals an additional protein band migrating at about 
60 kDa. This band might represent EAAT3. The hEAAT3 core protein has a 
calculated molecular mass of 57 kDa. The protein sequence contains four 
N-glycosylation consensus sequences at positions 
43NLST, 
85NVSG, 
178NMTE and 
195NKTK. 
43NLST is located between the transmembrane 
domains 1 and 2 at the extracellular side of the plasma membrane and 
should be glycosylated. 
85NVSG, on the other hand, is located between the 
transmembrane domains 2 and 3 in an intracellular domain, it is therefore 
unlikely to become glycosylated. The two last positions are homologues to 
the 
206NATS and 
216NETV consensus sequences in hEAAT2. It was shown in 
paragraph 2.4 that hEAAT2 is glycosylated at only one of its two 
consensus sites, probably because they are too close to each other to be 
occupied simultaneously by a bulky N-glycan. Given that the same 
phenomenon holds true with hEAAT3, it should carry 2 N-glycans and thus 
posses a calculated molecular mass of 63 kDa, assuming that the two 
N-glycans have a mass of 3 kDa each. It was further observed in 2.1.b 
that glutamate transporters migrate at 10-20% lower masses than 
calculated from their amino acid sequences. If this characteristic is also 
taken into consideration, the 60 kDa protein detected in Fig. 28A, lane 3 
can be judged to represent the core-glycosylated form of hEAAT3. III/ Results 
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    An important control in co-injection/co-purification experiments is to 
verify that the protein, which does not posses a (His)6-tag, does not bind 
non-specifically to the Ni
2+- N T A  b e a d s  w h e n  i t  is expressed alone. 
Fig.  28B shows a control experiment, in which single cRNAs coding for 
hEAAT2, hEAAT3, or (His)6-hEAAT2 were expressed in Xenopus oocytes. 
[
35S]-labeled proteins were purified by affinity chromatography with Ni
2+-
NTA agarose beads. The comparison between lanes 2 and 3 (Fig. 28B) 
leads to the conclusion that (His)6-ecgltP did not interact with hEAAT2. In 
this experiment (His)6-ecgltP seemed once again to interact with hEAAT3 
(Fig. 28B, lane 6), but the hEAAT3 band was also observed when EAAT3 
was expressed alone (Fig. 28B, lane 7), i.e. without His-tagged partner 
protein. Accordingly, the non-tagged form of hEAAT3 seemed to interact 
non-specifically with the Ni
2+-NTA beads. 
    The core-glycosylated hEAAT2 has a calculated molecular mass of 
66 kDa, which is unfortunately identical with the molecular mass of core-
glycosylated hEAAT3. Because the bands corresponding to the core-
glycosylated proteins overlap on SDS-polyacrylamide gels, it is not 
possible with the SDS-PAGE technique to determine if hEAAT2 and 
hEAAT3 interact together. 
    The conclusions of these experiments are that ecgltP neither interacts 
with hEAAT2 nor with hEAAT3. It was also not possible with these 
methods to demonstrate that hEAAT2 interacts with hEAAT3 to form 
hetero-oligomers. 
 
 
2.6  Study on the assembly motif of ecgltP using deletion mutants 
 
    In attempt to identify the motif responsible for the oligomerization of 
ecgltP, a series of deletion mutants was engineered. Incrementally larger 
pieces of the C-terminal part of the protein were removed. An additional 
construct (ecgltP
83-443) lacked the uttermost 82 N-terminal amino acids. 
Each construct was expressed by cRNA injection in oocytes, which were 
subsequently labeled with [
35S]methionine overnight. Proteins were III/ Results 
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purified by Ni
2+-affinity chromatography. The oligomeric state of each 
deletion mutant was analyzed by the blue-native PAGE technique and 
each was tested for its resistance to dissociate into lower order oligomers. 
Fig. 29 shows the proposed membrane topology of ecgltP and the position 
of the various truncations. 
  Fig. 30A represents an autoradiography of an SDS-polyacrylamide gel, 
which shows the expression level and the apparent masses of wild-type 
ecgltP and its seven mutants expressed in Xenopus oocytes. All proteins 
were expressed at a high level, and all (including the wild-type ecgltP) 
migrated much faster than expected from their calculated molecular 
masses (Fig. 30B). A faster migration was already described for the ecgltP 
wild-type in 2.1.b. The protein bands of the mutants F and G (Fig. 30A) 
were particularly broad. This anomalous migration is likely caused by the 
hydrophobic character of the proteins. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 29: Model for the membrane topology of glutamate transporters (Slotboom 
et al., 2001a) and positions of the different deletions engineered for the 
assembly study of ecgltP. Numbered rectangles indicate membrane-spanning 
segments, the reentrant loops are numbered 6a and 7a. Arrows show the position of the 
deleted fragments in ecgltP, brackets indicate the corresponding amino acids positions. 
 
 
  Deletion of up to 169 amino acid at the C-terminal side of the protein 
(mutant E: ecgltP
1-272) did not prevent the formation of a trimer (Fig. 31, 
panel C, first column). However, mutants shorter than mutant B 
(ecgltP
1-380) had a tendency to dissociate more easily into monomers 
when incubated in the presence of 0.1% SDS. Mutants F (ecgltP
1-186) and 
G (ecgltP
83-443) were not able anymore to assemble correctly (Fig. 31B). 
(1-317) 
(83-443) 
(1-186) 
(1-272) 
(1-354) 
(1-393) 
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Mutant F  (ecgltP
1-186) formed only dimers (Fig. 31B, lanes 7-9), while 
mutant G (ecgltP
83-443) existed almost entirely in the form of aggregates 
(Fig. 31B, lanes 4-6), which represent a non-organized association of 
proteins. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 30: Expression of ecgltP deletion mutants in Xenopus laevis oocytes. (A) 
His-ecgltP and many deletion mutants were expressed in Xenopus oocytes and purified 
by Ni-NTA chromatography after a 12h [
35S]methionine pulse. Proteins were resolved by 
reducing SDS-PAGE (10% acrylamide) in parallel with [
14C]-labeled molecular mass 
markers. A letter was assigned to the different mutants. The table represented in (B)  
indicates the amino acid portion contained in each mutant and the corresponding 
calculated molecular masses of the protein including the His-tag. 
 
 
    Taken together, an assembly motif in the ecgltP protein is probably 
located in the first 83 amino acids of the protein, but it seems that a 
protein domain located between amino acids 186 and 272 also plays an 
important role. 
 
 
2.7  BN-PAGE analysis of TetA(B), a tetracycline cation/proton antiporter 
 
  In an additional attempt to validate the blue-native PAGE technique as a 
convenient method for the determination of the oligomeric state of 
proteins, we expressed TetA(B) in Xenopus laevis oocytes and analyzed its 
oligomeric state by BN-PAGE. TetA(B) is a tetracycline cation/proton inner 
membrane antiporter, which mediates tetracycline resistance in Gram-
Mutant 
Amino 
acid 
position 
MW 
(kDa) 
A 1-393  46 
B 1-380  41.6 
C 1-354  39.2 
D 1-317  35.1 
E 1-272  30.3 
F 1-186  20.7 
G 83-443  43.2  Mutant  WT  A  B  C  MW  D  E  F  G 
1  2  3  4  5  6  7  8  9 
14.3 
20.1 
30 
45 
66 
97 
kDa  A B III/ Results 
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Fig. 31: Expression of ecgltP deletion mutants in Xenopus laevis oocytes and 
analysis of their oligomeric state by blue-native PAGE. His-ecgltP and the deletion 
mutants were expressed in Xenopus oocytes and purified by Ni
2+-NTA affinity 
chromatography after an overnight pulse with [
35S]methionine. Proteins were resolved by 
BN-PAGE (4-16% of acrylamide). (A, B) Examples of BN-PAGE analyses of the wild-type 
ecgltP and the ecgltP
1-393, ecgltP
83-443, ecgltP
1-186 deletion mutants. (c) Quantitative 
profiles determined by PhosphorImager analysis of the BN-polyacrylamide gels obtained 
with the indicated mutants and the wild-type ecgltP. The oligomeric structure of each 
protein was analyzed in native conditions and after denaturating with 0.1 ‰ SDS for 1h 
at 56°C. 
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negative bacteria. It has already been shown by the analysis of two-
dimensional crystals that TetA(B) displays a trimeric architecture (Yin et 
al., 2000). TetA(B) was used in our study as a positive control to confirm 
that BN-PAGE analyses and crystallography lead to the same conclusions 
concerning the oligomeric structure of membrane proteins. 
  A plasmide containing the cDNA coding for TetA(B) was kindly provided 
by Dr. Stuart B. Levy from the Center for Adaptation Genetics and Drug 
Resistance at the Tufts University School of Medicine (Boston, USA). This 
cDNA was subcloned into a pNKS vector, and a hexahistidyl tag was added 
in N-terminal of the open reading frame by site-directed mutagenesis. The 
cRNA coding for TetA(B) was then injected into Xenopus laevis oocytes, 
and proteins were purified by Ni
2+-NTA affinity chromatography. The 
autoradiographies of the SDS- and BN-polyacrylamide gels are presented 
in Fig. 32A and 32B, respectively. The SDS-PAGE analyze of TetA(B) 
(Fig.  32A) shows that the protein was well expressed by oocytes and 
migrated at its expected molecular mass of 43 kDa (Yin et al., 2000).  
    The BN-PAGE analysis revealed that TetA(B) failed to assemble into 
trimers in oocytes (Fig. 32B) or partially dissociated during the purification 
steps. In native conditions, TetA(B) run as dimers and predominantly as 
monomers (Fig. 32B, lane 2). The dimeric form was particularly resistant 
to denaturing treatment with SDS (Fig. 32B, lanes 4 and 5) and incubation 
in the presence of 1% SDS was required to produce a complete 
dissociation of the dimer into monomers (Fig. 32D, lanes 5 and 6). 
  These results suggest that either the TetA(B)-trimer is not stable enough 
to survive the experimental conditions used or that the oocytes are not 
able to fold and assembly this protein properly. Alternatively, it is also 
possible that the trimeric structure deduced from 2-D-crystals is incorrect. 
Caveats to structural prediction from 2D-crystals come from studies about 
the bacterial mechanosensitive ion channel MscL, which was first reported 
to form a hexamer (Saint et al., 1998) and later shown to be organized as  III/ Results 
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a pentamer (Chang et al., 1998). It is therefore not excluded that TetA(B) 
assembles as a dimer. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 32: Expression of (His)6-TetA(B) in Xenopus laevis oocytes and analysis of 
its oligomeric state by blue-native PAGE. His-TetA(B) was expressed in Xenopus 
oocytes and purified by Ni
2+-NTA affinity chromatography after an overnight pulse with 
[
35S]methionine (1% digitonin in homogenizing buffer). Proteins were resolved on a 
12.5% SDS-polyacrylamide gel (A) and on 4-16% BN-polyacrylamide gels (B, D). 
TetA(B) was analyzed in native conditions and after denaturation as indicated (B, D). (C) 
Quantitative profiles determined by PhosphorImager analysis of the BN-polyacrylamide 
gel represented in Fig. (B). 
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IV/ Discussion 
 
 
IV-1. Identification of proteins interacting with P2X receptors 
 
1.1  ßIII tubulin and MBP as binding partners of the rP2X2 subunit 
 
a- The rP2X2 subunit interacts directly with the cytoskeleton 
 
  Anchoring neurotransmitter receptors at appropriate locations on the cell 
surface is critical for the formation and functioning of chemical synapses. 
In the present study the direct, stable and specific interaction between 
ßIII tubulin (isoform of tubulin which is reported to be restricted to 
neuronal tissue) and the rP2X2 subunit was revealed. Tubulin exists as a 
heterodimer consisting of two tightly linked α and ß isoforms, and both 
subunits polymerize to form microtubules that provide a cytoskeletal 
network (Fig. 1). It can not be excluded that rP2X2 interacts with α 
tubulin. To verify this possibility, proteins eluted after pull-down with 
GST-rP2X2 have to be probed with a specific antibody to  α tubulin. It is 
unlikely that γ tubulin interacts with P2X2 because the two proteins are not 
located in the same region of the neuron. γ tubulin is a specialized minor 
form of tubulin and is one of the centrosome-specific proteins. 
  Many neurotransmitter receptors have been shown to interact directly or 
indirectly with tubulin. The GABAA receptor is linked to the microtubule 
network by the 13.9 kDa protein GABARAP (Wang et al., 1999), whereas 
gephyrin, a 93 kDa protein anchors the inhibitory glycine receptor at 
postsynaptic sites via binding to subsynaptic tubulin (Kirsch et al., 1991). 
On the other hand two types of glutamate receptors have been shown to 
interact directly with tubulin. van Rossum D. et al. found out that the 
NMDA receptors NR1 and NR2, which are ligand-gated ion channels, are 
able to interact directly with soluble tubulin (van Rossum et al., 1999a). 
The metabotropic glutamate receptor type 1α is also able to bind to IV/ Discussion 
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tubulin directly (Ciruela et al., 1999). The P2X2 receptors can be now 
added to this list of receptors which are in tight relationship with the 
microtubule cytoskeleton. These results suggest that interactions with the 
cytoskeleton could tether the P2X2A receptors to specific locations. 
Alternatively, the interaction with tubulin may play a role in the transport 
of the P2X2 receptors to the synapse. 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 1: Microtubule structure. (A) longitudinal view, (B) cross-section (Alberts et al., 
1994). (A,B) The right picture is a schematic representation of the microtubules and the 
left picture, a photo taken with an electronic microscope. 
 
 
  The C terminal tails of the rP2X5 and rP2X7 subunits do not interact with 
tubulin. This result underlines the fact that the different P2X receptors 
possess unique features and distinct functions. Kim and al. showed that 
the P2X7 receptor is in the center of an elaborated signalling complex (Kim 
et al., 2001). By co-immunoprecipitation followed by MALDI-TOF mass 
spectrometry the authors were able to identify 11 proteins that interact 
with the rat P2X7 receptor (Fig. 2). Among the interacting partners were 
α-actinin 4 and ß-actin. These results suggest that the P2X7 receptor is 
also anchored by the cytoskeleton at locations where it can efficiently play 
its role. Moreover, the high number of interacting partners may reflect the 
multiple roles of the P2X7 receptor in the nervous system as well as in the 
immune system. 
A 
B IV/ Discussion 
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Fig. 2: Schematic summary of P2X7 receptor signalling complex (Kim et al., 
2001). 
 
 
b- All three GST-P2X fusion proteins bind MBP 
 
    Myelin basic protein (MBP) binds to negatively charged lipids on the 
cytosolic surface of oligodendrocytes and is believed to be responsible for 
adhesion of these surfaces in the multilayered myelin sheath. In the 
present work MBP was one of the proteins purified by affinity 
chromatography with GST-P2X2, GST-P2X5 and GST-P2X7. The significance 
of this binding is difficult to interpret because myelin and/or MBP have 
functions and locations which are incompatible with those of P2X 
receptors. Recently, Boggs et al. suggested that another function of MBP 
may be to interact with the cytoskeleton (Boggs and Rangaraj, 2000). 
Indeed, this group demonstrated that MBP interacts with actin and 
induces its polymerization. It was suggested that MBP and actin are bound 
by an electrostatic interaction, positively charged residues of MBP would 
interact with negatively charged residues of actin.  
    The C-terminal tail of tubulin is known to be acidic and promotes the 
interaction with highly positively charged regions in MAPs (Microtubules 
associates proteins) (Maccioni and Cambiazo, 1995). Moreover, 
immunohistochemical colocalization studies in immature cultured IV/ Discussion 
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oligodendrocytes indicate that MBP is closely associated with microtubules 
and actin microfilaments (Wilson and Brophy, 1989). All these data 
together strongly suggest that MBP and tubulin could interact together 
through electrostatic binding. Our results did not answer the question of a 
direct binding between MBP and the different fusion proteins. 
  It is likely that MBP co-purified with tubulin bound to GST-P2X2 or with 
actin indirectly bound to GST-P2X7 (Kim et al., 2001). Almost the same 
observation was made with GAPDH (glyceraldehydes-3-phosphate de-
hydrogenase) and the mGluR 1α glutamate receptor. The mGluR 1α 
receptor interacts directly with tubulin and GAPDH was co-purified in 
pull-down experiments with the C-terminal domain of the mGluR 1α 
receptor because it was able to interact with tubulin (Ciruela et al., 1999). 
 
 
1.2  Localization of the tubulin binding motif on the rP2X2 subunit 
 
    By using GST fusion proteins that include various portions of the 
C-terminal tail of the P2X2 subunit, we were able to confine the binding 
domain of P2X2 for tubulin to a 42 amino acid long region, ranging from 
amino acid 371 to 412. 
    Interestingly, the tubulin binding sequence identified in the present 
study overlaps to a significant extent with a 69 amino acid long sequence 
(V
370-Q
438) which is lacking in a splice variant isoform (designated P2X2B) 
of the P2X2 subunit (Simon et al., 1997). In contrast to the 
nondesensitizing rP2X2A receptor, a more rapid desensitization in the 
continued presence of ATP was observed for the rP2X2B receptor. Simon et 
al. suggested that the channel formed of rP2X2B subunits is less tightly 
anchored to certain cytoskeletal or membrane proteins than P2X2A 
channels (Simon et al., 1997). This would influence conformational 
changes in the receptor. Using mutational analysis, Smith et al. identified 
amino acids within the P2X2 receptor C-terminus that regulate 
desensitization (Smith et al., 1999). They found that truncating the IV/ Discussion 
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receptor at the lysine 369 splice site dramatically increased the rate of 
desensitization. They identified two structural features, which are 
important in producing the slowly desensitizing phenotype that is 
characteristic of the P2X2A subtype. One is the presence of a hydrophobic 
amino acid at position 370 (V370) immediately adjacent to the splice site, 
and the other is the presence of several lysines within the 20 amino acid 
region that lies proximal to TM2 (Smith et al., 1999). Also in this study 
the authors considered the possibility that another associated protein is 
involved in regulating desensitizing. 
  It was observed many times that the P2X2 splice variants desensitized 
more rapidly when expressed in human kidney HEK 293 cells than in 
oocytes (Simon et al., 1997). Zhou & Hume also reported that in outside-
out membrane patches, P2X2 receptors desensitize considerably faster 
than in cell-attached patches (Zhou and Hume, 1998). This could be a 
consequence of the disruption of the cytoskeleton. When P2X1 receptors 
are stably expressed in HEK 293 cells and assayed by patch-clamp on the 
first day after passage of the culture, they are found to have whole-cell 
current kinetics which desensitize faster than those found in the native 
vas deferens tissue (Parker, 1998). By the second day after passage of 
the culture, however, the whole-cell current kinetics of the expressed 
receptors shifted, slowing in both activation and desensitization. 
Treatment of cells three days after passage with cytochalasine B or D 
caused a reversion to the rapid kinetic phenotype, implicating the actin 
cytoskeleton in the development of the native kinetic. P2X1 receptors may 
therefore require interaction with an intact actin cytoskeleton for native 
kinetics (Parker, 1998). 
    All these information together strongly suggest that the interaction 
between ßIII tubulin and P2X2 receptors may modulate the functions of 
the channel. Tubulin may protect the receptor from a rapid desensitization 
by an allosteric mechanism or by protecting the receptor against 
internalization. The faster desensitization of the P2X2B subunit may be 
attributed to the failure of this receptor to interact with tubulin due to the IV/ Discussion 
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lack of the tubulin binding domain. To test this hypothesis Dr. J. Rettinger 
performed electrophysiological studies in Xenopus oocytes of the P2X2A 
receptor in the presence of taxol as a tubulin depolymerizing agent. 
Unfortunately, he failed to show a difference in the currents of P2X2A in 
the presence or in the absence of taxol. 
 
 
 
 
 
 
371-TPKHPSSRWPVTLALVLGQIPPPPSHYSQDQPPSPPSGEGP-412 
 
 
 
 
 
 
 
Fig. 3: Binding motif of rP2X2 for ßIII tubulin. The amino acid sequence of the 
identified binding motif of P2X2 for ßIII tubulin is represented, proline residues are 
highlighted in yellow and serine residues in green. Putative PKC phosphorylation site and 
SH3 binding motif are indicated. 
 
  The tubulin binding domain identified in this study contains a total of six 
serine residues and twelve proline residues (Fig. 3). In contrast, both the 
P2X5 and P2X7 subunits do not possess domains rich in proline and serine 
residues, which may explain their inability to interact with tubulin (Fig. 4). 
  Proline residues 
372P and 
375P may be interpreted to constitute a binding 
motif for SH3 domains, at least when based on the minimal consensus 
motif, PXXP (Mayer, 2001). SH3 domains bind with moderate affinity and 
selectively to proline-rich ligands. These domains play critical roles in a 
wide variety of biological process ranging from regulation of enzymes by 
intramolecular interactions, increasing the local concentration or altering 
the subcellular localization of components of signalling pathways, and 
mediating the assembly of large multiprotein complexes (Mayer, 2001). 
SH3 domains provide the cell with an especially handy and adaptable 
means of bringing proteins together. The epithelial Na
+ channel ENaC, for 
example, is located at the apical membrane by binding to α-spectrin. The 
Putative 
protein kinase C 
phosphorylation site 
(TX(K/R)) 
Potential binding motif for 
SH3 domain 
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putative pore forming subunit of the rat ENaC (α-ENaC) binds through a 
unique proline-rich sequence located in its C-terminal region to the SH3 
domain of α-spectrin (Rotin et al., 1994). It could be speculated that P2X2A 
and ßIII tubulin interact through such an interaction. However the analyze 
of the ßIII tubulin protein sequence with the scanprosite program 
available in the Internet (http://us.expasy.org/cgi-bin/scanprosite) did not 
reveal the presence of SH3 domains in ßIII tubulin. 
  The  mGluR1α, the NR1 and NR2 glutamate receptors interact directly 
with tubulin through their C-terminal domains. The sequence alignment of 
the C-termini of these receptors with the tubulin binding motif of P2X2 did 
not show any analogy. Nevertheless microtubule-associated proteins 
(MAPs) such as MAP2, MAP4, and Tau also have a proline-rich region in 
their microtubule binding domain, which stimulate tubulin polymerization 
and stabilize microtubules inside cells (Aizawa et al., 1991). The 
proline-rich domain of P2X2 may play a role in the interaction between 
P2X2 and tubulin. 
 
 
|P2X2|    T------------------FMNKNKLYSHKKFDKVRTPKHPSSRWPVTLALVLGQIPPPP  395 
|P2X5|    Y------------------LIRKSEFYRDKKFEKVRGQKEDANVEVEANEMEQERPEDEP  401 
|P2X7|    TYASTCCRSRVYPSCKCCEPCAVNEYYYRKKCEPIVEPKPTLKYVSFVDEPHIWMVDQQL  416 
 
 
|P2X2|     SHYSQDQPPSPPSGEGPTLGEGAELPLAVQSPRPCSISALTEQVVDTLGQHMGQRPPVP  454 
|P2X5|     LERVRQDEQSQELAQSGRKQNSNCQVLLEPARFGLRENAIVNVKQSQILHPVKT       455 
|P2X7|     LGKSLQDVKGQEVPRPQTDFLELSRLSLSLHHSPPIPGQPEEMQLLQIEAVPRSRDSPD  475 
 
 
|P2X2|     EPSQQDSTSTDPKGLAQL                                           472 
|P2X7|     WCQCGNCLPSQLPENRRALEELCCRRKPGQCITTSELFSKIVLSREALQLLLLYQEPLL  534 
 
 
|P2X7|     ALEGEAINSKLRHCAYRSYATWRFVSQDMADFAILPSCCRWKIRKEFPKTQGQYSGFKY  593 
 
 
|P2X7|     PY                                                           595 
 
Fig. 4: Sequence comparison of the C-terminal part of rP2X2, rP2X5 and rP2X7. 
The amino acid sequences of the C-terminal part of rP2X2, rP2X5 and rP2X7 are 
represented. The sequence of the identified binding motif of P2X2 for ßIII tubulin is 
showed by a rectangular box. Proline residues are highlighted in yellow and serine 
residues in green. Identical amino acids are highlighted by shaded boxes. IV/ Discussion 
  - 119 -  119
  As shown in Fig.3, the binding motif of rP2X2 for ßIII tubulin contains a 
putative PKC phosphorylation site (
372TPK). The rP2X2 receptor contains 
two other potential protein kinase C sites, Thr
18 (
18TPK) located in the 
N-terminal domain, and Thr
464 (
464TDPK) located in the C-terminal 
domain. Boué-Grabot et al. showed that the Thr
18 is the only protein 
kinase C site, which is phosphorylated in Xenopus oocytes and that a 
mutant (K20T) that lacks this consensus site exhibited quickly 
desensitizing properties (Boue-Grabot et al., 2000). The PKC 
phosphorylation site at the position Thr
18 is highly conserved among the 
seven P2X receptors subunits (Boue-Grabot et al., 2000), which is not the 
case for the PKC phosphorylation site at the position Thr
372 (Fig. 3). 
However, when the two threonines in the C-terminal domain (Thr
372, 
Thr
464) are lacking, the mutated P2X2 channels exhibited two phenotypes 
when expressed in oocytes. ATP responses were either slowly 
desensitizing or had a biphasic phenotype with a quickly desensitizing 
current followed by a sustained phase (Boue-Grabot et al., 2000). The 
authors suggested that the C-terminal domain plays an important role in 
the stabilization of the slowly desensitizing kinetic. Their hypothesis was 
that the C-terminus domain would promote phosphorylation of the subunit 
and/or protect phosphorylated subunits from phosphatase activity. It is 
possible that the binding between ßIII tubulin and the C-terminal of the 
P2X2 receptor depends on the presence of the threonine at the position 
372, and that ßIII tubulin plays a role of protection against phosphatase. 
  The tubulin binding domain does not contains any PKA phosphorylation 
consensus site (RXXS). 
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1.3  Co-expression of rP2X2 and ßIII tubulin in heterologous expression 
systems 
 
a- Expression in Xenopus laevis oocytes 
 
    In a second part of the study on the interaction tubulin/P2X2, both 
proteins were expressed in Xenopus laevis oocytes in attempt to 
demonstrate that this interaction occurs in other expression systems. 
Unfortunately, it was not possible to prove by Ni
2+-NTA affinity 
chromatography that ßIII tubulin and rP2X2 interact with each other in 
Xenopus oocytes. This result can be explained by the existence of 
endogenous ß tubulin in Xenopus oocytes (Bieker and Yazdani-Buicky, 
1992). Indeed, this ß tubulin isoform (accession number AAA49977) is 
∼90% homologous to the rat ßIII tubulin (see Fig.5). 
 
Fig. 5: Amino acid sequence alignment of oocyte ß tubulin and rat ßIII tubulin. 
Sequences are deduced from NCBI accession numbers AAA49977 (oocyte ß tubulin) and 
P04691 (rat ßIII tubulin). The alignment was made using the ClustalW program available 
in the Internet (http://clustalw.genome.ad.jp/). 
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    It is therefore likely that the oocyte ß tubulin compete with the 
expressed ßIII tubulin for the binding to P2X2. The presence of an excess 
of endogenous non labeled ß tubulin may be an explanation why it was 
not possible to co-purify radioactive ßIII tubulin with the co-expressed rat 
P2X2 receptor in Xenopus laevis oocytes. 
  To bypass this problem, oocytes were injected with a cRNA coding for 
the rP2X2 receptor and the whole oocyte microtubules were purified after 
polymerization with GTP and taxol (Vallee, 1986). The aim of this 
experiment was to co-purify rP2X2 with the endogenous microtubules. This 
attempt was also unsuccessfull. van Rossum et al. showed that the NR1 
and NR2 glutamate receptors bind directly to tubulin but were also not 
able to isolate these two receptors with polymerized tubulin (van Rossum 
et al., 1999b). The authors suggested that the NR1 and NR2 receptors 
preferentially interact with soluble form of tubulin rather than with 
polymerized tubulin. Interaction of the rP2X2 receptor with soluble tubulin 
may also explain the impossibility to co-purify this receptor with 
endogenous tubulin. 
 
 
b- Expression of rP2X2-GFP in COS-7 cells 
 
  To  visualize  the  subcellular localization of the P2X2 receptor in 
mammalian cells, the fusion protein  rP2X2-GFP was expressed in COS-7 
cells. 
    Other groups already expressed rP2X2-GFP in mammalian cell lines. 
Fig.  6 shows the comparison of the pattern of expression obtained in 
COS-7 cells in the present study with the pattern of expression in HEK293 
cells or in hippocampal neurons (Bobanovic et al., 2002; Khakh et al., 
2001). Khakh et al. observed that the expression of rP2X2-GFP in neurons 
resulted in green fluorescence that localized to the plasma membrane and 
the cell interior (Fig. 6C right picture). They were able to measure the 
somatic rP2X2- G F P  r e c e p t o r  p o o l  s i z e  a n d  f o u n d  t h a t  m o s t  r P 2 X 2-GFP IV/ Discussion 
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receptors are located inside the cell. They suggested that this pool may be 
a source for delivery to the plasma membrane. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 6: Subcellular distribution of P2X2-GFP constructs in different cell types. 
(A) Expression of rP2X2-GFP in COS-7 cells. The cells were observed using a fluorescence 
microscope. (B) Expression of rP2X2-GFP in HEK293 cells (Bobanovic et al., 2002). The 
cells were observed using a confocal microscope. (C) Expression of rP2X2-GFP in 
embryonic hippocampal neurons (Khakh et al., 2001). The cells were observed using a 
confocal microscope. (Left) An image through the soma of a neuron expressing P2X2-GFP 
receptors. (Right) A confocal stack of 25 optical sections of the same neuron spaced at 
0.3 µm. 
 
    In contrast Bobanovic et al. observed that rP2X2-GFP in HEK293 cells 
were uniformly distributed and predominantly at the periphery of the cell 
(Fig. 6B). Observations in neurons and in HEK293 cells therefore suggest 
that P2X2 receptors localize as well at the plasma membrane as inside the 
cell. In COS-7 cells both localizations were observed simultaneously. 
    Interestingly, Khakh et al. reported that ATP application to dendrites 
caused receptor redistribution and the formation of varicose hot spots of 
higher P2X2-GFP receptor density (Khakh et al., 2001). Activation of 
glutamate receptors also results in the formation of varicosities in 
neuronal processes (Emery and Lucas, 1995), and the glutamate receptor 
subunit, mGluR1, moves from a cytosolic pool to the plasma membrane 
A  B 
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during activity in hippocampal neurons (Shi et al., 1999). These results 
show that the mGluR1 glutamate receptor and the P2X2 receptors share 
two important features. Both directly bind to tubulin and both move in the 
cell under activation by their respective ligands. Altogether these data 
strongly suggest an important role of tubulin in the anchoring and/or the 
dynamic of the P2X2 receptors. 
 
 
IV-2. Bacterial and human glutamate transporters share a trimeric 
quaternary structure 
 
2.1  Evidences for multimeric glutamate transporters 
 
  Excitatory  amino  acid  transporters (EAATs) buffer and remove 
synaptically released L-glutamate and maintain its concentrations below 
neurotoxic levels. EAAT also mediate a thermodynamically uncoupled 
substrate-gated anion conductance that may modulate cell excitability 
(Fairman et al., 1995). 
    The quaternary structure of two distantly related sodium-coupled 
glutamate transporters, the bacterial ecgltP and the human EAAT2 was 
investigated in the present study. Prokaryotic and eukaryotic glutamate 
transporters both exhibit a single oligomeric state formed by the assembly 
of three subunits. BN-PAGE analysis as well as chemical cross-linking 
demonstrated that both glutamate transporters exist in Xenopus oocytes 
primarily as multimers composed of three identical units. EcgltP purified 
as a recombinant protein from its natural host E.coli migrated also as a 
homotrimer in BN-PAGE (results obtained in our laboratory by N. Lang) 
and behaved in size exclusion chromatography as a homogenous protein 
of a single oligomeric state (experiments realized by the group of Prof. 
C. Fahlke). 
    When cRNA coding for (His)6-tagged ecgltP was injected in Xenopus 
oocytes, neither glutamate-induced inward current nor glutamate-induced IV/ Discussion 
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increase of anion currents were observed. As ecgltP is effectively 
translated in oocytes, this may either signify that the ecgltP transporter 
does not acquire a functional conformation in Xenopus oocytes or that it is 
not exported to the plasma membrane. Nevertheless the purified ecgltP 
trimer can mediate radioactive glutamate uptake after reconstitution in 
lipid vesicles and is therefore functional (experiments realized by the 
group of Prof. C.Fahlke). 
  A few years ago, the group of N.C. Danbold observed that the purified 
EAAT2 protein from fresh rat brain tissue presented different 
electrophoretic behaviors on SDS-PAGE if the protein was immediately 
resolved after solubilization or if the protein was resolved after six month 
storage at –75°C (Haugeto et al., 1996). In both cases no reducing agent 
was used for the preparation of the probes. Without storage EAAT2 
migrated as a single band corresponding to the monomeric form of the 
protein. During storage the proteins oxidized and higher molecular mass 
bands appeared on the gel. The authors suggested that during the 
oxidation monomers have been connected to each other by disulfide 
bridges and that the higher molecular mass bands corresponded to 
oligomers. They confirmed the oligomerization of EAAT2 and EAAT1 by 
performing cross-linking experiments in intact membranes purified from 
fresh rat forebrain or from transfected HeLa cells. These cross-linking 
experiments led to the conclusions that EAAT2 assembles predominantly 
as a trimer but that EAAT1 may also exist as dimers. However, as the 
authors observed in their cross-linking experiments also adducts larger 
than trimers, they were unable to come to a clear conclusion about the 
oligomeric structures of glutamate transporters. My results provide for the 
first time clear evidence that EAAT2 assembles as a trimer. Concerning 
EAAT1 or other EAAT subtypes further experiments are necessary to 
resolve the question of their stoichiometry. The SDS-induced dissociation 
of the EAAT2 trimers into monomers in the absence of reducing agents 
clearly indicates that the trimers are held together by non-covalent forces. IV/ Discussion 
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  Another study about the assembly of glutamate transporters was done 
by Eskandari et al. using the freeze-fracture electron microscopy 
technique (Eskandari et al., 2000). In this work EAAT3 was also expressed 
in Xenopus oocytes. By comparison with non-injected oocytes, the authors 
were able to identify particles which correspond to EAAT3 multimers. They 
used the principle that the cross-sectional area of freeze fracture particles 
of integral membrane proteins is proportional to the number of 
membrane-spanning  α-helices (1.4 nm
2/α-helix). By microscopical 
analysis, an area was determined which corresponded to a complex 
containing 35 ± 3 transmembrane α-helices. The membrane topology of 
glutamate transporters is not completely elucidated so far. The presence 
of 6 transmembrane α-helix in the N-terminal part of the protein is clearly 
indicated by hydropathy plots, but the topology of the C-terminal part of 
the protein is still debated (Danbolt, 2001). Nevertheless many studies 
investigating the extracellular accessibility of substituted cysteines 
suggested that the C-terminal domain is composed of two additional 
transmembrane  α-helices and two reentrant loop domains which could 
form a pore in the lipid bilayer (Grunewald and Kanner, 2000; Seal et al., 
2000; Slotboom et al., 2001b). Eskandari et al. deduced from their study 
that the EAAT3 glutamate transporter assembles as a pentamer in 
Xenopus laevis oocytes. These results are incompatible with the trimeric 
model deduced from our experiments. It is already known that the use of 
the freeze-fracture technique could be limited when the topology of the 
investigated proteins is not exactly known. Secondary structure like 
reentrant loops are also source of problems for the accuracy of the 
results. For all these reasons the results coming from the low-resolution 
freeze-fracture study of EAAT3 have to be considered with caution. 
  Recently Yernool D. et al. investigated the stoichiometry of two bacterial 
glutamate transporters, GltTBs from Bacillus caldotenax and GltTBc from 
Bacillus stearothermophilus (Yernool et al., 2003). By size exclusion 
chromatography and cross-linking experiments the authors were able to 
show that both proteins expressed in E.coli possess a trimeric IV/ Discussion 
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stoichiometry. These results agree with my own results obtained with 
ecgltP. In their cross-linking experiments Yernool D. et al observed the 
appearance of a faint high molecular weight band and suggested that this 
band may correspond to a dimer of trimers. By BN-PAGE analysis of ecgltP 
I also observed a slower migrating distinct band, most likely a ecgltP 
hexamer. In the case of EAAT2, no band with higher molecular mass than 
the trimer was detected excepted of a band corresponding to a trimer 
composed of complex-glycosylated EAAT2 subunits. For ecgltP I cannot 
entirely exclude that the hexamer represents the functional form of the 
protein. However, because of its stability, the trimer must be an essential 
element of the ecgltP architecture in vivo. 
 
 
2.2  What is the impact of the trimeric structure on the function of the 
EAAT glutamate transporters? Putative relationship between 
oligomerization and the chloride channel activity of EAAT 
transporters 
 
  For  neurotransmitter  transporters, monomeric as well as multimeric 
assemblies have been reported. The GAT/NET transporter family encodes 
carriers for neurotransmitters including GABA, dopamine, serotonin, 
norepinephrine, solutes and amino acids (Masson et al., 1999). Within this 
family separate subunit stoichiometries were observed. A prokaryotic 
GABA transporter (Li et al., 2001) and a mammalian glycine transporter 
were shown to form monomers (Horiuchi et al., 2001). There is evidence 
for the formation of tetrameric dopamine transporters (Hastrup et al., 
2003; Norgaard-Nielsen et al., 2002), and serotonin transporters were 
shown to be dimers and tetramers (Jess et al., 1996; Kilic and Rudnick, 
2000; Schmid et al., 2001). 
    In contrast to the different stoichiometry presented by the GAT/NET 
family members, the trimeric stoichiometry of glutamate transporters is 
conserved through evolution. This raise the important question concerning IV/ Discussion 
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the physiological significance of this oligomerization: does the trimeric 
structure have an importance for the transport process and/or for the 
associated ion channel activity? Results from radiation inactivation studies 
suggest that the neuronal (EAAT1-3) and the intestinal glutamate 
transporters function as oligomeric assemblies (Haugeto et al., 1996; 
Beliveau et al., 1990). However, evidence from other ion driven 
transporters indicate that assembly per se is not necessary for secondary 
active transport. Both mammalian Na
+/glucose co-transporter and E.coli 
lactose permease function as monomeric units (Eskandari et al., 1998; 
Sahin-Toth et al., 1994). 
  It has been shown that in addition to their function as secondary active 
transporters of glutamate, glutamate transporters behave as glutamate-
activated chloride channels (Fairman et al., 1995). Chloride flux through 
the channel is not thermodynamically coupled to glutamate transport 
(Masson et al., 1999; Seal and Amara, 1999). Moreover, it is possible by 
mutation and sulfhydryl modification of the glutamate transporter EAAT1 
to abolish the substrate transport, but not the substrate-gated anion 
conductance (Seal et al., 2001). Therefore, the two transporter-mediated 
activities are structurally separable. Anion conductance occurs in the 
absence of substrate transport, which imply that the pathway(s) for 
substrate and cotransported ions is to some degree structurally distinct 
from that for anions. Our data demonstrate that EAAT2 forms multimers 
in Xenopus laevis oocytes. It is possible that the trimer assembles in a 
manner that leads to the formation of a central pore constituting the ion 
conducting pathway lined by all three subunits. Many ligand-gated ion 
channels and voltage-gated cation channels form multimeric assemblies. 
The ion conduction pathway is formed by multiple subunits resulting in a 
symmetrical aqueous pore that allows coordinative binding of permeative 
anions by distinct subunits (Hille, 1992). For all these reasons it is 
tempting to speculate that the EAAT2 monomer performs secondary active 
glutamate transport, whereas the chloride channel mode seen in these 
transporters is a consequence of the oligomeric assembly. An attractive IV/ Discussion 
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hypothesis is that each of the subunits binds one sodium ion thus 
accounting for the three sodium ions binding steps involved in the 
glutamate transport cycle (Zerangue and Kavanaugh, 1996). 
    Similar to EAAT transporters, GAT/NET transporters not only exhibit a 
stoichiometric cotransport (Galli et al., 1999; Hilgemann and Lu, 1999), 
but also current components that appear to be conducted by permeation 
pathways similar to that of ion channels (Cammack and Schwartz, 1996; 
Galli et al., 1997; Lin et al., 1996; Mager et al., 1994). For rat and human 
SERT, this channel-like activity is becoming more prominent with 
increasing expression levels. This might suggest the existence of an 
endogenous regulatory protein that may interact with SERT in a variable 
stoichiometry and led to the generation of different protein complexes 
acting as channels in one stoichiometry and as carrier in another (Ramsey 
and DeFelice, 2002). Another possible explanation for this experimental 
finding is the existence of distinct oligomerization states (Ramsey and 
DeFelice, 2002), and this hypothesis could also account for the various 
experimentally determined subunit stoichiometries within the GAT/NET 
family. 
    In the case of EAAT transporters it was suggested many times  that 
putative interacting proteins could be involved in the anion channel 
activity of these transporters (Danbolt, 2001). There are, however, also 
many arguments against this hypothesis. First, EAAT glutamate 
transporters function as anion channel when expressed in different 
expression systems like oocytes, CHO cells, HEK cells, and COS cells for 
example. This would imply that these putative interacting proteins are 
expressed in all these different cell types, which is pretty unlikely. Second, 
no additional protein was co-purified by affinity chromatography in my 
own experiments after expression of hEAAT2 and ecgltP in Xenopus 
oocytes and purification by affinity chromatography. Many proteins were 
reported to interact with the C-termini of EAAT2, EAAT3 and EAAT4 (Marie 
et al., 2000; Lin et al., 2001; Jackson et al., 2001). In the case of EAAT4, 
one of the two identified proteins (GTRAP48) is a guanine nucleotide IV/ Discussion 
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exchange factor, and the other (GTRAP41) possesses 87% homology with 
β-spectrin III, an actin interacting protein (Jackson et al., 2001). The 
authors suggested that both proteins stabilize and/or anchor EAAT4 at the 
cell membrane, making it less likely to be internalized and subsequently 
degraded. This two interacting proteins do not seem to play a role in the 
modulation of the ion channel activity of the EAAT4 glutamate transporter. 
Taken together, these results indicate that one quaternary structure of 
glutamate transporters supports two distinct transport processes, 
glutamate uptake and chloride permeability. 
 
 
2.3  Study of the assembly motif of ecgltP 
 
  It is well established that the three-dimensional structure of proteins is 
far better conserved than the amino acid sequences and that protein with 
sequence identities as low as 30% have identical global structure 
(Lolkema and Slotboom, 1998; Yang and Honig, 2000). The human EAAT2 
and the ecgltP glutamate transporters share 38% sequence homology and 
22% identity. All members of the glutamate transporter family have the 
same membrane topology. Multiple sequence alignment of the 
transporters reveals sequence similarity throughout  the entire length of 
the proteins, but a stretch of about 150 residues in the C-terminal half is 
particularly well conserved (Slotboom et al., 1999). This part of the 
proteins contains several sequence motifs, which are involved in 
recognition and/or translocation of glutamate and cotransported cations 
(Slotboom et al., 2001b). Fig. 7 shows the amino acid sequence 
comparison of the intracellular C-termini of the different human EAAT 
isoforms and Fig. 8 shows the comparison of the same domains of hEAAT2 
and ecgltP. IV/ Discussion 
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EAAT1       IVLTSVGLPTDDITLIIAVDWFLDRLRTTTNVLGDSLGAGIVEHLSRHELKNRDVEMGNSVIE 
EAAT2       LILTAVGLPTEDISLLVAVDWLLDRMRTSVNVVGDSFGAGIVYHLSKSELDTIDSQHRVHEDI 
EAAT3       --------------------WLLDRFRTMVNVLGDAFGTGIVEKLSKKELEQMDVSSEVNIVN 
EAAT4       ------------------------RLRTMTNVLGDSIGAAVIEHLSQRELELQEAELTLPSLG 
EAAT5       ------------------RKDFARDTGTEKLLPCETKPVSLQEIVAAQQNGCVKSVAEASELT 
                                       *   :  ::  ..:   ::  :    .          
 
EAAT1       ENEMKKPYQLIAQDNETEKP-IDSETKM 
EAAT2       EMTKTQSIYDDMKNHRESNSNQCVYAAHNSVIVDECKVTLAANGKSADCSVEEEPWKREK 
EAAT3       PFALESTILDNEDSDTKKSYVNGGFAVDKSDTISFTQTSQF 
EAAT4       ----KPYKSLMAQEKGASRGRGGNESAM 
EAAT5       LGPTCPHHVPVQVERDEELPAASLNHCTIQISELETNV 
 
 
Fig. 7: Amino acid sequence alignment of the intracellular C-termini of the five 
EAAT isoforms. Sequences are deduced from NCBI accession numbers P43003, P43004, 
P43005, P48664, O00341 for EAAT1, EAAT2, EAAT3, EAAT4 and EAAT5 respectively. The 
alignment was made using the ClustalW program available in the Internet 
(http://clustalw.genome.ad.jp/). Residues which are identical in the different subtypes 
are highlighted in gray. The 22 amino acids underlined in the EAAT2 protein sequence 
form a leucine zipper motif (see explanations in the text). 
 
 
    As that the quaternary structure of hEAAT2 and ecgltP is conserved 
through the evolution and the C-terminal part is the most similar portion 
of these proteins, the presence of a putative assembly motif was first 
considered to be located in the intracellular C-terminal part of ecgltP. In 
addition, the C-terminal domain of hEAAT2 transporter includes a “leucine 
zipper motif” at amino acid positions 452-473. Leucine zipper motifs 
consist of a periodic repetition of leucine or isoleucine residues at every 
seventh position over a distance covering eight helical turns. This motif is 
frequently found in nuclear transcription factors, and its role in promoting 
the homo- and heterodimerization of these proteins has been well 
characterized (Busch and Sassone-Corsi, 1990; Blank and Andrews, 
1997). The leucine side chains extending from one α-helix interact with 
those from a similar α-helix of a second polypeptide, facilitating 
dimerization; the structure formed by cooperation of these two regions 
forms a coiled coil. It has been recently shown by Scholze P. et al. that 
mutations within an intramembrane leucine heptad repeat disrupt 
oligomer formation of the rat GABA transporter 1 (Scholze et al., 2002). IV/ Discussion 
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A 
 
EAAT2     469-LILTAVGLPTEDISLLVAVDWLLDRMRTSVNVVGDSFGAGIVYHLSKSELDTIDSQHRVH 
ecgltP    366-ATLGSVGIPLEGLAFIAGVDRILDMARTALNVVGN---ALAVLVIAKWEHKFDRKKALAY 
                * :**:* *.::::..** :**  **::****:   *  *  ::* * .   .:  .: 
 
 
 
 
EAAT2         EDIEMTKTQSIYDDMKNHRESNSNQCVYAAHNSVIVDECKVTLAANGKSADCSVEEEPWK 
ecgltP        EREVLGKFDKTADQ-437 
              *   : * :.  *: 
 
 
EAAT2         REK-574 
 
B 
 
 
 
 
 
 
 
 
 
Fig. 8: Amino acid sequence alignment of the intracellular C-termini of the 
human EAAT2 and the E.coli ecgltP proteins (A) and positions of the different 
deletions engineered for the assembly study of ecgltP (B). (A) Sequences are 
deduced from NCBI accession numbers P43004 (hEAAT2) and P21345 (ecgltP). The 
alignment was made using the ClustalW program available in the Internet 
(http://clustalw.genome.ad.jp/). Residues which are identical in both sequences are 
highlighted in gray. The 22 amino acids underlined in the EAAT2 protein sequence form a 
leucine zipper motif (see explanations in the text). (B) Numbered rectangles indicate 
membrane-spanning segments. The two reentrant loops are numbered with 6a and 7a. 
Arrows indicate the position at which the ecgltP molecule was truncated. The numbers in 
parenthesis indicate the amino acid residues constituting the respective deletion mutants. 
 
 
    In attempt to identify a motif responsible for the oligomerization of 
ecgltP, a series of deletion mutants was engineered. Using the BN-PAGE 
technique, it was possible to show that a deletion of up to 169 amino acids 
of the C-terminal part of the protein (mutant: ecgltP
1-272) did not prevent 
the trimerization of ecgltP subunits. The involvement of a leucine zipper 
motive in the oligomerization of glutamate transporters can therefore be 
excluded. Retrospectively, this result may have been expected as the 
leucine zipper motif pattern found in the hEAAT2 subunit is neither 
conserved among other human EAAT isoforms nor present in ecgltP. 
(1-317) 
(83-441) 
(1-186) 
(1-272) 
(1-354) 
(1-393) 
(1-380) 
Ï 
393 
(ecgltP) 
Ï 
380 
(ecgltP) IV/ Discussion 
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    Two other deletion mutants: ecgltP
1-186 and ecgltP
83-443 were not able 
anymore to assemble correctly. Taken together these results suggest that 
an assembly motif in the ecgltP protein is probably located within the first 
83 amino acids of the ecgltP subunit, but it seems that a protein domain 
located between amino acids 186 and 272 also plays an important role for 
assembly. It is possible that these two parts of the protein come close to 
each other when the protein is folded into the lipid bilayer, and that the 
domain responsible for the oligomerization is formed by the spatial 
association of two distinct amino acid sequences of ecgltP. It could also be 
possible that two different domains are necessary to achieve a complete 
assembly of ecgltP through two different interfaces, like it was suggested 
for the serotonin transporter SERT (Just et al., 2004). Further 
investigations are therefore needed to complete this study. 
 
 
2.4  Perspectives 
 
  The next challenges of this exciting story would be to demonstrate that 
the functional glutamate transporters incorporated into the plasma 
membrane operated also as trimers, and to show the oligomeric 
organization of EAAT glutamate transporters in mammalian cell types and 
in native tissues. To answer the question of the stoichiometry of EAAT2 at 
the plasma membrane, experiments are in progress in our laboratory to 
radioiodinate the protein at the plasma membrane for subsequent 
visualization of its oligomeric state on BN-polyacrylamide gels. 
  After completing the experimental part of my thesis, I have evaluated 
the oligomeric state of hEAAT2 transporter stably expressed in 
tetracycline-induced HEK cells. The transporter was metabolically labeled 
with [
35S]Methionine, natively purified by nickel affinity chromatography 
and resolved by BN-PAGE. These recent experiments clearly showed that 
hEAAT2 subunits assemble efficiently into trimers also in a mammalian cell 
line. This observation strengthens the view that EAAT2 transporters are IV/ Discussion 
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trimers and that the information leading to trimer formation is inherent to 
the EAAT2 polypeptide itself and converted into structure independent of 
the expressing host cell. 
 V/ Bibliography 
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VI-1. Abbreviations 
 
AD Alzheimer’s disease 
ALS Amyotrophic lateral sclerosis 
APS Ammonium  persulfate 
BN Blue native 
BSA Bovine serum albumine 
BzATP 2’,3’-(benzoyl-4-benzoyl)-ATP 
CBP Calmoduline binding peptide 
CNS Central nervous system 
2D two-dimensional 
DDM Dodecylmaltoside 
DMA Dimethyl adipimidate•2 HCl 
DMS Dimethyl suberimidate•2 HCl 
DNA Deoxyribonucleic acid 
DTSSP 3,3’-Dithiobis(sulfosuccinimidylpropionate) 
DTT Dithiothreitol 
EAAT Excitatory amino acid transporter 
ec Escherichia coli 
ECL enhanced chemiluminescence 
EDTA Ethylene Diamine Tetraacetic Acid 
EGFP Enhanced Green Fluorescent Protein 
EndoH Endoglycosidase H 
ER Endoplasmic reticulum 
FRET Fluorescence resonance energy transfer 
GFP Green fluorescent protein 
Glu Glutamate 
GST   Glutathione S-transferase 
GTP Guanosine 5'-triphosphate 
h human 
HEK293 Human embryonic kidney cell 293 
His Histidine 
HRP Horseradish peroxydase 
5-HT Serotonin 
IP Immunoprecipitation 
IPTG Isopropyl ß-D-thiogalactopyranoside 
KB kilobases 
kDa kiloDalton 
LB Luria Bertoni 
LGICs Ligand-gated ion channels 
MALDI Matrix-assisted laser desorption ionisation 
MBP Myelin basic protein 
MW Molecular weight marker 
N Asparagine 
NTA Nitrilotriacetic acid VI/ Appendix 
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dNTPs deoxyribonucleosides triphosphate 
NTR Non translated region 
PAGE Polyacrylamide gel electrophoresis 
PC12 Pheochromocytoma cell 
PCR Polymerase chain reaction 
PDI Protein disulfide isomerase 
PKA Protein kinase A 
PKC Protein kinase C 
PNGase F  Peptide N-glycosidase F 
PVDF Polyvinylidene difluoride 
r rat 
RNA Ribonucleic acid 
rpm rounds per minutes 
S Sulfur 
SDS Sodium dodecyl sulfate 
SH Sulfhydryl 
SRP Signal-recognition particle 
TAP Tandem affinity purification 
TBST Tris-buffer Saline-Tween 
TCA Tri-Chloro-acetic acid 
TE-buffer Tris-EDTA-buffer  
TEV Tobacco etch virus 
TM Transmembrane 
TOF Time of Flight 
v volume 
w weight 
WT Wild type VI/ Appendix 
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VI-2. Constructs and primers 
 
2.1  DNA constructs 
 
Name  Contruct  Cloning  Primers 
5´BamHI  943:AAAGGATCCATGAACAAAAACAAGCTCTACAGCCATAAGAA  Rat 
P2X2Cterm 
1029 in 
PGEX 2T  3´EcoRI  944 :AAAGAATTCTTATCAAAGTTGGGCCAAACCTTTGGG 
5´BamHI 951  :AAAGGATCCATGAGGAAGAGTGAGTTTTACCGAGACAAGAAGTTT  Rat 
P2X5Cterm 
1030 in 
PGEX 2T  3´EcoRI 952  :AAAGAATTCTTACTACGTCTTCACTGGATGCAAGATCTGTGA 
5´BamHI  1037:AAAGGATCCCAGACGGACTTCTTGGAACTGTCTAGGCTC  Rat 
P2X7Cterm 
1032 in 
PGEX 2T  3´EcoRI  1068:AAAGAATTCTTATCAGTAGGGATACTTGAAGCCACTGTACTGCC 
5´Aat II 
1128:AAAAAGACGTCGAAGTAGCCACCATGAGGGAAATCGTGCACATCC
AGG 
Tubulin 
1062 in 
PNKS 4 
3´EcoRI 
1129:AAAAAGAATTCTGCTCATTATGCCTCTTCTTCTGCCTCCTCTCCGAA
ATCC 
1171:GAAGTAGCCACCATGCATCATCATCATCATCATAGGGAAATCGTGC
AC 
His-Tubulin 
1063 in 
PNKS 4 
Mutagenesis 
1172:GTGCACGATTTCCCTATGATGATGATGATGATGCATGGTGGCTACT
TC 
5´Nco I  1105:TTAAAAGCTCGCACCATGGCTGATCAGCTGACTGAA 
Calmodulin 
1052 in 
PNKS 4  3´Xba I 
1106:TTTTCTAGAGGTCTTCATTTTGCAGTCATCATCTGTACGAATTCTTC
ATAGTTG 
1143:CGAAGTAGCCACCATGCATCATCATCATCATCATGCTGATCAGCTG
ACTG  His-
Calmodulin 
1077 in 
PNKS 4 
Mutagenesis 
1144:CAGTCAGCTGATCAGCATGATGATGATGATGATGCATGGTGGCTA
CTTCG 
5´BamHI 1130:AAAGGATCCCCATCAGGTGAAGGACCAACTTTGG  GST-
P2X2
406-472 
1064 in 
PGEX 2T  3´EcoRI 944 
5´BamHI  943  GST-
P2X2
356-412 
1065 in 
PGEX 2T  3´EcoRI  1140:AAAGAATTCTTATCATGGTCCTTCACCTGATGGAGGG 
5´BamHI 1183:CATCCCTCAAGTAGATGGCCTTAGAAGCTTGCCCTTGTCTTGGG  GST-
P2X2
356-381 
1132 in 
PGEX 2T  3´EcoRI 1184:CCCAAGACAAGGGCAAGCTTCTAAGGCCATCTACTTGAGGGATG 
5´BamHI  1205:AAAGGATCCACTCCAAAGCATCCCTCAAGTAGATGGCCTG  GST-
P2X2
371-412 
1147 in 
PGEX 2T  3´EcoRI  1206:AAAGAATTCTTATCATGGTCCTTCACCTGATGGAGGGCTGGGTG 
5´BamHI 944  GST-
P2X2
371-472 
1152 in 
PGEX 2T  3´EcoRI 1205:AAAGGATCCACTCCAAAGCATCCCTCAAGTAGATGGCCTG 
5´BamHI  1205  GST-
P2X2
371-390 
1181 in 
PGEX 2T  3´EcoRI  1263:AAAGAATTCTTATCAGATCTGGCCCAAGACAAGGGCAAGGGTC 
5´BamHI 1206  GST-
P2X2
391-412 
1180 in 
PGEX 2T  3´EcoRI 1262:AAAGGATCCCCTCCCCCACCTAGTCACTACTCCCAG 
5´AatII  1166:AAAAAGACGTCGGCTTGGGGAGGATGGGGCAGGAC 
Rapsyn 
1116 in 
PNKS2  3´EcoRI 
1167:AAAAAGAATTCTGCTTATCATACAAATCCAGGCTTCATGGAGGAGC
GG 
5´AatII  
His-P2X2a 
0849 in 
PNKS2  3´EcoRI  
3´EcoRI  1260: CACTATAGAATAAAAGCTTGGACGTCTGCAGGTCGACTCTAGAGG  His-P2X1-
GFP+AatII 
1179 in 
PNKS2  3´EcoRI  1261: CCTCTAGAGTCGACCTGCAGACGTCCAAGCTTTTATTCTATAGTG 
AatII  Ligation in 1179=862 (P2X1-GFP)+AatII  His-P2X2a-
GFP 
1218 in 
PNKS2  AccI/NarI  
5´AatII  1278:GTTCATGAACAAAAACAAGCTGTACAGCCATAAGAAGTTCG  His-
P2X2a+BsrG
I 
1194 in 
PNKS2  3´EcoRI  1279:CGAACTTCTTATGGCTGTACAGCTTGTTTTTGTTCATGAAC 
5´AatII 
Digestion of 1194 with BsrGI and NdeI; Ligation with the primers 
1298-1299 
1298GTACAGCCATAAGAAGTTCGACAAGGTGGTCGACACACTTGGCCAG
CA: 
His-P2X2b 
1195 in 
PNKS2 
3´EcoRI 
1299:TATGCTGGCCAAGTGTGTCGACCACCTTGTCGAACTTCTTATGGCT 
5´AatII  1278:GTTCATGAACAAAAACAAGCTGTACAGCCATAAGAAGTTCG  His-P2X2a-
GFP+BsrGI 
1680 in 
PNKS2  3´EcoRI  1279:CGAACTTCTTATGGCTGTACAGCTTGTTTTTGTTCATGAAC 
5´AatII 1880:GCATGGACGAGCTGTATAAGTCCGGACTCAG  His-P2X2a-
GFP∆BsrGI 
1681 in 
PNKS2  3´EcoRI 1881:CTGAGTCCGGACTTATACAGCTCGTCCATGC 
5´AatII  Digestion of 1681 with BsrGI and NdeI  His-P2X2b-
GFP 
1682 in 
PNKS2  3´EcoRI  Ligation with the primers 1298-1299 
5´AatII 
1934:AAAAAAGACGTCGAAGTAGCCACCATGAATAGTTCGACAAAGATC
GCATTGG  TetA(B) 
1722 in 
PNKS4 
3’ XbaI  1935: AAAAAATCTAGATGGCTTCAAGCACTTGTCTCCTGTTTACTCCCCT 
TetA(B)-His 
1723 in 
PNKS4 
Mutagenesis 
1936:CAGGAGACAAGTGCTCACCATCACCATCACCATTGAAGCCATCTAG
ACTAG VI/ Appendix 
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TetA(B)-His 
1723 in 
PNKS4 
Mutagenesis 
1937:CTAGTCTAGATGGCTTCAATGGTGATGGTGATGGTGAGCACTTGT
CTCCTG 
 
 
2.2  Primer used for sequencing 
 
Plasmid/construct  Region  Primers 
5’ NTR  1246: GGGCTGGCAAGCCACGTTTGGTG 
pGEX-2T 
3’ NTR  1247: CCGGGAGCTGCATGTGTCAGAGG 
5’ NTR  1103: CACATACGATTTAGGTGACACTATAG 
pNKS 
3’ NTR  900: TATTCCGTTTTTGTTTTGGGAC 
1012-1032 bp  1147: CTACCTCCTTCATGGACATCC reverse primer  Tubulin in PNKS4 
(1062)  330-347 bp  1148: GGTCAGTCTGGGGCAGGC 
GFP 5’  GFP  1314: CTCGACCAGGATGGGCAC intern GFP – reverse primer 
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VII/ Summary 
 
    Reliable communication in the central nervous system requires the 
precise control of the duration and the intensity of neurotransmitter action 
at specific molecular targets. After their release at the synapse, 
neurotransmitters activate pre- and/or postsynaptic receptors. To 
terminate synaptic transmission, neurotransmitters are in turn inactivated 
by either enzymatic degradation or active uptake into neuronal and/or 
glial cells by neurotransmitter transporters. In the present study, two 
types of membrane proteins involved in transcellular signal transduction 
were investigated, the P2X receptors, which are ATP-gated ion channels 
and the glutamate transporters of the EAAT family. 
  The first part of this study is concerned with the targeting and anchoring 
of P2X receptors at specific locations. P2X receptors play a role of fast 
excitatory neurotransmission to extracellular ATP in both the peripheral 
and central nervous system. For several ligand-gated ion channel, like 
glycine receptors or nicotinic acetylcholine receptors, it is known that 
specific binding proteins exist, which are involved in receptor trafficking 
and anchoring of the receptors at appropriate sites on the synapse. Within 
the P2X family, amino acid homology is scattered over the protein 
sequence excepted of the cytoplasmic C-terminal tails, which do not share 
significant sequence similarity, indicating that they might provide peculiar 
properties to the respective receptor isoforms. Using GST fusion proteins 
containing the C terminal end of the P2X2A, P2X5 and P2X7 subunits as 
baits, ßIII tubulin was identified by MALDI-TOF mass spectrometry as a 
direct interacting partner of P2X2A. ßIII tubulin did not interact with P2X5 
nor with P2X7. The tubulin binding motif of P2X2A could be confined to a 42 
amino acid long region ranging from amino acid 371 to 412 of the 
complete P2X2A subunit. This domain, which includes a total of six serine 
residues and twelve proline residues, interestingly overlaps to a significant 
extent with a 69 amino acid long sequence, which is lacking in P2X2B, a 
splice variant of P2X2A. P2X2B receptors are known to desensitize VII/ Summary 
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significantly faster than P2X2A receptors. The interaction of the P2X2A 
receptor with ßIII tubulin may contribute to receptor desensitization as 
well as tethering of the P2X2A receptor at specialized regions of the cell. 
    I n  a  s e c o n d  p a r t  o f  t h i s  w o r k ,  the oligomeric state of two distantly 
related glutamate transporters, the human glial glutamate transporter 
hEAAT2, and the glutamate transporter ecgltP of E.coli was determined. 
Excitatory amino acid transporters (EAATs) buffer and remove synaptically 
released L-glutamate and maintain its concentration below neurotoxic 
levels. Mammalian glutamate transporter subunits are known to form 
homomultimers, but controversial numbers of subunits per transporter 
complex have been reported, ranging from 2-5. Both hEAAT2 and ecgltP 
proteins expressed at high levels in Xenopus laevis oocytes, from which 
they were purified in a [
35S]methionine-labeled  form under non-
denaturing conditions by metal affinity chromatography. Blue native PAGE 
analysis revealed that both the hEAAT2 and ecgltP transporters exist 
exclusively as homogenous populations of homotrimers in Xenopus 
oocytes. The trimeric structure was corroborated by chemical cross-
linking. Also, ecgltP purified as a recombinant protein from its natural host 
E.coli migrated as a trimeric protein on blue native PAGE gels. The 
conservation of the quaternary structure from prokaryotes to mammals 
assigns an important functional role to the trimeric structure. Glutamate 
transporters are known to exhibit a dual mode of operation by functioning 
both as glutamate Na
+/K
+/H
+ co-transporters and as anion channels. It is 
intriguing to speculate that the EAAT monomer is responsible for the 
secondary active transport of glutamate, whereas a barrel-like 
arrangement of the three subunits forms a central anion pore mediating 
anion conductivity. VIII/ Deutsche Zusammenfassung 
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VIII/ Deutsche Zusammenfassung 
 
    Zuverlässige Kommunikation in Zentralnervensystem benötigt die 
präzise Kontrolle der Dauer und der Intensität der Wirkung eines 
Neurotransmitters an seiner spezifischen molekularen Zielstruktur. Nach 
ihrer Freisetzung in den synaptischen Spalt aktivieren Neurotransmitter 
prä- und postsynaptische Rezeptoren. Um die synaptische Erregungs-
übertragung zu beenden, werden die Neurotransmitter entweder durch 
enzymatischen Abbau inaktiviert oder durch aktive Rückaufnahme in die 
präsynaptische Nervenendigung und/oder Aufnahme in Glial-Zellen aus 
dem subsynaptischen Spalt entfernt. In der vorliegenden Studie wurden 
zwei Membranprotein-Typen, die beide bei der transzellulären 
Signaltansduktion beteiligt sind, untersucht, (i) als P2X-Rezeptoren 
bezeichnete ATP-gesteuerte Ionenkanäle und (ii) Glutamattransporter aus 
der EAAT-Familie. 
  Der erste Teil dieser Studie befasst sich mit der biochemischen Suche 
nach Proteinen, die mit P2X-Rezeptoren interagieren. P2X-Rezeptoren sind 
Liganden-gesteuerte Ionenkanäle, die von extrazellulärem ATP aktiviert 
werden und die eine wichtige Rolle bei verschiedenen Prozessen spielen 
wie beispielsweise der schnellen aktivierenden synaptischen 
Erregungsübertragung zwischen Neuronen, von Neuronen auf glatte 
Muskelzellen und der Lyse Antigen-präsentierender Zellen. Die sieben 
Untereinheiten-Isoformen, die die P2X-Rezeptorfamilie begründen, teilen 
eine gemeinsame Membran-Topologie mit zwei Membran-
durchspannenden Regionen, die beide zur Ausbildung der inneren Wand 
des Kationenkanals beitragen. Zwischen den P2X-Isoformen homologe 
Bereiche erstrecken sich über die gesamten Polypeptidketten mit 
Ausnahme der cytoplasmatisch lokalisierten C-terminalen Enden, die 
praktisch keine Sequenzähnlichkeiten besitzen. Die fehlenden 
Sequenzähnlichkeit legt den Gedanken nahe, dass die cytoplasmatischen 
C-Termini den verschiedenen P2X-Rezeptoren Subtyp-spezifische 
Eigenschaften verleihen könnten. VIII/ Deutsche Zusammenfassung 
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  Für mehrere Ligand-gesteuerte Ionenkanäle wie Glycin-Rezeptoren und 
nikotinische Acetylcholin-Rezeptoren wurden spezifische Bindungsproteine 
identifiziert, die dem „intrazellulären Trafficking“ sowie der Verankerung 
an der Synapse dienen. Zu den Proteinen, die sich in postsynaptischen 
Membranverdickungen (PSD, post synaptic density) anreichern und eine 
Verbindung zum Cytoskelet herstellen, gehören Gephyrin, Rapsyn und 
GABARAP. Um zu untersuchen, ob ähnliche spezifische Bindeproteine auch 
für P2X-Rezeptoren vorkommen, wurden GST-Fusionsproteine, die die 
intrazellulären C-terminalen Domänen von P2X2-, P2X5- und P2X7-
Untereinheiten beinhalten, in E.coli exprimiert und über eine Glutathion-
Sepharose-Matrix aufgereinigt. Diese drei GST-Fusionsproteine wurden als 
Köder eingesetzt, um interagierende Proteine aus Detergenzextrakt von 
Rattengehirnen zu „fischen“ und anschließend durch SDS-PAGE und 
Coomassie-Färbung darzustellen. Auf diese Weise gefundene Proteine 
wurden weiter durch MALDI-TOF-Massenspektrometrie analysiert. Als 
Interaktionspartner der P2X2-Untereinheit wurden ßIII-Tubulin und MBP 
(Myelin Basic Protein) identifiziert. Diese Interaktionen wurden durch 
Immunoblot-Analysen bestätigt. Während MBP mit allen drei GST-
Fusionsproteinen ko-isoliert wurde, war die Interaktion von ßIII-Tubulin 
P2X2-spezifisch. Durch einen „Overlay-Assay“ konnte gezeigt werden, dass 
der cytoplasmatische C-Terminus der P2X2-Untereinheit und ßIII-Tubulin 
direkt miteinander interagieren. 
    Um das Tubulin-Bindungsmotiv auf der P2X2-Untereinheit genauer zu 
lokalisieren, wurden eine Reihe weiterer GST-P2X2-Fusionsproteine 
hergestellt, die unterschiedliche Bereiche des cytoplasmatischen Endes der 
P2X2-Untereinheit einschlossen. Durch den Bindungsassay mit 
Rattengehirnextrakt in Verbindung mit SDS-PAGE und Immunoblotting 
konnte das Tubulin-Bindungsmotif auf eine 42 Aminosäure lange Region 
der P2X2-Untereinheit eingeschränkt werden, die sich von Aminosäure 371 
bis 412 der intakten P2X2-Untereinheit erstreckt. Diese Domäne, die 
insgesamt sechs Serinreste sowie zwölf Prolinreste enthält, überlappt 
interessanterweise weitgehend mit einer 69 Aminosäuren langen Sequenz, VIII/ Deutsche Zusammenfassung 
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die der P2X2B-Untereinheit - einer Splice-Variante der P2X2-Untereinheit - 
fehlt. P2X2B-Rezeptoren sind bekannt dafür, dass sie schneller als P2X2 
Rezeptoren desensibilisieren. Die Interaktion zwischen P2X2-Rezeptoren 
und ßIII-Tubulin könnte sowohl für die Rezeptor-Desensibilisierung als 
auch für die subzelluläre Lokalisierung von P2X2-Rezeptoren von 
Bedeutung sein. 
    In einem zweiten Teil dieser Arbeit wurde die Quartärstruktur zweier 
entfernt verwandter Glutamattransporter, dem humanem 
Glutamattransporter hEAAT2 und dem E. coli-Glutamattransporter ecgltP 
bestimmt. Die Aminosäure L-Glutamat wird als wichtigster exzitatorischer 
Neurotransmitter im Zentralnervensystem angesehen und ist bei vielen 
zentralen Gehirnfunktionen wie Erkennen, Gedächtnis und Lernen 
beteiligt. In hohen Konzentrationen ist Glutamat jedoch neurotoxisch. 
Plasmamembranständige Transporter für exzitatorische Aminosäuren 
(EAATs, excitatory amino acid transporters) puffern die subsynaptische 
Glutamatkonzentration ab und halten sie unter dem neurotoxischen 
Spiegel, indem sie L-Glutamat aus dem synaptischen Spalt wieder 
entfernen. Sowohl an der Plasmamembran als auch in Membranen 
synaptischer Vesikel ist die Neurotransmitter-Aufnahme direkt an 
transmembranäre Ionengradienten gekoppelt, die die Energie für die 
Aufnahme liefern. 
  Von Säugetier-Glutamattransporter-Untereinheiten ist bekannt, dass sie 
Homomultimere ausbilden. Die genaue Anzahl an Untereinheiten pro 
Transporter ist jedoch umstritten und schwankt zwischen zwei und fünf. In 
der vorliegenden Arbeit wurden der humane EAAT2-Transporter hEAAT2 
und der E. coli-Glutamattransporter ecgltP durch cRNA-Injektion in 
Xenopus-Oocyten exprimiert, und, nach metabolischer Markierung mit 
[
35S]Methionin, durch Ni
2+-NTA-Chromatografie unter nicht-
denaturierenden Bedingungen gereinigt. Analyse der nicht-denaturierten 
und partiell denaturierten Proteinproben durch blaue native Polyacrylamid-
Gelelektrophorese ergab, dass der hEAAT2-Transporter als homogene 
Population von Homotrimeren in Xenopus-Oozyten vorliegt. Die trimere VIII/ Deutsche Zusammenfassung 
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Struktur wurde durch chemische Vernetzung mit den beiden Cross-linkern 
DMA (Dimethyl-adipimidat) und DMS (Dimethyl-suberimidat) bestätigt.  
  Durch  Glycosidasen-Behandlung  und Expression von N-Glycan-Minus-
Mutanten konnte gezeigt werden, dass jede EAAT2-Untereinheit nur eine 
Kohlenhydrat-Seitenkette trägt, die – in zeitlichem Abstand zur Synthese - 
im homotrimeren Proteinkomplex Endoglycosidase-H-resistente Zucker 
erwirbt. Glykosylierung war allerdings weder für die Stabilität des 
Proteines noch für die Assemblierung zu Homotrimeren von Bedeutung, da 
eine nicht-glykosylierbare EAAT2-Mutante ebenfalls gut exprimiert wurde 
und effizient zu Homotrimeren assemblierte. 
  Analoge Experimente mit dem bakteriellen Glutamattransporter ergaben, 
dass ecgltP als N-Glykan-freies bakterielles Protein bemerkenswert gut in 
Xenopus-Oozyten synthetisiert wird und ebenfalls effizient zu einem 
Homotrimer assembliert. Auch für diesen (in Oocyten allerdings nicht 
funktionellen) Transporter konnte die homotrimere Struktur durch 
chemische Quervernetzung in Verbindung mit SDS-PAGE und 
Autoradiografie abgesichert werden. Zusätzlich wurde ein ecgltP-
Concatamer exprimiert, dass aus zwei hintereinandergeschalteten ecgltP-
Monomeren besteht. Die beiden Monomere waren durch eine 18 
Aminosäuren lange Linkersequenz kovalent miteinander verbunden. Die 
oligomeren Strukturen, die dieses dimere ecgltP-Concatamer eingingen, 
sind vollkommen mit der homotrimeren Struktur des Wildtyp-ecgltP-
Transporters vereinbar. Bemerkenswerter Weise wurde ein nicht 
unerheblicher Teil der concatameren Dimere zeitabhängig proteolytisch in 
Monomere gespalten. Nach der sich um 1-2 kDa unterscheidenden Masse 
der proteolytisch gebildeten Monomere zu urteilen, muss die Spaltung 
kurz vor bzw. hinter dem Linker eingetreten sein. Diese durch Proteolyse 
entstandenen Monomere assemblierten zu Homotrimeren, die sich auf den 
blauen nativen PAGE-Gelen wie Homotrimere verhielten, die aus 
exprimierten Monomeren assemblierten. Es handelt sich (neben einem 
P2X1-Concatamer) hierbei um das zweite Beispiel eines in unserer 
Arbeitsgruppe analysierten Membranprotein-Concatamers, das in Oocyten VIII/ Deutsche Zusammenfassung 
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zu Monomeren prozessiert wird. Die Expression von Concatameren ist in 
der Ionenkanalanalyse ein beliebtes Verfahren, um aus funktionellen 
Messungen Rückschlüsse über die Stöchiometrie und die Anordnung von 
Untereinheiten in multimeren Proteinkomplexen zu bestimmen. Da die 
Prozessierung von Concatameren zu kleineren Proteinen, die sich 
praktisch nicht von exprimierten Monomeren unterscheiden, offenbar kein 
Einzelfalls ist, scheinen funktionelle Daten solange fragwürdig, bis das 
Entstehen von Proteolyseprodukten durch biochemische Analysen mit 
Sicherheit ausgeshclossen ist. 
  In einer letzten Serie von Experimenten bin ich der Frage nachgegangen, 
welche Domänen bei der ecgltP-Trimerisierung beteiligt sind. Zu diesem 
Zweck habe ich verschiedene ecgltP-Deletionmutanten in Xenopus-
Oocyten exprimiert und, nach nativer Reinigung durch Ni
2+-NA-
Chromatografie, durch blaue native PAGE analysiert. Deletion von bis zu 
169 C-terminalen Aminosäuren störte die Trimerisierung nicht. 
Umfassendere Deletionen von bis zu 207 Aminosäuren verhinderte 
dagegen die Trimerisierung ebenso wie Deletion der ersten N-terminalen 
83 Aminosäuren. Diese Daten lassen den Schluss zu, dass mindestens 
eine N- und eine C-terminale Proteindomäne an der Assemblierung zu 
Trimeren beteiligt sind. 
    Die evolutionäre Konservierung der trimeren Struktur der 
Glutamattransporter von E. coli bis zum Menschen ist ein starker Hinweis 
darauf, dass der Quartärstruktur eine wichtige funktionelle Rolle 
zukommt. In diesem Zusammenhang ist interessant, dass Glutamat-
transporter sowohl als Transporter als auch als Anionenkanäle fungieren, 
indem sie neben dem an den Glutamattransport gekoppelten elektrogenen 
Ionenflux auch eine Anionen-Leitfähigkeit vermitteln, der vom 
Glutamattransport thermodynamisch abgekoppelt ist. Es ist vorgeschlagen 
worden, dass die Anionen-Leitfähigkeit der Dämpfung der neuronalen 
Erregbarkeit dient. Möglicherweise steht die Anionenkanal-Funktion in 
direkten Zusammenhang mit der trimeren Struktur, die dazu dienen 
könnte, durch ringförmige Anordnung bestimmter Transmembrandomänen VIII/ Deutsche Zusammenfassung 
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jeder der drei Untereinheiten eine Ionenkanal-ähnliche zentrale Ionenpore 
zu schaffen. IX/ References 
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